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Gametogenesis is a highly complex process that requires stringent control of 
gene expression, in which translational regulation plays an essential role. Deleted in 
Azoospermia-like (DAZL) belongs to the DAZ family of RNA-binding proteins, 
which are restricted to germ cells, and regulate mRNA translation. Importantly, loss 
of function of these proteins results in infertility in both males and females in a wide 
variety of organisms. 
A model for the mechanism by which DAZL stimulates translation has been 
proposed based on work in Xenopus laevis (X. laevis) oocytes. In this model, DAZL 
functions by recruiting the translation initiation factor poly(A)-binding protein 
(PABP) to the 3’ untranslated region (UTR) of messenger RNAs. Simultaneous 
binding of PABP to Dazl and factors at the 5’ end confers a “closed-loop” mRNA 
conformation, which promotes translation initiation. 
To examine whether DAZL plays a similar role in mammals, co-expression 
of Dazl and PABP family members was investigated in fetal and adult mouse 
gonads. In contrast to X. laevis, mammals encode four cytoplasmic PABPs which 
share a similar domain organisation: PABP1, tPABP, ePABP and PABP4, of which 
PABP1 and PABP4 appear to be expressed in a wide range of tissues. 
Immunohistochemistry revealed that Dazl, Pabp1 and Pabp4 are all expressed in 
primordial germ cells (PGCs) but these show different expression patterns following 
germ cell sex differentiation. In adult testes Dazl is expressed in spermatogonia and 
spermatocytes, coinciding with the peak of Pabp4 expression. In contrast, the peak of 
Pabp1 expression occurs later than that of Dazl, with these proteins only being co-
expressed in late pachytene and secondary spermatocyte phases. In adult ovaries, 
Pabp1, Pabp4 and Dazl are all expressed in the oocytes of primordial and primary 
follicles. Since both PABP family members are co-expressed with Dazl, the ability of 
DAZL to interact with PABP1 and PABP4 was investigated in vitro and in vivo. 
Surprisingly, these studies showed that DAZL discriminates between different PABP 
family members, only interacting with PABP1, providing the first report of a PABP-





Several putative DAZL mutations have been identified in patients with 
impaired fertility. Two of these mutations, I37A and R115G, are located in the RNA 
recognition motif (RRM), a domain which is found in many RNA-binding proteins 
and mediates both RNA and protein interactions. Thus, the role of these mutations in 
the ability of DAZL to stimulate translation was investigated. To this end, a 
translational target of human DAZL (hDAZL) was sought. The 3’UTR of growth 
differentiation factor 9 (hGDF9) mRNA was found to confer regulation by hDAZL 
and thus the ability of mutant DAZLs to stimulate reporter mRNAs containing this 
3’UTR was examined. This revealed that both mutations compromised the ability of 
hDAZL to stimulate hGDF9 translation, suggesting a causative effect. These results 
were further confirmed in assays in which hDAZL is artificially tethered to mRNAs. 
The ability of mutant hDAZLs to stimulate translation in this assay was 
compromised suggesting that loss of function is, at least in part, due to impaired 
protein-protein interactions rather than altered RNA-binding. 
 This work provides insights into the molecular mechanism by which DAZL 
stimulates the translation of specific mRNAs during mammalian gametogenesis and 
provides evidence that this function may play an important physiological role in 
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1.1 Mammalian Gametogenesis  
Gametogenesis is a complex process that results in the production of haploid 
gametes (oocytes and sperm), which transmit genetic information to the next 
generation. Oogenesis and spermatogenesis involve multiple rounds of mitosis 
followed by meiosis and maturation. These are sexually dimorphic processes 
however, with important differences in timing, gamete number and error occurrence. 
Germ cells do not develop autonomously, but work closely together with somatic 
cells, in a bidirectional program of developmental control (Murray et al., 2010). The 
regulation of this multi-step process requires stringent control of gene expression by 
a plethora of mechanisms that are only starting to be understood.  
 
1.1.1 Primordial Germ cells 
In mouse the earliest identifiable cells of the germ cell lineage occur at 6.25 
days post coitum (dpc) (Ohinata et al., 2005). At this stage a small group of six cells 
expressing the transcriptional repressor Blimp1 (McLaren and Lawson, 2005) can be 
detected in the proximal epiblast adjacent to the extraembryonic ectoderm (Lawson 
and Hage, 1994). Blimp1 has been proposed to regulate this lineage by repressing the 
expression of the somatic cell specific Hox genes (Ohinata et al., 2005, Saitou et al., 
2005, Vincent et al., 2005). By 7.5 dpc 40 migrating cells expressing Blimp1 can be 
detected. It is thought that this increase in numbers is due to a rise in cells expressing 
Blimp1 and division of some of the original Blimp1-expressing cells (McLaren and 
Lawson, 2005). At this stage these germ cell lineage restricted cells start expressing 
Stella (also known as PCG7 and Dppa3) (Saitou et al., 2002), a factor that prevents 
DNA demethylation (Nakamura et al., 2007) and are known as primordial germ cells 
(PGCs).  
During migration and following their arrival at the genital ridges, between 
10.5 and 11.5 dpc, the PGCs continue to proliferate with an estimated 4000 sexually 
indistinguishable PGCs being present by 12 dpc. By 13.5 dpc the developing gonads 
contain around 24,000 germ cells known as gonocytes since they are now committed 
to sex specific pathways (Monk and McLaren, 1981, Tam and Snow, 1981).  




1.1.2 Sex Differentiation 
Although genetic sex is determined at fertilization, differences between the 
germ cells only become evident after they reach the genital ridges (reviewed in 
(Kocer et al., 2009)). After undergoing one last common round of mitosis at 12.5 dpc 
they commit to sex-specific pathways that ultimately lead to oocyte and spermatozoa 
production. The sexual identity of germ cells is determined by a combination of sex 
chromosomes and the somatic environment surrounding the germ cells (reviewed in 
(Murray et al., 2010)). In male mice, sex differentiation of germ cells is preceded by 
the transient expression of the HMG-box transcription factor sex-determining region 
of the Y (Sry) at 10.5 dpc (Figure 1.1). Sry up-regulates the transcription factor Sox9 
inducing Sertoli cell differentiation (Sekido et al., 2004, Sekido and Lovell-Badge, 
2008) which in turn conditions germ cells to a male specific pathway. By inducing 
expression of the fibroblast growth factor 9 (Fgf9) Sox9 reinforces male 
development through a positive feedback and represses female development (Colvin 
et al., 2001). In females, absence of Sry leads to up-regulation of the signalling 
molecules Rspo1 and Wnt4, which down-regulate Sox9, leading to the germ cells 
entering meiosis at 13.5 dpc (Figure 1.1). Retinoic acid (RA) is another modulator of 
germ cell sex differentiation. Despite being present in both male and female 
urogenital region, levels of RA are considerably higher in the developing ovaries 
(Bowles et al., 2006, Koubova et al., 2006). RA promotes the expression of Stra8 in 
the mouse ovary from 12.5 dpc (Chuma and Nakatsuji, 2001), a protein essential for 
the initiation of meiosis (Anderson et al., 2008). In males high levels of the P450 
enzyme Cyp26b1, metabolises RA and inhibits male germ cells from entering 
meiosis (Bowles et al., 2006, Koubova et al., 2006, Bowles and Koopman, 2007). 
Nanos2, an RNA binding protein, is also involved in a male sexual development. 
This is specifically expressed in males, following Fgf9 expression (Tsuda et al., 
2003), and represses Stra8 expression therefore repressing entry into meiosis (Suzuki 
and Saga, 2008). There are also studies that report the existence of other meiosis 
preventing substances secreted by Sertoli cells within the testicular cords. For 
instance leukaemia inhibitory factor (LIF) expression is stronger in the embryonic 
testes than in ovaries and it was shown to prevent meiosis (Farini et al., 2005). 




Figure 1.1 - Germ cell sex determination in mice. Schematic diagram 
showing differentiation of germ cells towards a sex specific pathway in the 
developing gonads. In red, changes in gene expression that drive differentiation 
of supporting somatic cells. Blue – male specific pathway; pink – female specific 
pathway. [RA] – retinoic acid concentration; dpc – days post coitum. Adapted 
from (Lin et al., 2008) and (Kocer et al., 2009).  
 
1.1.3 Oogenesis 
1.1.3.1 Fetal development  
In the genital ridges of 13.5 dpc female mice, oogonia cluster together in 
small groups surrounded by a basement membrane referred to as “germ cell nests”. 
These proliferating oogonia are linked by extended intracellular bridges which allow 
for an exchange of molecules and may account for the developmental 
synchronization within each cluster (Pepling and Spradling, 1998). At this stage, 
oogonia initiate prophase of meiosis I (Figure 1.2) which can be subdivided into 
leptotene, zygotene and pachytene until they reach the diplotene stage where they 
arrest in a state known as the  dictyate arrest (Baillet and Mandon-Pepin, 2011) until 
puberty.  
In the developing ovaries the quiescent oocytes become associated with 
somatic cells, presumptive granulosa cells (Byskov, 1975), and depend on these for 
survival. The granulosa cells surround the oocyte and enclose themselves within a 
basement membrane, forming a primordial follicle (Hirshfield and DeSanti, 1995). 
At birth, oocytes that have not been incorporated into primordial follicles undergo 
atresia. At this point the ovary contains a finite, non-renewable and ever-diminishing 
reserve of oocytes, which becomes depleted through life (Kerr et al., 2006). 




However, this idea has been contested  (Johnson et al., 2004, Johnson et al., 2005), 
but only very recently has it become more accepted that oogonial stem cells may be 
present in postnatal ovaries both in rodents and humans (White et al., 2012). In 
particular, this report showed that the adult ovary of reproductive-age women 
possess oogonial stem cells that can be propagated and differentiated in vitro to 
generate oocytes both in vitro and in vivo. However, the predominant view is still 
that that newborn ovaries contain a finite and non-renewable pool of primordial 
follicles.  
 
Figure 1.2 - Prophase I stages. Chromosomal changes with the progression of 
meiosis. In females meiosis starts during fetal life and reaches dictyate arrest 
(arrest of prophase I). Meiosis is only resumed again after puberty. From (Baillet 
and Mandon-Pepin, 2011). 
 
The number of germ cell in females results from a number of factors, as they 
can succumb to apoptosis and die during fetal development, undergo atresia at any 
stage of the female reproductive life or, for a very small number (of the original 
millions) be recruited from the pool of primordial follicles to develop, and if acquire 
dominance be ovulated (Kerr et al., 2006). Once the ovaries become completely 
depleted of germ cells, females enter menopause which corresponds to the 
termination of ovarian function. Therefore it is important that the recruitment of 




germ cells to either undergo atresia or ovulation is tightly controlled, to ensure that a 
supply of oocytes is not exhausted prematurely leading to premature ovarian failure 
(POF) also known as premature ovarian insufficiency (POI).  
 
Figure 1.3 - Mammalian female gametogenesis. Mammalian female 
gametogenesis comprises two interlinked but distinct events, with meiotic 
events related to oogenesis and folliculogenesis related to development of the 
somatic cells that support the developing oocyte. From 
http://seem2success.com/wp-content/uploads/2012/02/oogenesis.jpg . 
 
1.1.3.2 Folliculogenesis  
Folliculogenesis describes the coordinated development between oocytes 
(oogenesis) and the surrounding somatic cells, which are important sites of 
steroidogenesis (Figure 1.3). These intrinsically linked events are dependent on 
bidirectional communication between the oocytes and the granulosa cells within the 
follicle (Eppig, 2001), e.g. removal of oocytes from follicles results in a failure of 
granulosa cells to differentiate and proliferate (Sugiura et al., 2005). Follicles also 
contain theca cells, which are recruited to the follicle later in development. Oocyte-
thecal cell communication is also important, e.g. oocyte derived growth and 




differentiation factor 9 (GDF9) appears to be required for androgen biosynthesis by 
the thecal cells (Solovyeva et al., 2000) which is in turn important for 
folliculogenesis. 
After birth a selected number of primordial follicles become committed to 
growth. Their recruitment is thought to be negatively regulated by AMH (anti-
Müllerian hormone) (Durlinger et al., 2002), since the number of follicles 
undergoing growth increases in AMH null mice. The single layer of flattened 
granulosa cells differentiates and proliferates to form primary and then secondary 
follicles surrounded by a single and then double layer of cuboidal granulosa cells. 
After this initial hormone independent growth, follicles become responsive to 
follicle-stimulating hormone (FSH) which leads to the formation of early antral 
follicles, characterised by fluid filled spaces between the proliferating granulosa cells 
(reviewed in (Adashi, 1994, Canipari, 2000). These spaces eventually get 
amalgamated into one large fluid filled antral cavity. The FSH responsive antral 
follicle becomes FSH-dependent and grows substantially due to increased 
proliferation of the follicular cells and an increased volume of follicular fluid, 
composed of water, serum proteins, steroid hormones and electrolytes. Only a very 
small number of follicles achieve dominance capacity, the ability to respond to 
luteinising hormone (LH) and ovulate, with the remaining developing follicles 
succumbing to atresia. From primordial until late antral follicles, the oocyte remains 
in dictyate arrest but grows substantially ((Hsieh et al., 2009) reviewed in (Richards 
et al., 2002)). 
 
1.1.3.3 Oocyte maturation and the completion of meiosis II 
In the pre-ovulatory follicle, the oocyte undergoes meiotic maturation and 
granulosa cells undergo important phenotypic changes that results in ovulation with 
the ruptured follicle releasing a mature oocyte which is ready to be fertilised. This 
process is triggered by an LH surge from the pituitary. It is the somatic cells which 
respond to this LH surge underlining the importance of somatic-germ cell 
communication ((Chen et al., 1990, Tirone et al., 1997) reviewed in (Conti et al., 
2011)). The resumption of meiosis occurs in response to the flow of cyclic AMP 
from the granulosa cells (Wert and Larsen, 1990) being suppressed which initiates a 




number of intracellular signalling cascades culminating in germinal vesicle 
breakdown (GVBD) and the extrusion of the first polar body followed by a 
subsequent meiosis II arrest at metaphase. Meiosis II is only completed following 
fertilisation (reviewed in (Baker and Spears, 1999, Eppig, 2001, Richards, 2005)). 
Following ovulation the follicular cells undergo further differentiation to form the 
corpus luteum (Richards, 2005).  
 
1.1.4 Spermatogenesis 
In mouse fetal testes, germ cells confined within the mesenchymal tissue stop 
mitotic proliferation and are prevented from entering meiosis. Prior to puberty a 
surge of steroids drives Sertoli cell maturation which restarts mitosis (Weinbaeur and 
Niechlag, 1993, Sharpe, 1994). In mammals, a pool of spermatogonia acts as 
precursor cells proliferating through mitotic division in a process called 
spermatocytogenesis. These spermatogonia either continue to divide to maintain this 
pool, or become spermatocytes entering meiosis I before undergoing 
spermatidogenesis in which the now haploid germ cells differentiate into round 
spermatids and then elongate to form spermatozoa (Clermont, 1972, Russel, 1993) 
(Figure 1.4). In mice, this process takes 35 days and can be divided in twelve stages 
(Russell et al., 1990), which are described in detail in the relevant result sections. In 
mice, the spermatogenic wave progresses in topographically well-coordinated 
manner. In humans this pattern is not as clear as the tubules progress with a “helical” 
organization (Johnson, 2007).  
During spermatocytogenesis, progressive rounds of cell division produce 
three distinct spermatogonial cell populations: undifferentiated, dividing and 
differentiated spermatogonia (Hermo et al., 2009). Undifferentiated spermatogonia 
are known as type A-single (As), and dividing spermatogonia as paired and aligned 
spermatogonia (Apr and Aal). These differentiate into A1-A2-A3-A4 spermatogonia, 
followed by intermediate and B-spermatogonia. B-spermatogonia undergo a last 
round of mitosis before differentiating into primary spermatocytes (Hermo et al., 
2009). Despite this being the commonly accepted pathway for the initial steps of 
spermatogenesis, there is still some debate regarding A spermatogonia 
differentiation. Specifically, whether differentiation results from a symmetrical 




division with As cell committed to renewal or differentiation, or asymmetrical with 
one daughter cell committed to renewal and the other to differentiation (Oatley and 
Brinster, 2008).  
 
 
Figure 1.4 - Mouse spermatogenesis. Schematic diagram of 
mouse spermatogenesis progression. H&E staining of mouse adult 
testis depicting different cell phases. n - chromosome number.    
 
In the final mitosis, B-spermatogonia produce two primary spermatocytes 
which enter meiosis, starting with prophase I. Prophase I accounts for 90% of the 
time spent in meiosis during spermatogenesis, and the DNA processes follows those 
outlined in figure 1.2. However in males this is only started at puberty. Briefly: 




primary spermatocytes engage in meiosis starting a prophase I, and proceed through 
leptotene, zygotene and pachytene spermatocytes, followed by diplotene (Zickler and 
Kleckner, 1999) and a meiosis I to meiosis II transition. Following meiosis I each 
primary spermatocyte has given rise to two secondary spermatocytes, containing two 
sister chromatids. These secondary spermatocytes engage in a new round of cell 
division without DNA replication, meiosis II, which is a very rapid process and 
therefore rarely observed in fixed sections. The resulting round spermatids each 
contain one set of sister chromatids. A more detailed description of meiosis is 
provided in section 1.1.5. 
In the last stage of spermatogenesis, the spermatids undergo profound 
morphological changes known as spermiogenesis. One of the most striking changes 
is the reduction in nuclear volume, facilitated by the almost complete replacement of 
histones by protamines which allow denser DNA packaging, maintaining it in a 
highly condensed transcriptionally-inactive state (Brewer et al., 1999, Braun, 2001). 
Head elongation starts at spermatid phase 9. During this process the spermatid head 
starts to form a “cap”. This structure contains important digestive enzymes that allow 
the spermatozoa to break through the zona pellucida of the ovum (Abou-Haila and 
Tulsiani, 2000). During the spermatid elongation phase, the cytoplasm is displaced 
towards the caudal end of the spermatid and eventually sloughs off as a residual body 
and is phagocytosed by the Sertoli cells and drawn down towards the basement 
membrane. During elongation a tail is also generated to allow forward propulsion of 
the sperm. Despite, being morphologically mature, these spermatozoa lack motility 
which is only acquired with passage through the efferent ducts and epididymis.  
Many of the features of spermatogenesis have been discerned by studying the 
first wave of spermatogenesis, as during this timeframe cells progress synchronously 
through the different developmental phases (Table 1.1 and Figure 1.5). However, the 
initial stages and subsequent waves differ in that differentiated spermatogonia are 
thought to arise directly from prospermatogonia rather than from undifferentiated 
spermatogonia previously derived from prospermatogonia (Yoshida et al., 2006). 
Throughout adult life a stem-cell population of mitotically dividing male germ cells 
is retained which the testis, providing continuous waves of spermatogenesis (Handel 
and Eppig, 1998, Morelli and Cohen, 2005). 






6 8 10 12 14 16 18 20 
Prespermatogonia 16 - - - - - - - 
A Spermatogonia - 17 7 7 6 9 3 4 
B spermatognia - 10 11 8 6 8 7 6 
Preletotene Spermatocytes - - 15 11 9 5 10 7 
Leptotene spermatocytes - - 15 12 13 5 5 9 
Zygotene spermatocytes - - - 23 14 7 8 8 
Pachytene spermatocytes - - - - 15 27 36 33 
Secondary spermatocytes - - - - - - 1 1 
Round spermatids - - - - - - 1 4 
Sertoli cells 84 73 52 39 37 39 29 28 
 
Table 1.1 - Temporal appearance of spermatogenic cells.  
Adapted from (Bellve et al., 1977). 
 
Figure 1.5 - First wave of mouse spermatogenesis. Schematic representation of 
male germ cell development in mouse. PGCs –primordial germ cells; PSg – 
prospermatogonia; Sg – spermatogonia; pLs –preleptotene spermatocyte; LS – 
Leptotene spermatocyte; ZS – zygotene spermatocyte; PS – pachytene 
spermatocyte; D- diplotene spermatocyte; MI-MII – meiosis 1 to meiosis 2 transition; 




1.1.5 Meiotic division 
Meiosis is a specialised mode of cell division in which a diploid precursor 
cell generates four haploid cells. Meiosis is distinct from mitosis in that cells undergo 
one round of DNA replication followed by two cell divisions known as meiosis I and 
meiosis II. In a pre-meiotic event, maternal and paternal homologous chromosomes 
replicate to produce sister chromatids (Figure 1.6). Initiation of meiosis is 
characterised by the formation of double strand breaks (DSB), marked by the 
phosphorylation of histone H2AX (γH2AX) (Mahadevaiah et al., 2001). 
Homologous recombination allows for the exchange of DNA at DSBs between sister 




chromatids (reviewed in (Marston and Amon, 2004)) which are held together by 
cohesions (Pelttari et al., 2001, Prieto et al., 2001) and the synaptonemal complex 
(SC). The axial element of the SC starts to form at leptotene (Keeney et al., 1997), 
concomitantly with homologous chromosome pairing (Schalk et al., 1998, Yang et 
al., 2008a, Yang et al., 2008b), and is mainly composed of synaptonemal complex 
protein 2 (Sycp2) and Sycp3. Whereas the transversal element of the SC, mainly 
composed by Sycp1, only starts to form at zygotene (Meuwissen et al., 1992) (Figure 
1.7).  
 
Figure 1.6 - Meiotic progression. Following replication of the homologous 
chromosomes, recombination is initiated by the formation of double strand 
breaks. Through the action of recombinases, opposite strands of homologous 
chromosomes form cross-strand exchanges known as crossing overs. The 
contact point between both chromatid strands is known as chiasmata. Following 
recombination, cells undergoes two rounds of chromosome segregation, 
resulting after meiosis I in two cells each containing 2 sister chromatids, and 
after meiosis II four daughter cells each with 1 sister chromatid (haploid). 
Adapted from (Marston and Amon, 2004) 
 
The complete attachment of the SC along the full length of the chromosome 
arms marks the start of the pachytene phase. At pachytene, γH2AX is no longer 
associated with the chromosomes suggesting that DBS have been repaired. 
Following pachytene of prophase I, through diplotene and diakinesis SC disassembly 
occurs but the crossover points, known as chiasmata, keep homologous 
chromosomes together. During prometaphase, microtubules from opposing poles of 
the cell attach the centromeres and create a tension force resisted by the chiasmata. 
This tension aligns the homologous chromosomes along the metaphase plate (Toth et 
al., 2000, Petronczki et al., 2003). Chiasmata resolution occurs by a loss of 




peripheral cohesion at the arms of sister chromatids, resulting in homologous 
chromosome segregation (Buonomo et al., 2000, Kudo et al., 2006). Following 
meiosis I, centromeric cohesion is retained (Kitajima et al., 2006), and regulates the 
alignment of sister chromatids at metaphase II. Proteolysis of the remaining cohesion 
allows progression to anaphase II (Kudo et al., 2006) and the formation of haploid 
gametes each with one sister chromatid.  
 
 
Figure 1.7 - Synaptonemal complex. Schematic representation of the 
synaptonemal complex (SC) at the pachytene phase of prophase I. SC is 
formed by three different elements, the central, transversal and axial 
elements. The SC is essential for homologous chromosome pairing and is 
present from leptotene to pachytene-diplotene phase. From (Baillet and 
Mandon-Pepin, 2011) 
 
1.2 Gene expression 
Gene expression refers to the multi-step process by which DNA is transcribed 
into RNA and then translated into protein. Control can be exerted at multiple stages 
including transcription, mRNA processing, export, translation or turnover (Figure 
1.8) (reviewed in (Orphanides and Reinberg, 2002, Villard, 2004). However, recent 
work has uncovered the importance of post-transcriptional regulatory mechanisms 
and in particular translational control in biological processes such as gametogenesis 
((Schwanhausser et al., 2011) reviewed in (Lackner and Bahler, 2008)). This may, in 
part, stem from the periods of transcriptional quiescence during spermatogenesis and 
oogenesis which mean that changes in the patterns of protein synthesis are dependent 




on the activation, repression or destruction of mRNAs transcribed at earlier stages 
(Prasad et al., 2008, Standart and Minshall, 2008).  
Figure 1.8 - Eukaryotic gene expression. Schematic representation of the 
different steps of gene expression in eukaryotic cells. Regulation can be 
transcriptional or post-transcriptional, with the latter occurring both within the 
nucleus and the cytoplasm. From (Orphanides and Reinberg, 2002). 
 
1.2.1 mRNA translation control  
During transcription and processing of pre-mRNAs in the nucleus, the mRNA 
is bound by proteins that escort it through the nuclear pores to the cytoplasm (Figure 
1.8) (Le Hir et al., 2000a, Le Hir et al., 2000b, Le Hir et al., 2001, Stewart, 2007). 
Whilst many of these factors, including the nuclear cap complex and nuclear 
poly(A)-binding protein (PABPN1), are replaced by cytoplasmic counterparts, e.g. 
eukaryotic translation initiation factor (eIF) 4F and PABP (reviewed in (Carmody 
and Wente, 2009) other nuclear proteins remain bound to mRNAs and can affect 
their utilisation (e.g. direct their localisation or efficient translation). 




Translational regulation classically refers to a change in the rate of protein 
synthesis without a corresponding change in mRNA levels (Newbury, 2006). 
However in many cases, changes in translation are accompanied by downstream 
changes in mRNA stability as these processes are intimately linked. Translational 
regulation allows for rapid, temporal and or spatial control of gene expression 
(Mignone et al., 2002), and in a few exceptional cases can also contribute to protein 
diversity (Atkins et al., 1990).  
There are two main types of quantitative translational regulation, namely 
global, which affects most cellular mRNAs, or specific, which regulates the activity 
of a single or a subset of mRNAs (Gebauer and Hentze, 2004). These processes are 
not exclusive and can occur simultaneously to promote a rapid reprogramming of 
cellular protein synthesis (Gray and Wickens, 1998, Spriggs et al., 2010). Although 
translation elongation and termination are subject to regulation, by far the majority of 
mechanisms act at the level of initiation (Gray and Wickens, 1998).  
 
1.2.2 Translation initiation 
 In eukaryotes, mRNAs leave the nucleus with a 5’ m7G cap structure and a 
tail of approximately 250 adenosines (poly(A)-tail) at the 3’end, features which are 
fundamental determinants of translation initiation. As such, the functions of the 
proteins/protein complexes which bind to them are often the targets of regulation.  
Initiation is a complex multi-step process that requires at least 12 eukaryotic 
initiation factors (eIFs), and which is not yet fully delineated. The following brief 
description reflects the current prevailing model (detailed reviews on initiation can 
be found (Sonenberg and Hinnebusch, 2009a, Jackson et al., 2010)). 
Initiation starts with the joining of the ternary complex (eIF2, GTP and Met-
tRNAi) to the 40S ribosomal subunit to form a 43S pre-initiation complex (PIC). 
This processes is mediated by a complex series of interactions between eIF1, eIF1A, 
eIF5, eIF3, eIF2 and the 40S subunit (Majumdar et al., 2003).  
The first mRNA-dependent step is binding of the cap by eIF4F also known as 
the cap-binding complex. eIF4F consists of the cytoplasmic cap-binding protein 
eIF4E, the scaffold protein eIF4G and the DEAD-box RNA helicase eIF4A. The 
interaction between eIF4G and eIF4E enhances eIF4E binding to the cap structure 




(Yanagiya et al., 2012). Most mRNAs contain some degree of secondary structure 
that needs to be removed to facilitate binding of the 43S PIC (Pestova et al., 2007a), 
a function that is mediated by the RNA helicase eIF4A, whose function is stimulated 
by eIF4F and eIF4B. eIF4F also directly aids 43S complex joining via interactions 
between eIF4G and eIF3 bound to the 43S complex (Imataka and Sonenberg, 1997, 
De Gregorio et al., 1999, Martineau et al., 2008). 43S recruitment might also be 
further promoted by interactions of eIF3 with eIF4B and PAIP-1 (Martineau et al., 
2008). These interactions recruit the 43S complex at or near to the cap, forming a 
48S complex. 
 
Figure 1.9 - Translation Initiation. Simplified diagram showing important 
steps in eukaryotic translation initiation (from Klann and Dever, 2004). 




Surprisingly, poly(A)-binding protein (PABP) which is bound to the 3’ 
poly(A)-tail, and mediates it’s function, also promotes 43S PIC joining. By 
simultaneously binding eF4G, and other eIFs, at the 5’end and the poly(A)-tail at the 
3’end, PABP effectively circularizes the mRNA bringing the mRNA ends into 
functional proximity to form a closed-loop conformation (Figure 1.23) (Kahvejian et 
al., 2001, Kahvejian et al., 2005, Pestova et al., 2007b, Brook et al., 2009, Sonenberg 
and Hinnebusch, 2009b). The role of PABPs and the closed-loop will be discussed in 
more detail later (section 1.3 and Figure 1.23).  
Once bound to the 5’end, the 43S complex starts to move through the 5’UTR 
to locate a start codon (most frequently an AUG) in a process known as scanning. 
This process is aided by eIF1 and eIF1A (Pestova et al., 1998). The start codon is 
normally, but not always, the first AUG encountered and recognition is influenced by 
the surrounding sequence or context with GCC(A/C)CCAUGG being considered 
optimal (Kozak, 1991b, Grunert and Jackson, 1994). AUG recognition is directed by 
complementarity with the Met-tRNAi anticodon and is promoted by eIF1 and eIF1A 
(Pestova and Kolupaeva, 2002, Fekete et al., 2007). Upon codon-anticodon pairing 
the PIC undergoes structural rearrangements going from an “open” scanning-
competent state to a “closed” scanning-arrested state, locking the ribosome to the 
mRNA (Maag et al., 2005, Maag et al., 2006, Cheung et al., 2007, Passmore et al., 
2007). This conformation change induces the dissociation of eIF1 which prompts 
eIF5 to hydrolyse eIF2-bound GTP which reduces the affinity of eIF2 (eIF2-GDP) 
for the Met-tRNAi (Algire et al., 2005, Nanda et al., 2009). Finally, the interaction of 
eIF5B with eIF1A triggers the dissociation of initiation factors and stimulates 60S 
ribosomal subunit joining, forming an 80S ribosome competent to begin elongation. 
Figure 1.9 represents a simplified diagram of the steps involved in translation 
initiation.  
 
1.2.3  Global translational control  
Global regulation is normally mediated by changes in the activity of the basal 
translation factors in response to intracellular or extracellular stimuli (e.g. cell stress, 
viral infection or hormone levels).  




Two well characterised mechanisms of global translation initiation regulation 
involve the initiation factors eIF2 and eIF4E. During initiation eIF2-GTP is 
hydrolysed to eIF2-GDP (Clemens, 1996) which must be recycled to eIF2-GTP by 
eIF2B for new rounds of initiation (Figure 1.10), (Clemens, 1997, Clemens and Elia, 
1997, Wek et al., 2006, Dever et al., 2007). Importantly, eIF2 is a substrate for a 
variety of cellular kinases which are activated in response to diverse conditions (e.g. 
amino acid starvation, viral infection and ER-stress), thus eIF2 phosphorylation acts 
as a point of convergence for multiple pathways to regulate protein synthesis. 
Phosphorylated eIF2-GDP interacts with eIF2B to form a stable complex that inhibits 
the dissociation of eIF2B from eIF2-GDP. This sequesters eIF2B and since this 
factor is limiting this causes a decrease in available eIF2-GTP, resulting in a global 
decrease in translation initiation (Oldfield et al., 1994, Clemens, 1996, 
Krishnamoorthy et al., 2001). Translation can be recovered by dephosphorylation of 
eIF2 (Garcia-Bonilla et al., 2007, Lee et al., 2009).  
Similarly, regulation of the cap-binding protein eIF4E (Figure 1.9) acts as a 
central control point and a major regulator of cell growth and differentiation (Morley 
1997). For instance, sequestration of eIF4E by 4E-binding proteins (4E-BP1, 2 and 
3) (Poulin et al., 1998), disrupts the formation of the eIF4F complex (Haghighat et 
al., 1995, Richter and Sonenberg, 2005) as 4E-BPs competitively bind to the same 
surface of eIF4E as eIF4G. The binding of 4E-BP and eIF4E is regulated by the 
phosphorylation status of the 4E-BP proteins, with hypophosphorylation resulting in 
down regulation of translation, whilst hyperphosphorylation inhibits 4E-BP 
interaction with eIF4E leading to increased translation (Pause et al., 1994, Gingras et 
al., 1999). 4E-BPs are a major target of mTOR (mammalian target of rapamycin 
(Gingras et al., 1998), which coordinates the responses of multiple signalling 
pathways to extra-cellular cues such as hormones, nutrient sensors, mitogens and 
growth factors (Raught and Gingras, 2007) and thus 4E-BPs play a central role in 












Figure 1.10 - Formation of active ternary complex and sequestration of 
eIF-2B acts as a central control point. Formation of active ternary complex 
requires eIF2-GTP. Following initiation, eIF2-GTP is hydrolysed to eIF2-GDP. 
which must be recycling by eIF2B for subsequent rounds of initiation. Multiple 
stimuli phosphorylate the α-subunit of eIF2, which blocks dissociation of eIF2B. 
As eIF2B is limiting its sequestration results in availbale eIF2-GTP. Adapted 
from (Holcik and Sonenberg, 2005). 
 
Interestingly, both eIF2 phosphorylation and sequestration of eIF4E by 
mRNA-specific binding proteins can also modulate specific mRNA translation, in 
some cases switching on the translation of specific mRNAs during global 
translational arrest (see section 1.2.4.1). 
 
1.2.4  Specific control of translation 
Together with global translation control cells can regulate translation of 
specific subsets of mRNA. Specific regulation is most frequently rendered by cis-
acting control elements within the 5’ and the 3’ UTRs some of which serve as 




binding sites for positive and negative trans-acting factors  (Figure 1.11) (reviewed 
in (Gray, 1998, Lackner and Bahler, 2008)). 
 
 
Figure 1.11 - Translation control elements. The m7G (m7GpppN) cap and 
poly(A) tail (An) are primary determinants of translation efficiency. Secondary 
structures (hairpin) generally impede translation and can serve as sequence-
specific binding sites for trans-acting factors, although binding sites can also be 
unstructured (green ovals). Upstream open reading frames (uORFs) and uAUG 
codons (not shown) reduce translation by competing with the main ORF for the 
translational machinery. Internal ribosome entry sequences (IRES) mediate 
initiation independently of cap function. From (Gebauer and Hentze, 2004)  
 
1.2.4.1 5’ UTR translation control elements  
Upstream open reading frames (uORFs) and upstream AUGs (uAUGs) are 5’ 
cis-acting elements that usually inhibit translation by acting as initiation sites and 
sequestering ribosomes from the main ORF. As a result uORFs that do not overlap 
with the main ORF can be less inhibitory than uAUGs as they provide the possibility 
for re-initiation, although this process is inefficient (reviewed in (Morris and Geballe, 
2000). Although most uORFs have an inhibitory effect on translation, they can also 
facilitate translation of specific mRNAs under certain circumstances. This is 
exemplified by GCN4, a yeast transcription factor, which contains multiple uORFs 
within its 5’UTR and is translated during amino acid starvation when eIF2 is 
phosphorylated. eIF2 phosphorylation retards ternary complex recycling after 
translation of the initial uORF and therefore a new ternary complex is not recruited 
in time to re-initiate at downstream uORFs but only at the main ORF (reviewed in 
(Gebauer and Hentze, 2004, Hinnebusch et al., 2007).  
Secondary structure such as stable stem-loops located within the 5’UTR are 
also inhibitory to initiation since they interfere with 43S PIC joining or ribosomal 
subunit scanning depending on their position with respect to the cap ((Kozak, 1989, 
Kozak, 1991c, Kozak, 1991a, Kozak, 1991b) reviewed in (Day and Tuite, 1998)). 




Stem-loops can also act as binding sites for mRNA-specific repressor proteins such 
as iron regulatory protein which allow for regulated steric interference with 43S PIC 
joining or scanning (Stripecke and Hentze, 1992, Gray and Hentze, 1994, 
Muckenthaler et al., 1998, Paraskeva et al., 1999).  
Counter-intuitively, hairpins can occasionally enhance translation. For 
instance, when positioned immediately downstream of a start codon they can slow 
scanning, allowing more time for AUG recognition (Kozak, 1990). Secondary 
structures can also act as internal ribosome entry sites (IRES) which allow an 
alternative form of initiation that is cap-independent and therefore does not require 
all the canonical initiation factors (reviewed in (Spriggs et al., 2008). This provides 
cells with a mechanism to translate specific mRNAs (e.g. fibroblast growth factor 2; 
(Bonnal et al., 2005) under conditions (e.g. cell stress) when the activity of key eIFs 
(e.g. eIF4E) is impaired (reviewed in (Spriggs et al., 2008)).  
 
1.2.4.2 3’ UTR–mediated translational control regulated 
changes in poly(A)-tail length  
As mentioned, the poly(A)-tail is a primary determinant of translation 
efficiency (Munroe and Jacobson, 1990, Gallie, 1991) and is progressively shortened 
until full degradation of the message is induced. However, poly(A)-tail length can be 
subject to dynamic control, with regulated deadenylation leading to translation 
silencing and/or degradation (reviewed in (Garneau et al., 2007)) and with 
cytoplasmic polyadenylation leading to translation activation (reviewed in (Richter, 
2007)). The latter is best studied in oocytes, where many maternal mRNAs are 
rapidly deadenylated upon leaving the nucleus and are stored in a translational 
silenced state until they undergo cytoplasmic polyadenylation and translation 
activation e.g. during oocyte maturation or early embryogenesis (Fox et al., 1992, 
Sheets et al., 1995, de Moor and Richter, 1999).  
The dynamic regulation of poly(A)-tail length of mRNAs in oocytes is driven 
by balancing the functions of a cytoplasmic poly(A) polymerase Gld2 and poly(A) 
ribonuclease (PARN). This requires the hexanucleotide A2UA3 which is bound by 
CPSF (Cleavage and polyadenylation specificity factor) and is also required for 




nuclear polyadenylation (Mendez and Richter, 2001). In addition other regulatory 
elements are required. The best characterised of these is the cytoplasmic 
polyadenylation element (CPE) which has the consensus sequence U5[A/U]U, and is 
bound by CPE-binding protein (CPEB) (Tay and Richter, 2001, Racki and Richter, 
2006) (Figure 1.12). CPEB is present in complexes with the scaffolding protein 
symplekin, CPSF, Gld2 but also PARN which antagonistically shortens poly(A)-
tails. Because PARN activity overrides Gdl2 this maintains the mRNA in a 
deadenylated translationally silent state (Kim and Richter, 2006). Upon oocyte 
maturation, kinase Aurora A is activated and phosphorylates CPEB which promotes 
PARN dissociation (Sarkissian et al., 2004), enabling Gld2 action to elongate the 
poly(A) tail.  
 
Figure 1.12 - Cytoplasmic polyadenylation by CPEB in X. laevis 
oocytes. CPE containing mRNAs are bound by a complex containing 
CPEB, CPSF, PARN, Gld2 and symplekin. The simultaneous activity of 
PARN and Gld2 results in controlled deadenylation. Upon oocyte 
maturation PARN dissociates due to CPEB phosphorylation, changing this 
equilibrium, resulting in polyadenylation. From (Richter, 2007) 
 
1.2.4.2.1 CPE-mediated cytoplasmic polyadenylation and 
oogenesis 
It is now clear that the translation of many oocyte mRNAs is activated in a 
strict temporal order through cytoplasmic polyadenylation. Indeed bioinformatic 
analysis suggests that more than 30% of mouse and human mRNAs involved in 
oogenesis are regulated by CPE-mediated polyadenylation alone (Pique et al., 2008, 
Brook et al., 2009). The timing and extent of polyadenylation is determined, in part, 
by the number and position of CPEs (Pique et al., 2008). 
The physiological importance of cytoplasmic polyadenylation for oocyte 
maturation was shown in seminal studies in X. laevis examining the translational 




activation of endogenous c-mos mRNA (Sheets et al., 1994). Selective removal of its 
3’UTR prevented both its cytoplasmic adenylation and oocyte maturation and could 
be rescued by injection of a “prosthetic” 3’UTR containing CPEs. c-mos mRNA in 
mouse and human oocytes is also under CPE-mediated cytoplasmic polyadenylation 
(Figure 1.13), showing the conservation of this regulation across species (Gebauer et 
al., 1994, Racki and Richter, 2006, Prasad et al., 2008).  
 
Figure 1.13 - CPEB1 regulates the translation of mRNAs at multiple stages of 
oogenesis. CPEB is required at pacyhtene for the cytoplasmic polyadenylation of 
mRNAs including Sycp1 and Sycp3. CPEB is phosphorylated by Aurora A, at 
pachytene and dephosphorylated by PP1 (protein phosphatase 1) prior to dicytate 
arrest (Tay et al., 2003). Although CPEB1 action is required to promote the 
translation of mRNAs necessary for oocyte growth and folliculogenesis e.g. Gdf9, 
its phosphorylation status at this stage is unknown. CPEB1 is once again 
phosphorylated by Aurora A in pre-ovulatory follicles and is required for oocyte 
maturation where it promotes the translation of mRNAs including c-mos (mos) and 
cyclin B1 (Gebauer et al., 1994, Tay et al., 2000, Hodgman et al., 2001). From 
(Racki and Richter, 2006) 
 
In mice, CPEB-mediated control is not only important during oocyte 
maturation (Gebauer and Richter, 1997, Gebauer and Hentze, 2001, Gebauer and 
Hentze, 2004), as both male and female knock-out mice arrest at meiotic prophase I 




(Tay and Richter, 2001). This may be due in part to reduced translation of 
synaptonemal complex proteins (Sycp) 1 and 3 (Tay and Richter, 2001, Brook et al., 
2009), which are required for the formation of the synaptonemal complex. Similarly, 
short interfering (si)RNA knockdown of Cpeb in growing dictyate oocytes revealed 
its importance for oocyte growth and folliculogenesis (Racki and Richter, 2006) as 
phenotypes including abnormal spindles, detachment from granulosa cells, increased 
granulosa cell apoptosis and oocyte atresia, precocious follicle activation, premature 
oocyte maturation and parthenogenesis were all observed. Amongst the CPEB-bound 
mRNAs identified during these stages was Gdf9, which encodes a growth factor that 
coordinates oocyte-follicle development (Matzuk et al., 2002, Racki and Richter, 
2006), whose poly(A)-tail was considerably shorter in the transgenic animals 
confirming it as a target of CPEB-mediated polyadenylation (Racki and Richter, 
2006).  
 
1.2.4.3 Poly(A)-independent stimulation of translation of 
specific mRNAs  
Not all mRNAs that are activated during oocyte maturation require changes 
in their poly(A)-tail length. One well characterised example of this is metazoan 
replication-dependent histone mRNAs which lack a poly(A) tail and end in a 
conserved stem-loop structure (Martin et al., 1997). This 3’ stem-loop is bound by 
stem-loop binding protein (SLBP) which activates translation (Ling et al., 2002, 
Cakmakci et al., 2008) by formation an alternative closed-loop that does not utilise 
PABP (Gorgoni et al., 2005). This closed-loop results from a concomitant interaction 
of the SLBP-interacting protein 1 (SLIP1) with the SLBP bound to the 3’UTR and 
eIF4G bound to the 5’end (reviewed in (Marzluff et al., 2008)).  
Although these non-adenylated histone mRNAs represent unique cellular 
mRNAs, several viruses have mRNAs that lack a poly(A) tail. For instance, 
rotaviruses have capped non-adenylated mRNAs, which contain a 3’UTR element 
that is bound by non-structural protein 3 (NSP3) (Figure 1.14.). NSP3 interacts 
directly with eIF4G conferring a poly(A)-tail and PABP independent closed-loop 
confirmation (Vende et al., 2000, Mazumder et al., 2003). However, knockdown of 




NSP3 does not abrogate viral mRNA translation, suggesting that they may also 
utilise an NSP3-independent translation mechanism (Montero et al., 2006). 
Figure 1.14 - Poly(A)-independent rotavirus translation. NSP3 binds an 
element at the 3’end and simultaneously binds the eIF4G promoting a closed 
loop conformation. From (Mazumder et al., 2003) 
 
Interestingly, translation of Dengue virus (DV) mRNA which also lack a 
poly(A)-tail still appears to require PABP, as their translation in cell-free extracts is 
sensitivity to PABP-interacting protein 2 (PAIP-2), a negative regulator that 
sequesters PABP (Polacek et al., 2009a, Polacek et al., 2009b). PABP was found to 
be recruited to these mRNAs via at least two PABP binding sequences located within 
its 3’ UTR (Figure 1.15).  
Figure 1.15 - Dengue virus mRNA translation. PABP binds specific 3’ UTR 
elements (hatched boxes) within non-adenylated DV mRNAs, likely promoting 
translation in a manner analogous to poly(A)-bound PABP. Dotted arrows 
represent predicted protein-protein interactions. From (Smith and Gray, 2010).   
 
1.2.4.4 3’UTR-mediated translational repression  
Translation can also be regulated by 3’UTR-bound repressor proteins, many 
of which function in multi-protein complexes. For example, CPE-binding protein 
(CPEB) which promotes cytoplasmic polyadenylation can also mediate translational 
repression when in an appropriate context. In X. laevis, CPEB achieves this by 




interacting with maskin, a eIF4E interacting protein that shares eIF4E-binding motifs 
with eIF4G and 4E-BPs. Analogous to 4E-BPs, the CPEB-maskin interaction inhibits 
the eIF4E-eIF4G interaction, repressing translation but only of the mRNAs to which 
they are bound via CPEB (Figure 1.16) (Stebbins-Boaz et al., 1999, Richter and 
Sonenberg, 2005). mRNA-specific translational repression by proteins that bind 
eIF4E and block its interaction with eIF4G has also been described in invertebrates, 
e.g. Drosophila Cup which interacts with 3’UTR-bound Bruno to repress oskar 
mRNA (Figure 1.17) (Nakamura et al., 2004) and in mammals e.g. CYFIP1 which 
interacts with FMRP to regulate target mRNAs (Napoli et al., 2008). Assembly of 
the eIF4F complex at the cap is a key regulatory step and can also be targeted by 
proteins that directly interact with the cap rather than with eIF4E. For instance, X. 
laevis Pumilio-2 simultaneously interacts with the m7G cap and pumilio-binding 
elements (PBEs) in the 3’UTR of RINGO mRNA, inhibiting eIF4E binding to the 
cap (Cao et al., 2010).   
 
Figure 1.16 - Maskin-mediated translation repression. During X. laevis oocyte 
development, a subset of mRNAs containing CPEs can be translationally 
repressed by CPEB-maskin complexes, which compete with eIF4G for binding of 
eIF4E. Upon maturation, Aurora kinase 1 phosphorylates CPEB dissociating 
maskin from eIF4E and facilitating CPSF binding, which in turn recruits poly(A) 
polymerase resulting in polyadenylation. PABP binds the newly synthesised 
poly(A)-tail and eIF4G, which is bound to the newly liberated eIF4E. The 
formation of the closed-loop promotes 43S complex recruitment and translation 
initiation. From (Kuersten and Goodwin, 2003) 
 





1.2.4.4.1 MicroRNA-mediated repression 
3’UTR-mediated repression can also be achieved by the binding of 
microRNAs (miRNAs) as well as protein factors to the 3’UTR. miRNAs are small 
non-coding RNA molecules of approximately 22 nucleotides which inhibit 
translation and frequently also induce mRNA degradation. Bioinformatic approaches 
estimate that up to 60% of mammalian messages may be modulated by this 
mechanism (Friedman et al., 2009) with most regulated mRNAs containing multiple 
miRNA-binding sites. 
miRNAs associate with proteins to form functional miRNA-containing RNA-
induced silencing complexes (miRISC). Many different models have been proposed 
for miRNA function, most focusing on translation initiation. These suggest that 
miRISC complexes disrupt cap binding by eIF4E (Humphreys et al., 2005, Pillai et 
al., 2005), or that TNRC6, a PABP-binding component of the RISC complex, 
disrupts PABP1-eIF4G interactions and/or induce deadenylation, since TNRC6 can 
also recruit deadenylases (this will be developed further in section 1.3.2.4) ((Walters 
et al., 2010) reviewed in (Brook and Gray, 2012)). However, it has also been 
reported that miRNAs cause ribosomal dissociation during translation elongation 
(Petersen et al., 2006).  
 
 
Figure 1.17 - Translational repression of oskar by bruno. Bruno interacts 
with specific elements in the oskar 3’UTR and with cup. By directly interacting 
with eIF4E, cup prevents eIF4G-binding. Inhibition of the eIF4E-eIF4G results 
in decreased translation. Brown curved line represents oskar mRNA. From 
(Dasgupta and Ladd, 2012).  




1.2.4.5 5’- 3’ end mediated regulation. 
As previously mentioned, the same proteins can participate in different 
regulatory events. Their function on individual mRNAs depends on the position of 
their binding site within the mRNA and/or the protein partners with which they 
collaborate. This multi-functionality allows for the co-ordinated regulation of 
mRNAs. For instance, IRP (iron regulatory protein) can block 43S complex 
recruitment (Gray and Hentze, 1994) or scanning (Paraskeva et al., 1999) depending 
on its position with the 5’UTR but can also regulate mRNA stability when bound to 
the 3’UTR. The latter is achieved by steric inhibition of an endonuclease cleavage 
site (Rouault, 2006, Wang and Pantopoulos, 2011). Thus IRP can simultaneously 
repress the translation of iron storage proteins (i.e. ferritin) and enhance the stability 
of mRNAs (e.g. transferrin receptor) that encode proteins which mediate cellular iron 
uptake (Figure 1.18). As the RNA-binding capacity of IRP is regulated by 
intracellular iron concentrations, this allows the maintenance of cellular iron 
homeostasis.  
The 5’ and 3’UTRs of the same mRNA can also be bound by the same RNA-
binding protein to achieve regulation by distinct UTR-specific molecular 
mechanisms. This has been described for the regulation of Drosophila male-specific 
lethal-2 (msl-2) which functions in X-chromosome dosage compensation in males 
(Bashaw and Baker, 1997). In females, msl-2 is not expressed due to the action of a 
female specific RNA-binding protein sex-lethal (SXL) (Kelley et al., 1997). When 
bound to the 3’UTR of msl-2 mRNA, SXL collaborates with a co-repressor UNR 
(upstream of N-ras) to inhibit 43S recruitment (Figure 1.19) (Duncan et al., 2009). 
However, SXL also binds to the 5’ UTR of msl-2, where it blocks the scanning of 
any 43S complexes that have escaped the 43S-binding block (Beckmann et al., 2005, 
Duncan et al., 2006, Duncan et al., 2009). Together these two regulatory 













Figure 1.18 - IRP function is regulated by the location of its binding sites. Iron 
regulatory proteins (IRPs), modulate cellular iron homeostasis. Ferritin mRNA 
contains IRP binding sites, known as iron responsive elements (IREs) within its 5’ 
UTR, whilst transferring receptor (TfR) mRNA contains multiple IREs within its 3’ 
UTR. Binding of IRP to these mRNAs results translational repression and protection 
from endonucleases action, respectively. From (Rouault, 2006). 
 
 




Figure 1.19 - Male specific lethal 2 mRNA (msl-2) translational repression by 
sex-lethal protein (SXL). In female Drosophila cells, SXL recruits UNR to the 3’UTR 
of msl-2 mRNA (1), which represses 43S recruitment (2). SXL also binds the 5’ UTR 




1.2.5 mRNA stability and localisation are often 
intimately linked to mRNA translation 
mRNA translation and turnover are often intimately linked. In part this results 
from the closed-loop conformation that promotes initiation also protecting the ends 
of the mRNA from deadenylases (i.e. PAN2/3, CCR4-NOT and PARN) and 
decapping (i.e. DCP1/DCP2), events which precede the degradation of the mRNA 
body (Figure 1.20). Thus translational repression frequently results in reduced 
mRNA stability as the ends become more accessible to these activities (Schwartz and 
Parker, 2000). However, their relationships are complex and extend far beyond this 
correlation. For instance, active translation can disrupt mRNP complexes that 
stabilise specific mRNAs leading to their turnover (Grosset et al., 2000) and limiting 
their lifetime. 
Translation and mRNA localisation can also be intimately linked. This allows 
for the localised synthesis of proteins that need to be spatially regulated. Thus, 
mechanisms have evolved to repress the translation of mRNAs, avoiding mis-
localised protein expression, and to activate their efficient translation when localised 
at specific sites. For instance, early embryonic development in Drosophila requires 
protein gradients of oskar (osk), gurken (grk), nanos (nos) and bicoid (bcd) for the 




formation of anterior-posterior and dorsal-ventral axes (Gavis et al., 2007). These 
mRNAs are synthesised during oogenesis and are transported to specific localisations 
within the oocyte and are only activated later in development. The localisation and 
translational repression and activation of these mRNAs are regulated by a variety of 
mRNP complexes. For instance, osk mRNA translation is repressed by Cup-Bruno 
(Figure 1.17) (Nakamura et al., 2004), with Cup also participating in its transport by 




Figure 1.20 - Deadenylation is an initial and rate limiting step in mRNA 
degradation. Following PAN2/3 (not shown), CCR4-NOT or PARN 
deadenylation, mRNAs undergo decapping and then 5’ to 3’ degradation 
promoted by Xrn1 or 3 to 5’ degradation by exosome activity. Lsm1-7 promotes 












1.3 Poly(A) binding proteins (PABPs) 
The poly(A)-tail is a primary determinant of translational efficiency and is 
bound by poly(A)-binding proteins (PABPs), which were first described in mouse L 
cells and rat hepatocytes (Blobel, 1973). Subsequent work has shown the important 
role of PABPs in driving translation initiation from yeast to mammals (reviewed in 
(Mangus et al., 2003, Gorgoni and Gray, 2004). Moreover, tethering experiments 
using unadenylated reporter mRNAs established that PABPs can functionally replace 
the poly(A)-tail, indicating that they merely serves as a scaffold for PABP-binding 
(Gray et al., 2000), although poly(A)-binding per se is thought to enhance PABP 
function in some species (Tarun and Sachs, 1996, Le et al., 1997, Wei et al., 1998). 
PABPs also have complex roles in basal and regulated mRNA turnover, which are 
outside the scope of this thesis, but are discussed briefly in section 1.3.2.4 and have 
been reviewed in detail recently (Brook and Gray, 2012). Whilst S. cerevisiae 
encodes only a single PABP (Pab-1), vertebrates encode three cytoplasmic PABPs 
(PABP1, PABP4 and ePABP) with two further homologues (tPABP and PABP5) 
being present in mammals (Figure 1.21). Most species also encode a nuclear PABP 
protein (PABPN1) which bears little sequence resemblance to cytoplasmic PABPs 
and vertebrates also possess ePABP2, which is most closely related to PABPN1 but 
appears predominantly cytoplasmic in mouse and X. laevis oocytes and in X. laevis 
early embryos (Cosson et al., 2004, Good et al., 2004). The categorisation of the 
PABP family members is based on structural similarities, sub-cellular distribution 
and function, although both cytoplasmic PABPs and nuclear PABP shuttle (Afonina 
et al., 1998, Calado et al., 2000, Burgess et al., 2011). As the function of nuclear 
PABP, and most likely ePABP2, are distinct from those of the cytoplasmic PABPs 
these proteins will not be discussed further, although a nuclear PABP homologue in 
Drosophila has been reported to modulate polyadenylation of oskar and cyclin B 
mRNAs in the cytoplasm (Benoit et al., 2005) (reviewed in (Gorgoni and Gray, 
2004).  
 




Figure 1.21 - Human cytoplasmic poly(A) binding proteins. PABP1 (also 
known as PABPC1), tPABP (PABPC2/PABPC3), PABP4 (iPABP, PABPC4) 
and ePABP (ePAB, PABP1L) share a common domain organisation with four 
non-identical RNA recognition motifs (RRMs) and a globular C-terminal domain 
(PABC), linked by an unstructured proline-rich region (P-rich). PABP5 lacks the 
proline rich-region and the PABC domain. PABP1, tPABP, PABP4 and ePABP 
have predicted molecular weights of 70 kDa and PABP5 of 43 kDa. Percentage 
identity for each functional domain is shown; PABP4-002 and ePABP 
PABPC1L-201 isoforms were used for homology comparison. Adapted from 
(Burgess and Gray, 2010). 
 
1.3.1 PABP domain organisation  
Cytoplasmic PABPs have four N-terminal non-identical RNA recognition 
motifs (RRM) and with the exception of PABP5, a globular PABC domain at the C-
terminus, connected to the RRMs by a highly variable proline-rich region (Figure 
1.21) (Blanco et al., 2001, Kuhn and Wahle, 2004). Analysis of the domains of 
PABP1 has shown that the RRMs can bind both RNA and protein, with the structure 
of RRMs 1-2 bound to poly(A) showing how the other face is available for protein-
protein interactions (Deo et al., 1999). The C-terminal region (Ct) is comprised of a 
proline-rich region and the PABC domain. The PABC domain of PABP1 mediates 
multiple protein-protein interactions including those with proteins that contain a 
PABP-interacting motif 2 (PAM2) (Kozlov et al., 2001, Roy et al., 2002, Albrecht 
and Lengauer, 2004). The proline-rich region is the least conserved between PABPs 




but contributes to the ability of PABP1 to self associate, which is important for 
ordered high affinity binding to poly(A) (Kuhn and Pieler, 1996, Melo et al., 2003).  
 
 
Figure 1.22 - PABP1 interacting proteins. The prototypical PABP, PABP1 has 
been demonstrated to have multiple protein partners. Interactions: TOB 
(Ezzeddine et al., 2007); PAN (Siddiqui et al., 2007); IMP1 (Patel and Bag, 
2006); PABP (Melo et al., 2003); eIF4G (Imataka et al., 1998); Paxillin (Woods 
et al., 2005); DAZL (Collier et al., 2005b); UNR (Chang et al., 2004); eIF4B 
(Bushell et al., 2001); eRF3 (Cosson et al., 2002a); PAIP-1 (Roy et al., 2002); 
PAIP-2 (Khaleghpour et al., 2001); GW182 (Zekri et al., 2009, Jinek et al., 
2010). Lines represent the currently defined minimal binding sites. The N-
terminal border of the eIF4B binding site remains unknown. Adapted from 




PABP1 (PABPC1, PABP, PAB), the prototypical PABP, is conserved across 
eukaryotes (Table 1.2) and is by far the best characterised family member. As a 
result it is often generically referred to as PABP, with many authors not taking 
account of additional family members that may also be present in their assays. 
PABP1 is essential in Saccharomyces cerevisiae (S. cerevisiae), Drosophila 
melanogaster (Drosophila) and in X. laevis (Sachs et al., 1987, Sigrist et al., 2000, 
Gorgoni et al., 2011). It is a multi-functional protein with roles in translation 
initiation, positive and negative translational regulation of specific mRNAs, miRNA 




mediated regulation, global and mRNA specific regulation of mRNA 
turnover/stability and nonsense-mediated decay. Consistent with this multi-













Pab-1, Pab-2 52% 
Xenopus laevis PABP1,ePABP, PABP4 93% 
Mus musculus Pabp1, tPabp, ePabp, Pabp4, Pabp5 99% 
Homo sapiens 




Table 1.2 - Cytoplasmic PABPs are conserved in eukaryotes. PABP 
proteins are conserved throughout eukaryotes. The percentage identity of 
PABP1 proteins from different species to human PABP1 (hPABP1) is given.  
 
 
1.3.2.1 PABP1 mRNA poly(A) binding activity  
PABP1 performs most of its functions bound to the poly(A)-tail, but can also 
bind to poly(U) and poly(G) substrates but to a lesser extent (Nietfeld et al., 1990, 
Gorlach et al., 1994, Kuhn and Pieler, 1996, Deardorff and Sachs, 1997, Sladic et al., 
2004). RNA-binding is conferred by the RRMs with two RRMs binding more 
efficiently than one (Burd et al., 1991, Kuhn and Pieler, 1996).  
Poly(A)-binding is achieved by RRMs 1-2 which require a minimum of 10-
12 adenosines to bind (Sachs et al., 1986, Burd et al., 1991, Kuhn and Pieler, 1996, 
Deo et al., 1999). RRMs 3-4 also have some affinity for poly(A), with mutagenesis 
experiments suggesting that these regions also contribute to poly(A) binding 
(Deardorff and Sachs, 1997). However, the specificity of RRMs 3-4 is less clear but 
it has been suggested that they may mediate binding to A-U rich sequences (Burd et 
al., 1991, Kuhn and Pieler, 1996, Sladic et al., 2004).  
PABP1 has been shown to bind poly(A) in an ordered repeated manner, with 
multiple PABP1s oligomerising along the same mRNA poly(A)-tail (Baer and 
Kornberg, 1983, Gorlach et al., 1994, Kuhn and Pieler, 1996). This is promoted by 




PABP1 ability to self-associate, and leads to cooperative high affinity binding (Kuhn 
and Pieler, 1996, Melo et al., 2003). PABP1 self-association is dependent on the 
proline rich linker region, since it has been demonstrated in vitro that the C-terminal 
region, but not PABC domain, is required for this function (Melo et al., 2003).  
PABP1 has also been shown to bind mRNAs independent of the poly(A)-tail. 
This mRNA-specific binding will be discussed in the relevant sections (see 1.2.4.3, 
1.3.2.3, 1.3.2.4)  
 
1.3.2.2 Stimulation of translation initiation by PABP1 
The best characterised function of PABP1 is its basal role in stimulating 
translation initiation when bound to the poly(A)-tail. An important insight into how 
PABP1 achieves this function came from the observation that yeast Pab-1 interacts 
with eIF4G (Tarun and Sachs, 1996). This led to a model in which the simultaneous 
interaction of eIF4G with poly(A)-bound PABP and cap-bound eIF4E brings the 
ends of mRNAs into functional proximity by inducing a closed-loop conformation 
(Figure 1.23). Such functional interactions between the cap and the poly(A) tail 
would account for their synergistic effects on translation (Gallie, 1991, Tarun and 
Sachs, 1995, Michel et al., 2000). 
In support of this hypothesis, mutations that disrupt the Pab-1-eIF4G 
interaction inhibit translation (Tarun and Sachs, 1996, Amrani et al., 2008) and 
atomic force microscopy showed that purified recombinant eIF4G, eIF4E and Pab-1 
bound to RNA can form a diamond ring like structure (Wells et al., 1998), where the 
multi-protein complex bound to the mRNA ends is the diamond and the looped out 
RNA, the ring. Subsequent work has shown that this interaction is highly conserved 
being present in plants (Le et al., 1997), vertebrates e.g. X. laevis (Gray et al., 2000) 
and mammals e.g. humans (Imataka et al., 1998).  
Although the closed-loop model is central to models of translational regulation 
by 3’UTR-binding proteins, an understanding of how PABP stimulates initiation is 
still incomplete, although analysis of initiation intermediates has shown that it 
mainly acts by enhancing small ribosomal subunit recruitment (Tarun and Sachs, 
1995).  




Insights into how the PABP1-eIF4G interaction may enhance small subunit 
joining have predominantly come from studies in cell-free translation systems from a 
variety of organisms. Studies of plant PABP showed that interaction with eIF4G, 
increased the affinity of PABP for poly(A) (Le et al., 1997) and eIF4E for the cap 
(Wei et al., 1998). Effects of mammalian PABP1 on cap binding have subsequently 
been observed (Borman et al., 2000). Recently, efficient eIF4E binding to the cap 
was shown to be dependent on eIF4G binding to RNA (Yanagiya et al., 2009), 
providing a potential explanation for how the PABP-eIF4G interaction may enhance 
cap-binding. However, a demonstration that PABP-eIF4G interactions actually 
enhance the binding of eIF4G to RNA is still required.  
 
 
Figure 1.23 - Simplified “closed-loop” model showing how PABP 
stimulates translation initiation by bringing together the 5’ and 3’UTRs. 
Interaction of PABP1 with eIF4G which also binds eIF4E brings the ends of the 
mRNA into functional proximity. Additional interactions of PABP1 with Paip1, 
and perhaps eIF4B (shown with a dotted outline), further stabilise this closed-
loop conformation, which is proposed to enhance PABP, eIF4G and eIF4E-
binding, increasing the recruitment of 43S PIC complexes (not shown). From 
(Brook et al., 2009) 
 
However, it is clear that PABP-eIF4G interactions are not able to fully account 
for the effects of PABP1 on initiation (Gray et al., 2000, Kahvejian et al., 2005) 
Indeed, multiple additional interactions, including those of PABP1 with other factors, 
appear to stabilise the closed-loop conformation (Figure 1.23, see also Figure 1.22 




for a summary of protein binding sites within PABP). For instance, PABP1 in 
vertebrates interacts with the positive effector of translation, poly(A)-interacting 
protein (PAIP) 1 (Craig et al., 1998, Gray et al., 2000), which also interacts with 
eIF4A and eIF3 (Craig et al., 1998, Martineau et al., 2008). PABP1 can also interact 
with eIF4B (Le et al., 1997, Bushell et al., 2001), although functional evidence for a 
role of this interaction has only been presented in plants. In plants, the interaction of 
PABP with eIF4B and eIF4G (both of which enhance eIF4A action), has a positive 
effect on the ATPase and RNA helicase activity of eIF4A-eIF4B-eIF4G complexes. 
eIF4A mediates the unwinding of secondary structures within the 5’UTR (Bi and 
Goss, 2000) and thus these interactions should enhance small subunit recruitment, 
similar to increased recruitment of the cap-binding complex. 
PABP1 has also been suggested to enhance steps downstream of small 
ribosomal subunit recruitment, as depleting PABP1 in Kreb-2 cell extracts decreases 
both 48S and 80S complex formation (Kahvejian et al., 2005). An involvement of 
PABP1 in 60S recruitment was also inferred from early experiments examining the 
formation of initiation complexes on polyadenylated and unadenylated mRNAs 
(Munroe and Jacobson, 1990). However, the mechanism by which PABP1 affects 
60S joining this effect remains unknown.  
Moreover, interaction of PABP1 with a translation termination factor (eRF) 3 
(Hoshino et al., 1999, Cosson et al., 2002a, Cosson et al., 2002b, Uchida et al., 
2002) has also been suggested to enhance translation by promoting efficient 
termination, allowing ribosomal subunits to be recycled for new rounds of translation 
(Uchida et al., 2002). This interaction is also important in PABPs role in nonsense-
mediated decay and may serve to link mRNA translation and deadenylation mRNA 
turnover, as discussed in section 1.2.9 (Hosoda et al., 2003, Singh et al., 2008) 
 
1.3.2.3 Role of PABP1 in mRNA-specific translational 
activation  
PABP has been implicated in the translation of unadenylated viral mRNAs 
(Figure 1.15) but also in relieving repression of a specific cellular mRNA to promote 
its translation. Y-box-binding protein 1 (YB-1) is a multi-function RNA-binding 




protein that regulates global translation but also represses its own translation by 
binding to an element within its 3’UTR (Skabkina et al., 2005). PABP also binds to 
this 3’UTR and depletion of PABP or removal of the 3’UTR sequence required to 
bind PABP ablates the repression of an YB-1 reporter. Similarly, titration of PABP 
overcomes YB-1 mediated repression (Figure 1.24). PABP1 was found to interact 
with a poly(A) stretch that overlaps the YB-1 binding site and to compete YB-1 
binding to this 3’UTR, suggesting that it relieves YB-1 repression by interfering with 
YB-1 binding (Skabkina et al., 2003, Lyabin et al., 2011). PABP also has a more 
direct role in mRNA-specific translational activation by the cellular protein DAZL 
that will be discussed in section 1.4.4.1.  
 
Figure 1.24 - YB-1 mRNA translation regulation. PABP1 and YB-1 compete for 
overlapping binding sites in the 3’UTR of YB-1 mRNA. Binding by YB-1 repress 
translation. This is blocked by binding of PABP1 allowing translation. From (Burgess 
and Gray, 2010)  
 
 
1.3.2.4 Other functions of PABP1  
As highlighted already in sections 1.2.4.3 (DV translation - Figure 1.15) and 
1.4.2.3 (YB-1 translation - Figure 1.24) PABP has mRNA specific roles in 
translation, with additional examples being discussed in sections 1.4.2.5 (auto-
regulation) and 1.4.4.1 (Dazl-mediated translation). 
As introduced in section 1.2.4.4.1, the miRISC complex also interacts with 
PABP1. The interaction between PABP1 and GW182 (TNRC6) is required for 
miRNA directed translational silencing and turnover (Figure 1.25). This interaction 
may compete with the PABP1-eIF4G interaction (see Figure 1.22 for binding site) to 
inhibit the closed loop conformation repressing translation and thereby making the 




poly(A) tail more susceptible to deadenylase action (Figure 1.20) (Zekri et al., 2009). 




Figure 1.25 - Regulation by miRNA requires PABP1. Argonaute (Ago) 
recruits GW182. GW182 interacts with PABP1 and may inhibit, by 
competitive binding, its interaction with eIF4G (4G), breaking the closed-
loop and weakening its interaction with the poly(A)-tail allowing access of 
deadenylases. The GW182-PABP1 interaction may also serve to bring 
GW182 bound-deadenylases into proximity with the poly(A) tail. From 
(Burgess and Gray, 2010)  
 
In addition to regulating translation, PABP1 has a number of additional and 
often related roles in regulating mRNA turnover and quality. Firstly, PABP1 protects 
messages from degradation: reporter mRNAs are turned over ten times faster in cell-
free extracts lacking PABP1 (Bernstein et al., 1989). This effect is due to PABP1 
precluding the access of deadenylases to the poly(A)-tail (reviewed in (Mangus et 
al., 2003)). Deadenylation is the initial and main rate limiting step in mRNA 
turnover (Figure 1.20). Moreover, PABP1 is also thought to inhibit decapping by the 
stabilising the closed-loop conformation maintaining eIF4E on the cap (Gorgoni and 
Gray, 2004, Kuhn and Wahle, 2004, Brook and Gray, 2012). 
Paradoxically PABP1 can also recruit two deadenylation complexes, Caf1-
CCR4 indirectly via TOBs (transducer of ErbB2) and PAN2-PAN3 (Funakoshi et al., 
2007, Siddiqui et al., 2007) and stimulate deadenylation (Uchida et al., 2004, 
Funakoshi et al., 2007). These opposing functions in protecting from and stimulating 
deadenylases may be coordinated by mutually exclusive interactions of the PABC 
domain with eRF3, TOB1/2 and PAN3, with eRF3 preventing interaction with the 




deadenylases until translation termination. In addition to this global role in 
controlling mRNA turnover, PABP1 also functions mRNA-specifically. For instance, 
it protects α-globin mRNA from endonucleolytic cleavage (Wang and Kiledjian, 
2000) and is part of a multi-protein complex that directs translationally coupled 
deadenylation of c-fos mRNA (Chang et al., 2004). 
Nonsense-mediated decay (NMD) induces degradation of mRNAs with 
premature termination codons (PTCs) (reviewed in (Brook and Gray, 2012). 
Selection of mRNAs for NMD is believed to be, in part, the result of competitive 
binding between PABP1 and the NMD machinery component UPF1 (up-stream 
frame shift 1) for eRF3 which distinguishes between “normal” and “premature” 
termination (Ivanov et al., 2008, Singh et al., 2008). At a natural stop codon PABP1 
interacts with eRF3 to induce efficient termination, at a PTC the absence of this 
interaction allows UPF1 to interact with eRF3 and recruit further NMD factors 
including endonucleases ((Singh et al., 2008) reviewed in (Schoenberg and Maquat, 
2012)).  
 
1.3.2.5 PABP1 Expression 
Despite the extensive work on PABP1 function, virtually nothing is known 
about its expression pattern. However, poly(A)-tails are an almost universal feature 
of eukaryotic mRNAs, Pab-1 is essential in yeast and PABP1 appears to be present in 
all characterised mammalian cell lines (Burgess et al., 2011). This led to a widely 
held belief that PABP1 is ubiquitously expressed. In keeping with this idea, PABP1 
mRNA is present but to varying extents in all mice and human tissues analysed by 
Northern blotting (Kleene et al., 1994, Yang et al., 1995, Feral et al., 2001).  
RNA analysis of enriched germ cell populations from dissociated mouse testes, 
revealed that PABP1 mRNAs was abundant in pachytene spermatocytes and round 
but not elongating spermatids (Kleene et al., 1994). RNA expression in these cell 
types was confirmed by in situ hybridisation of human testes (Feral et al., 2001). 
However, extrapolation from mRNA to protein expression is complicated by the 
tight regulation of PABP1 mRNA by at least two 5’ UTR independent mechanisms: 
via an A-rich auto-regulatory sequence (ARS) (Figure 1.26) (de Melo Neto et al., 
1995) and a terminal oligopyrimidine tract (TOP) motif (Hornstein et al., 1999). 




Consistent with this, western blotting of multiple mouse tissues revealed that PABP1 
was undetectable in a number of tissues (Hannah Burgess, personal communication.) 
which had been shown to contain significant levels of PABP1 mRNA (Yang et al., 
1995). Taken together these findings suggest that PABP1 may not be ubiquitously 




Figure 1.26 - PABP1 auto-regulation. PABP1 binds its own 5’UTR at an 
A-rich auto-regulatory sequence (ARS) as a complex with URN and IMP1. 
This inhibits PABP1 translation most likely by blocking 43S complex 
scanning. From (Burgess and Gray, 2010). 
 
 
1.3.3 Other PABP family members  
Higher eukaryotes express multiple PABP family members that share an 
identical domain structure and considerable protein sequence identity (Figure 1.21 
and Table 1.3). With the exception of PABP5, which has a variant domain structure, 
all the other PABPs have been shown to bind poly(A) (Kleene et al., 1994, Yang et 
al., 1995, Feral et al., 2001, Voeltz et al., 2001), suggesting they may share at least 
some of the functions of PABP1.  
 
 tPABP ePABP PABP4 PABP5 
PABP1 92 % 69 % 75 % 62 % 
tPABP  65 % 70 % 59 % 
ePABP   65  % 56 % 
PABP4    63 % 
Table 1.3 - Percentage identity between human PABP family 
members. PABP5 homology was analysed only against the conserved 
RRMs since this lacks the proline-rich region and the PABC domain. 
ePABP - PABPC1L-001; PABP4 – PABP4.002. 
 




In C. elegans, which encodes two PABPs, RNA interference (RNAi) of Pab-1 
and Pab-2 result in high and low penetrance sterility respectively (Maciejowski et al., 
2005). Since depletion of both Pab-1 and Pab-2 results in additional soma defects, 
this suggests that they function redundantly in soma but have a specific germline 
requirement for Pab-1 (Ciosk et al., 2004). In vertebrates morpholino knockdown in 
X. laevis embryos showed that PABP1, ePABP and PABP4 are all important for 
development, since their individual ablation resulted in lethality at different stages 
(Gorgoni et al., 2011). Cross-rescue experiments with expression constructs with 
identical 5’ and 3’UTRs to achieve identical expression showed that neither ePABP 
nor PABP4 are able to fully rescue the PABP1 phenotype revealing that they are not 
functionally equivalent (Gorgoni et al., 2011). Since this study also showed that they 
share a similar mechanistic role in promoting global translation, this suggested that 
these PABPs may have distinct functions in mRNA-specific translation or mRNA 
decay(Gorgoni et al., 2011). C-terminal domain swaps showed that some of these 
distinct functions must be mediated by protein-protein interactions (Gorgoni et al., 
2011), most likely those associated with the variable proline-rich region.  
 
1.3.3.1 Testis PABP (tPABP) 
Testis PABP (tPABP, Pabpc2 in mice and PABPc3in humans) shares a high 
degree of identity with PABP1 (92%) is intron-less and believed to have originated 
from a PABP1 retro-transposition event in mammals (Kleene et al., 1998). Its mRNA 
appears restricted to testes in mouse being present in late pachytene spermatids and 
increasing in haploid round spermatids (Kleene et al., 1994) where it is also detected 
in human testes (Feral et al., 2001). Recently, immunofluorescence using tPABP-
specific antibodies confirmed the presence of tPABP in haploid spermatids (Kimura 
et al., 2009). In keeping with this, analysis of testis extracts during the first wave of 
spermatogenesis suggested that appearance of tPABP mRNA and protein coincides 
with the first spermatids at day 18 dpp (Kimura et al., 2009).  
The function of tPABP has not been extensively characterised but the high 
degree of homology between both proteins suggests that tPABP is likely to retain 
PABP1 functions. Consistent with this, human tPABP binds poly(A) with the similar 
affinity as PABP1 (Feral et al., 2001), can modestly stimulate translation of reporter 




mRNAs in non poly(A)-dependent rabbit reticulocyte lysates (RRL) (Kimura et al., 
2009), and can interact in vitro with the PABP1 interacting proteins eIF4G, PAIP1 
and PAIP2 (Kimura et al., 2009). Intriguingly however, unlike PABP1, tPABP is not 
well represented in the polyribosome fractions of testicular extracts and appears to be 
present within distinct cytoplasmic foci in round spermatids which have been 
suggested to be chromatoid bodies (Kimura et al., 2009). These latter observations 
indicate that tPABP may have a different role in mRNA regulation to that of PABP1, 
despite their similarities.  
 
1.3.3.2 Embryonic PABP (ePABP) 
Embryonic PABP (ePABP, ePAB) was initially identified in X. laevis as the 
predominant PABP present during the later stages of oogenesis and early 
embryogenesis, where it essentially replaces PABP1 (Voeltz et al., 2001, Cosson et 
al., 2002c, Wilkie et al., 2005). Consistent with this, ePABP is critical for both X. 
laevis oocyte maturation (Friend et al., 2012) and early development (Gorgoni et al., 
2011). ePABP mRNA shows a similarly restricted pattern in mouse (Seli et al., 2005, 
Wilkie et al., 2005, Guzeloglu-Kayisli et al., 2012) where it is also essential for 
oocyte maturation (Seli et al., 2005, Guzeloglu-Kayisli et al., 2012) but has slighter 
wider distribution in humans (Guzeloglu-Kayisli et al., 2008). 
Analysed aspects of ePABP function appear to highly resemble that of 
PABP1. ePABP has been shown to bind poly(A) (Cosson et al., 2002c, Gorgoni et 
al., 2011) and to stimulate translation to a similar level as PABP1 in tethering assays 
in X. laevis oocytes (Wilkie et al., 2005). Their mechanisms of action may also be 
similar as ePABP interacts with eIF4G, PAIP2, eRF3, PAIP1 (Wilkie et al., 2005, 
Kim and Richter, 2007, Gorgoni et al., 2011) and the cap complex (Cosson et al., 
2002c). X. laevis ePABP has also been shown to protect mRNA from deadenylation 
and both mouse and X. laevis ePABP can promote cytoplasmic polyadenylation (Seli 
et al., 2005, Kim and Richter, 2006, Friend et al., 2012, Guzeloglu-Kayisli et al., 
2012). However, despite these similarities, ePABP is unable to fully rescue PABP1 
phenotypes in X laevis embryos, indicating that these proteins are not functionally 
redundant (Gorgoni et al., 2011). 





PABP4 (PABPC4) was firstly described in 1995 under the name of inducible 
PABP (iPABP) since it was described as an mRNA that could be upregulated in 
activated human T-cells (Yang et al., 1995). Like PABP1, PABP4 mRNA appears to 
be present at different levels in a range of human tissues (Yang et al., 1995). 
Human PABP4 has been shown to bind poly(A) (Yang et al., 1995, Houng et 
al., 1997), although with lower affinity than PABP1 (Sladic et al., 2004), a property 
that is shared with X. laevis PABP4 (Gorgoni et al., 2011). Both X. laevis and 
mammalian PABP4 associate with polysomes indicating it may stimulate translation 
(Gorgoni et al., 2011, Burgess and Gray 2012). Consistent with this idea, X. laevis 
PABP4 stimulates translation in tether assays (Gorgoni et al., 2011) and mammalian 
PABP4 can stimulate the translation of a luciferase reporter with the interleukin-2 
(IL-2) 3’UTR in vitro (Okochi et al., 2005). PABP4 has also been reported to interact 
with a number of PABP1 partners including eIF4G, PAIP1, PAIP2, eRF3 (Cosson et 
al., 2002a, Gorgoni et al., 2011) and TOB (Okochi et al., 2005), suggesting it may 
retain critical functions in turnover as well as translation. 
PABP4 has been found to be critical for normal vertebrate development, with 
morpholino mediated knockdown in X. laevis embryos resulting in anterior defects 
and embryonic lethality (Gorgoni et al., 2011). However, as mentioned, PABP4 is 
unable to completely rescue PABP1 lethality (Gorgoni et al., 2011), showing that 




The least characterised member of the PABP family member is PABP5 which 
is mammalian specific. PABP5 transcripts can be detected at low level by RT-PCR 
in human fetal brain and various adult tissues (Blanco et al., 2001).  
As, PABP5 lacks the PABC domain, responsible for many PABP protein 
interactions, and the proline-rich region (Figure 1.21), and is more diverse in terms 
of its primary sequence, it is unclear whether it shares any of the functions of 
PABP1. 




1.4 DAZ family proteins 
Studies of micro-deletions within the Y-chromosomes of men with non-
obstructive azoospermia (i.e. no sperm in the semen, (Reijo et al., 1995)) led to the 
description of three azoospermia factor (AZF) regions (Vogt et al., 1995, Reijo et al., 
1996a). Further studies led to the identification of a putative RNA-binding protein, 
Deleted in AZoospermia (DAZ), present as multiple copies within the AZFc region 
(Yen et al., 1997). DAZ genes contain an RNA recognition motif (RRM) and up to 
fifteen copies of a 24 amino acid sequence known as the DAZ motif which is unique 
to this family (Saxena et al., 1996). Two autosomal family members, Dazl (deleted in 
azoospermia-like) and Boule were subsequently described and share these features, 
although they contain only a single DAZ repeat (Figure 1.27), (Cooke et al., 1996, 
Reijo et al., 1996b, Yen et al., 1996, Xu et al., 2001). This family has a conserved 
essential role in gametogenesis from worms to humans (Section 1.4.4). 
 
Figure 1.27 - Human DAZ family. Domain structure of the human DAZ family 
with corresponding percentages of amino acid homology shown for the N-
terminal region up to and including the first DAZ repeat. From (Smith, 2007). 
 
1.4.1 Evolution of DAZ family 
Despite being the first DAZ family member to be identified, phylogenetic 
studies have shown that DAZ is actually the most recently evolved of the three 
family members (Xu et al., 2001).  
Boule is thought to be the ancestral family member and orthologues of Boule 
have been found in C. elegans, Drosophila, mouse and humans (Eberhart et al., 1996, 




Karashima et al., 2000, Xu et al., 2001, Shah et al., 2010), but are not in fungi and 
plants (Shah et al., 2010) (Figure 1.28). 
DAZL orthologues are only found in vertebrates (Yen, 2004) and are believed 
to have arisen during the early stages of vertebrate radiation (Xu et al., 2001, Shah et 
al., 2010, VanGompel and Xu, 2011) by a duplication of the ancestor Boule gene 
followed by autosomal transposition.  
 
Figure 1.28 - Distribution and sex specific expression of the DAZ family. The 
DAZ family ancestor Boule (B) is present from worms to humans whilst DAZL (L) 
arose by duplication early in vertebrate evolution. Interestingly, DAZ (D) arose 
from an autosome to Y chromosome duplication-transposition of the DAZL gene 
during simian evolution. Boule is mainly associated with male gametogenesis 
(excluding fly) whilst DAZL is important in both sexes. DAZ is testis specific. From 
(VanGompel and Xu, 2011).  
 
DAZ itself is believed to have originated during simiiformes evolution, since it 
is only present in the parvorder catarrhini which includes old world monkeys, apes 
and humans. It is believed to have arisen from a duplication of the autosomal DAZL 
gene followed by translocation to the Y chromosome meaning that is only present in 
males (Cooke et al., 1996, Venables et al., 2001). Repeated amplification resulted in 
variable numbers of DAZ genes in the human male population, with the reference 
sequence having four copies, but approximately 2 % of fertile men only carrying two 
copies (Repping et al., 2003). The multiple copies are not always identical varying in 
the number of RRMs and DAZ repeats (Yen et al., 1996, Saxena et al., 2000). 
Nonetheless, western blot analysis of human testes extracts only detects a single 




protein band for DAZ, suggesting that not all DAZ genes may be translated (Slee et 
al., 1999, Reijo et al., 2000). As a consequence of this, nucleotide sequence 
divergence is greater between DAZ genes, diverging as much as 10.9 % (Xu et al., 
2001) in humans and cynomologus whereas divergence between DAZL orthologues  
is roughly 1.5 %.  
 
1.4.2 Expression pattern of the DAZ family  
The differential expression of DAZ family members is an important 
determinant of the different phenotypes observed upon their loss of function.  
 
1.4.2.1 Invertebrates  
Invertebrates only encode the ancestor member of the DAZ family, Boule, 
which is confusingly referred to as daz-1 in C. elegans (Karashima et al., 2000). 
During C. elegans larval development daz-1 mRNA can be detected in the mitotic 
germ cells within the distal area of the gonad and increases with progression into the 
meiotic transition, peaking at the proximal pachytene region of the gonad but being 
absent in mature sperm within the spermatheca. In adults, daz-1 transcripts were 
restricted to the female germ cell developmental (Karashima et al., 2000, Maruyama 
et al., 2005). 
In Drosophila boule is not expressed in the female germ line but can be 
detected in pre-meiotic and meiotic spermatocytes and in post-meiotic spermatids by 
immunoblotting and immunohistochemistry (Cheng et al., 1998). An isoform of 
boule is also present in nervous cells of Drosophila (Joiner and Wu, 2004, Hoopfer et 
al., 2008) where it works as a negative regulator of axon pruning, suggesting that at 
least in flies the function of this family member is not restricted to germ cells 
(Hoopfer et al., 2008).  
Curiously flatworms (Macrostomum lignano (M. lignano)) express three 
different orthologues of boule, with macbol1 and 2 being specific for testes and 
macbol3 being restricted to ovaries and developing eggs (Kuales et al., 2011). 
 
 




1.4.2.2 Zebrafish and X. laevis 
Northern blot analysis of adult gonads in zebrafish detected zDazl transcripts 
in both sexes, with in situ hybridisation revealing their presence in oocytes 
(Maegawa et al., 1999), spermatogonia and early spermatocytes (Maegawa et al., 
2002) but not in late spermatocytes, spermatids or mature sperm (Maegawa et al., 
2002). In the early embryo maternal zDazl mRNA was detected at the vegetal pole 
by in situ hybridation and migrated towards the blastomeres, with zDazl being 
detectable in migrating PGCs (Maegawa et al., 1999, Hashimoto et al., 2004) 
(Maegawa et al., 1999).  
Xdazl has been described in all stages of male and female germ cell 
development in adult X. laevis, with the exception of the mature spermatozoa (Mita 
and Yamashita, 2000). Consistent with its localisation in the germ plasm of oocytes, 
maternally inherited Xdazl was detected in the germ plasm of blastula embryos 
(Houston and King, 2000). Xdazl can also be detected in PGCs until the early tailbud 
stage (Houston et al., 1998, Houston and King, 2000). Thus both zDazl mRNA and 
xDazl appear restricted to the germ line.  
 
1.4.2.3 Mice  
Mice encode two members of the DAZ family, Boule (mBoule) and Dazl 
(mDazl) although to date most work has focused on Dazl.  
Northern blot analysis has shown that Dazl expression in mice is restricted to 
the gonads of both males and females (Cooke et al., 1996, Reijo et al., 1996b, Yen et 
al., 1996). In contrast, Dazl was not detected in Northern blots from two mouse lines 
( XXSXRA, white spotted or steel gene mutated) that lacked germ cells (Cooke et al., 
1996, Reijo et al., 1996b) nor was it detected in a Sertoli cell line (TM4) (Reijo et 
al., 1996b), suggesting that Dazl mRNA is germ cell specific.  
During fetal development mDazl transcripts have been reported by in situ 
hybridisation in testes from 11.5 c dpc (Lin and Page, 2005) and by northern blot in 
ovaries at 14.5 dpc (Seligman and Page, 1998), the earliest points examined for both 
sexes. In both sexes, northern blotting detected mDazl mRNA up until 18.5 dpc, the 
last fetal gonad stage analysed (Seligman and Page, 1998). Notwithstanding, the data 




provided show a peak of Dazl expression at 14.5 dpc for both males and females, 
when the first oogonia enter meiosis. At 16.5 dpc there is an abrupt decrease in Dazl 
expression in both sexes which is maintained in the developing testes at 18.5 dpc 
although Dazl mRNA levels increase considerably in ovaries. These differences may 
indicate a sexual specific requirement for Dazl during fetal development, or just a 
difference in number of germ cells in both sexes (Seligman and Page, 1998).  
 Northern blots from postpartum males detect Dazl as early as 1 day 
postpartum (dpp), although its level increase with the appearance of the first 
spermatogonia at 6 dpp and plateau by 10 dpp when the first spermatogenic cells 
enter meiosis (Reijo et al., 1996b). Although, a different report suggested that it 
peaks later at 20 dpp coinciding with the appearance of the first round spermatids 
(Cooke et al., 1996). In situ hybridisation showed expression of Dazl transcripts in 
spermatogonia at stages IV-VI, with a peak of expression in the intermediate to B 
spermatogonia passage, just before meiotic initiation, consistent with northern blots 
(Niederberger et al., 1997). No Dazl RNA was reported in spermatocytes or 
spermatids. 
 Dazl protein is expressed in type B spermatogonia, preleptotene, zygotene 
and pachytene spermatocytes (stage I-VIII) (Ruggiu et al., 1997) and has also been 
examined in females where it is highly expressed in the cytoplasm of pachytene 
oocytes at 17.5 dpc and at lower levels after birth in the cytoplasm of primordial and 
growing follicles (Ruggiu et al., 1997, McNeilly et al., 2011). Interestingly, Dazl has 
also been detected by IHC in the cytoplasm of granulosa cells of growing follicles 
(Ruggiu et al., 1997) although in situ hybridisation data is not available to confirm 
whether Dazl mRNA is present in these somatic cells. 
Northern blotting only detected Boule mRNA in male gonads (Xu et al., 
2001) with IHC showing expression in a subset of male germ cells; Boule is present 
in late spermatocytes with a peak of expression just before metaphase, decreases 
during meiotic division, but increases again in round spermatids where it can be 
detected until round spermatid-5. Boule mRNA was described as absent from mouse 
ovaries, although the report failed to present the data (Xu et al., 2001). Nevertheless 
this would be consistent with the lack of a phenotype in female knockout mice 
(VanGompel and Xu, 2010). 





In first trimester ovaries and testes, DAZL was present in the nucleus of 
OCT4 positive germ cells. In the second trimester DAZL is only expressed in the 
more cortical OCT3/4 negative germ cells located within germ cell clusters 
(Anderson et al., 2007), where it is cytoplasmic. In the developing testes at the 
second trimester DAZL expression was uniformly spread through all germ cells 
within the gonad and remains predominantly nuclear (Dorfman et al., 1999, 
Brekhman et al., 2000, Anderson et al., 2007). No data is available for DAZL 
expression in the last trimester of human gestation. 
In adults DAZL is expressed in the oocyte cytoplasm of primordial and 
secondary follicles (Dorfman et al., 1999). As reported for mice, DAZL has also 
controversially been detected in the cytoplasm of the lutein cells of the corpus luteum 
(Dorfman et al., 1999, Pan et al., 2002, Pan et al., 2009). In adult testes DAZL 
protein is present in spermatogonia, early and late spermatocytes (Reijo et al., 2000) 
but not in no expression has been observed in any of the later stages of 
spermatogenesis including round and elongating spermatids (Reijo et al., 2000).  
BOULE and DAZ proteins are considerably less characterised than DAZL. 
Boule can be detected in spermatocytes and early spermatids by IHC, but not in 
spermatogonia or late spermatids (Xu et al., 2001, Luetjens et al., 2004). Expression 
of Boule in ovaries has not been examined since its mRNA is undetectable in this 
tissue (Xu et al., 2001). Analysis of DAZ expression is complicated by the existence 
of four DAZ genes (Huang et al., 2008) but DAZ was only detected in the cytoplasm 
of spermatogonia in adult testes samples (Huang et al., 2008). Another report 
suggested that DAZ was also present in spermatogonia and early spermatocytes, but 
the antibody utilised also detects DAZL, suggesting that this difference may be due 
to cross-reaction (Reijo et al., 2000).  
 
1.4.2.5 Sub-cellular expression  
Despite being predominantly cytoplasmic, at specific germ cell stages, DAZ 
family members can also be nuclear. This was first reported in flies where boule is 
nuclear in spermatocytes and only transits to the cytoplasm before the onset of 




metaphase (Shah et al., 2010). However, Boule may not function in this 
compartment as blocking its nuclear localisation results in no obvious phenotype 
(Cheng et al., 1998). In humans, DAZL has been detected in the nucleus of 
gonocytes during fetal developmental but is reported to relocate to the cytoplasm of 
spermatogonia and spermatocytes after birth (Ruggiu et al., 2000). In females, DAZL 
translocates to the cytoplasm of oogonia in the second trimester (Anderson et al., 
2007) 
 
1.4.3 DAZ family phenotypes 
Loss of function studies have been performed in both non-mammalian and 
mammalian species and both result in compromised gametogenesis in one or both 
sexes.  
 
1.4.3.1 Invertebrates and non-mammalian vertebrates 
Transposon-induced ablation of boule in Drosophila results in a meiosis I 
arrest at pachytene spermatocytes (Eberhart et al., 1996). In contrast, RNAi of boule 
(daz-1) results in a lack of oocytes in hermaphroditic worms, with C. elegans 
showing a pachytene arrest during oogenesis (Karashima et al., 2000) and C. 
Briggsae a block in the sperm-oocyte transition (Otori et al., 2006). RNAi of the 
three Boule orthologues in M. lignano results in different phenotypes: the male 
specific macbol2 show no germ cell defects but the other male specific boule, 
macbol1 blocks spermatocyte differentiation. In females RNAi knockdown of 
macbol3 impairs egg maturation resulting in sterility (Kuales et al., 2011). 
 In vertebrates, morpholino mediated knockdown of maternal Xdazl mRNA 
results in a loss of both male and female germ cells in X. laevis, due to defects in 
PGC proliferation and migration during their transit from ventral to dorsal endoderm 
(Houston and King, 2000).  
 
1.4.3.2 Mice  
In mice, Dazl-knockout (DazlaTm1Hgu/DazlaTm1Hgu (Ruggiu et al., 1997)) 
(Dazl-KO) results in loss of germ cells in both males and females, with the onset of 




the phenotype varying according to sex and being influenced by the genetic 
background. 
In a C57Bl6 Dazl-KO outbred strain no significant differences are observed 
in fetal gonads at 15.5 dpc (Ruggiu et al., 1997, Saunders et al., 2003). However, in 
females a substantial decrease in germ cells is observed by 17.5 dpc, suggesting a 
meiotic progression phenotype (Saunders et al., 2003), with no follicles having being 
formed by birth (McNeilly et al., 2000), and a complete absence of germ cells by 4 
dpp (Ruggiu et al., 1997, Saunders et al., 2003). In males, a decrease in germ cell 
number can be observed by 19.5 dpc (Ruggiu et al., 1997, Saunders et al., 2003). 
Since male gonocytes have not entered meiosis at this stage, this phenotype appears 
to be associated with mitotic rather than meiotic progression (Saunders et al., 2003). 
However, the most striking male phenotype is observed during the first wave of 
spermatogenesis, where pachytene spermatocytes can be observed, albeit in reduced 
numbers, but show clear signs of atresia suggesting a leptotene-zygotene arrest due 
to impaired synaptonemal formation, indicating a role for Dazl in meiotic 
progression during spermatogenesis (Saunders et al., 2003). Spermatogonial 
differentiation also appears to be impaired in prepubertal Dazl-KO mice as As and 
Apr spermatogonia are present but fail to differentiate into Aal (Schrans-Stassen et al., 
2001).  
Analysis of inbreed C57Bl6 Dazl-KO strain has suggested additional roles 
since atretic germ cells can be observed as early 15.5 dpc in both male and female 
mice (Lin and Page, 2005, Lin et al., 2008). These female mice also show abnormal 
expression of meiotic markers (γH2AX and Sycp3) at 15.5 dpc suggesting impaired 
meiotic progression. More recently the same group has described an additional 
phenotype as PGCs fail to undergo sexual differentiation (Gill et al., 2011). This 
indicates that Dazl may play an even earlier role in allowing germ cells to respond to 
sexual differentiation cues from the developing gonad.  
Moreover, the imprinting status of sex specific genes appears to be affected in 
inbred C57Bl6 Dazl-KO mice. Imprinting at the H19 locus of paternal genomes is 
normally lost by 13.5 dpc and re-established by 16.5 dpc. In Dazl-KO mice erasure 
of this male specific imprinting is delayed and is not re-established by 16.5 dpc 
(Haston et al., 2009).  




Most recently, morpholino-mediated Dazl knockdown in oocytes showed that 
Dazl is also a major regulator of meiotic oocyte maturation. Dazl depleted oocytes 
show reduced completion of meiosis I and disruption of the transition into MII as 
they display impaired spindle formation, aberrant chromosome segregation, and a 
comparatively high rate of aneuploidy (Chen et al., 2011). Interestingly, knock-down 
in early zygotes blocks embryonic cleavage revealing an unexpected post-
fertilisation role (Chen et al., 2011).  
In contrast, Boule-KO females have no oogenesis phenotype and produce 
viable offspring (VanGompel and Xu, 2010). Boule deficient males progress through 
meiosis I and II apparently normally but arrest at round spermatid-6. This suggests a 
role for Boule in spermatid differentiation contrasting with its phenotype in both 
worms and flies, which show a pachytene arrest (Eberhart et al., 1996, Karashima et 
al., 2000, VanGompel and Xu, 2010).  
 
1.4.3.3 Humans 
To date, causality between loss of DAZ family function and impaired fertility 
has not been established in humans. Although, DAZ gene deletions are present in 
men with reduced sperm number (Reijo et al., 1995), some men harbouring DAZ 
deletions still produce low levels of sperm (Reijo et al., 1996a) suggesting it is not 
essential. Moreover, a possible role in sperm maturation has also been suggested due 
to the success of ISCI (intracytoplasmic sperm injection) in men carrying DAZ 
deletions with severely reduced spermatogenesis (Kamischke et al., 1999, Mau Kai 
et al., 2008).  
Histological analysis of men with meiotic spermatogenic arrest showed no 
BOULE expression (Luetjens et al., 2004), but to date no mutations have been 
identified in Boule in males with reproductive phenotypes.  
In humans, several putative mutations in DAZL have been described in 
patients with either premature ovarian failure, early onset menopause and 
azoospermia (Tung 2006). However, the effect of these amino acid substitutions on 
DAZL function remains to be determined.   
 




1.4.3.4 DAZ family redundancy 
The ability of family members to at least partially cross-rescue loss of 
function phenotypes from different species suggests that they share closely related 
molecular functions and interactions. For instance, the meiotic phenotype of 
Drosophila Boule can be rescued by the flatworm macbol1 (Kuales et al., 2011) 
although the resulting sperm show abnormal morphology and do not produce 
offspring (Kuales et al., 2011). Similarly, this phenotype can also be partially 
rescued with X. laevis dazl (Houston et al., 1998) and human BOULE  (Xu et al., 
2003). Moreover, the mouse Dazl phenotype was partially rescued with human 
DAZL (Vogel et al., 2002) and human DAZ (Slee et al., 1999), indicating that 
different family members share common functional properties. In keeping with this, 
all three family members can enhance differentiation of ESCs into germ cells with 
spermatid features in vitro (Kee et al., 2009), although ESCs in vivo only appear to 
express Dazl. These observations suggest their differential expression is likely to be 
an important contributory factor to phenotype development in species which possess 
multiple family members. 
 
1.4.4  DAZ family functions  
Clinical, genetic and molecular studies have demonstrated the importance of 
DAZ family members in gametogenesis but to date the mechanisms by which they 
achieve these functions are not completely understood. The existence of different 
family members, sex and species specific phenotypes together with major temporal 
and spatial differences in gametogenesis between sexes all add to the complexity of 
analysing their function.  
Nonetheless several functions have been proposed based on their 
predominantly cytoplasmic localisation, ability to bind RNA (Tsui et al., 2000a, 
Venables et al., 2001) and  interacting proteins (Figure 1.30 for summary of protein 
interactions) focusing on potential roles in regulating mRNAs within this sub-cellular 
compartment (Figure 1.31). In some cases, most notably for translational activation 
of mRNAs, direct experimental support for the role of DAZ family members in these 
processes is available.  




1.4.4.1 Translation initiation regulation by DAZ family 
Post-transcriptional regulation of cytoplasmic mRNAs is critical for 
gametogenesis (reviewed in (Nguyen-Chi and Morello, 2011, Idler and Yan, 2012)). 
The first evidence suggesting a potential role in translational regulation for this 
family came from seminal studies in Drosophila, which showed that boule null flies 
had impaired meiotic progression, similar to the phenotype observed in twine null 
flies (Maines and Wasserman, 1999). Importantly, they found that the level of twine 
transcripts was unchanged in boule mutants, although levels of twine protein was 
significantly reduced compared to WT (Maines and Wasserman, 1999), suggesting 
either a direct or indirect effect on twine mRNA translation.  
Potential roles in translation in vertebrates was first highlighted by the 
association of mouse Dazl (mDazl) and zebrafish Dazl (zDazl) with actively 
translating polysomes (Tsui et al., 2000b, Maegawa et al., 2002). Reporter mRNA 
assays in micro-injected X. laevis oocytes directly established the ability of X. laevis, 
mouse and human DAZL and also human DAZ and BOULE to robustly stimulate the 
translation of mRNAs to which they were bound, revealing that they shared a 
conserved function as mRNA-specific translational activators (Collier et al., 2005b). 
These observations were in keeping with subtle effects of zDazl on the translation of 
reporter mRNAs in transfected somatic cells (Maegawa et al., 2002). Subsequently, 
this function has been verified in vivo for mouse Dazl and C. elegans Daz-1 by the 
identification and verification of mRNAs that they translationally activate (Reynolds 
et al., 2005, Otori et al., 2006, Reynolds et al., 2007, Chen et al., 2011) (Section 
1.4.4.2). 
Insights into the mechanism by which DAZ family members stimulate 
translation was provided by analysis of the step at which it acts, which revealed that 
Dazl promotes the initiation phase of translation (Collier et al., 2005b). A Y2H 
screen of initiation factors revealed that Xdazl interacted with PABP1 but not other 
canonical initiation factors (eIF1, eIF1A, eIF2, eIF2B, eIF3, eIF4A, eIF4E, eIF4G, 
eIG4H, eIF5, eIF5A and eIF5B). Interaction with endogenous X. laevis PABP1 and 
ePABP was confirmed by co-immunoprecipitation. Mammalian DAZ family 
members that were able to stimulate translation in X. laevis oocytes showed a 




conserved ability to interact with X. laevis PABPs, suggesting this interaction may be 
functionally important (Collier et al., 2005b). To probe whether this interaction was 
required for the ability of mDazl to stimulate translation, a series of deletion mutants 
were made. Importantly, deletion of the minimal PABP-binding region but not other 
regions of mDazl abrogated its ability to stimulate translation (Collier et al., 2005b) 
indicating that this interaction was functionally required (Collier et al., 2005b). As 
mDazl efficiently stimulates the translation of unadenylated reporter mRNAs (Collier 
et al., 2005b), this suggests that this interaction is sufficient to allow the direct 
poly(A)-independent recruitment of PABPs to mRNAs via protein-proteins 
interaction, providing an mechanism of activating germ cell that is distinct from 
cytoplasmic polyadenylation (Collier et al., 2005b, Pique et al., 2008). 
 
 
Figure 1.29 - DAZL-PABP Closed-loop conformation. By working as an 
interacting scaffold, DAZL enables PABP to bring together the 5’ and the 3’ 
ends of the mRNA via protein-protein interactions, leading to enhanced 
translation initiation. The outline of eIF4B is broken, as although suggested 
to be a PABP-binding protein in mammalian cell free extracts (Bushell JBC 
2001), this report awaits verification (from Brook et al, 2009).  
 
Together these studies provide the basis for the DAZL-PABP model, in which 
DAZ proteins bound to the 3’UTR of specific mRNAs recruit PABPs, which in turn 
interacts with the 5’end factors (i.e. eIF4G and PAIP1), promoting an alternative 
closed-loop conformation (Figure 1.29) (Collier et al., 2005b, Brook et al., 2009). As 
would be predicted from this model, mDazl was found to stimulate the translation of 
adenylated reporter mRNAs to a lesser extent that that of unadenylated mRNAs 




(Collier et al., 2005b), as the former have the capacity to bind PABP independently 
of Dazl. 
Whilst genetic evidence to support this model is absent in vertebrates, pab-1 
deficient C. elegans show an early meiotic block in female oogenesis, similar to that 
observed in daz-1 deficient C. elegans (Maciejowski et al., 2005, Maruyama et al., 
2005). However, verification of this model in genetically accessible mammalian 
models remains an important goal.  
 
1.4.4.2 Translational targets of the DAZ family  
Initial studies of the RNA-binding capacity of this family revealed a general 
affinity for poly(U) and to a lesser extent, poly(G) homopolymers (Tsui et al., 2000a) 
with mutation or deletion of the RRM in mDazl and hDAZL respectively confirming 
the importance of this region in RNA-binding (Ruggiu and Cooke, 2000, Tsui et al., 
2000a). SELEX and yeast-three hybrid screens suggested that Dazl may bind U-rich 
sequences interrupted by G or Cs (Venables et al., 2001). Recently, the structure of 
mouse Dazl bound to RNA has been solved showing that the RRM of mDazl has 
high affinity towards GUU[U/C] in different sequence contexts (Jenkins et al., 
2011). 
Although Drosophila twine was not shown to be a direct target of Drosophila 
boule (Maines and Wasserman, 1999), it was subsequently shown that reporter 
mRNAs containing this 3’UTR could be stimulated by zDazl in transfected CV-1 
cells, an effect that was dependent on a GUUC sequence (Maegawa et al., 2002). 
Despite the human homologue, CDC25A, being proposed as a target for human 
family members, no evidence to support this has been provided, although testes 
sections lacking BOULE also lack CDC25A protein (Luetjens et al., 2004).  
In mammals, several studies have aimed to identify mRNA targets, most 
involving the isolation of mRNA from testes extracts with purified proteins, but very 
few targets have been validated in vivo. A pull-down of mRNAs from testes extracts 
using GST-mDazl identified potential mouse Dazl targets (Jiao et al., 2002) 
including Tpx-1, a testicular cell adhesion protein that modulates spermatogenesis 
progression, Grsf-1, a RNA-binding protein that regulates translation, and the 




transcription factor Trf-2. Another screen using the same approach (Zeng et al., 
2008), re-isolated Tpx-1 (Jiao et al., 2002) and a new variety of potential targets 
including testis-specific serine kinase 2 (Tssk2) which is a member of a family of 
Ser/Thr protein kinases implicated in male germ cell development (Kueng et al., 
1997). TSSK2 binding to mDazl was confirmed by electrophoretic mobility shift 
assay (EMSA) (Zeng et al., 2008) and human DAZL was found to be able to pull-
down human TSSK1, TSSK2, TSSK4 and TSSK5. A similar screen using hDAZL 
and mRNA from human testes isolated over 60 possible targets, with SDAD1, a 
homolog of the yeast severe depolymerastion of actin (sda1) gene being confirmed as 
a potential binding mRNA by immunoprecipitation of human testes mRNA with 
purified hDAZL protein (Fox et al., 2005). However, none of these potential targets 
have been shown to be regulated by DAZ family members in vitro, in cell culture or 
in vivo. 
Potential targets were also isolated from rodent testes extracts by RNA-IP 
using antibodies against endogenous Dazl and hybridised to microarrays. 
Comparison to mRNAs isolated by another RNA-binding protein and in the presence 
of peptide control resulted in the identification of 15 potential targets of mDazl 
(Maratou et al., 2004, Reynolds et al., 2005). Comparisons of the 3’UTR of these 
mRNAs led to the proposed consensus U2-10G-CU2-10 (Reynolds et al., 2005), 
similar to the motif present in mRNAs from previous screens (Jiao et al., 2002) and 
consistent with the solved structure of Dazl-bound to RNA (Jenkins et al., 2011). 
Importantly, two of potential targets, mouse vasa homologue (Mvh) and the 
synaptonemal complex protein 3 (Sycp3) mRNAs, were validated in a series of 
assays (Reynolds et al., 2005, Reynolds et al., 2007). mDazl was shown to bind the 
3’UTR of both transcripts and reporter mRNAs carrying these 3’UTRs were shown 
to be translationally activated by mDazl in microinjected X. laevis oocytes (Reynolds 
et al., 2005, Reynolds et al., 2007). Importantly, mutations within these 3’UTRs that 
abrogated Dazl binding in vitro also prevented their translational activation in these 
assays (Reynolds et al., 2007). The phenotypes of both the Mvh (Tanaka et al., 2000) 
and Sycp3 (Yuan et al., 2000) KO mice resemble the outbred Dazl-KO phenotype 
(Saunders et al., 2003). Specifically Mvh-KO males have a leptotene to zygotene 
block at meiosis I (Tanaka et al., 2000) and Sycp3 KO males have a meiotic arrest at 




prophase I (Yuan et al., 2000). Critically, the levels of both proteins was decreased in 
Dazl-KO mice compared to WT (Reynolds et al., 2005, Reynolds et al., 2007), 
which combined with evidence that they can be bound and translationally activated 
by Dazl provides strong evidence that they are bona fide target mRNAs. The residual 
levels of Mvh and Sycp3 observed in Dazl KO mice is consistent with Dazl 
stimulating, rather than being essential for, their basal translation (Collier et al., 
2005b).  
Recently, potential Dazl target mRNAs in female mice have been identified 
and in some cases validated in a genome-wide study to identify mRNAs involved in 
progression through oocyte maturation (Chen et al., 2011). Polysome profiling, in 
which mRNAs are recovered from the translating ribosomes, was performed GV, MI 
and MII matured oocytes. This showed that many of the RNAs that moved onto 
polysomes during maturation contained CPEs (U4A[A/U]U) and/or DAZL (U2-10G-
CU2-10) binding sites. Consistent with the idea that Dazl may be regulating the 
translation of mRNAs critical for this process, morpholino-mediated knock-down of 
Dazl impaired meiotic maturation (Chen et al., 2011). The translation of reporter 
mRNAs containing the 3’UTR of three of the putative Dazl regulated mRNAs, Dazl, 
Tex19.1 and Tpx2 was investigated in morpholino injected oocytes. This confirmed 
that their translational recruitment during maturation was Dazl-dependent, and in the 
case of Tex-19 this effect was shown to require the Dazl binding sites (Chen et al., 
2011). Tex-19.1 was previously identified as a potential target mRNA in mouse testis 
(Reynolds et al., 2005) although the results here were in contrast with those in 
zebrafish embryos injected with mDazl where a subtle repression of a Tex-19 
reporter was observed (Zeng et al., 2009). Tpx2 has been previously shown to 
regulate spindle formation and activation of Aurora A (Eyers and Maller, 2004). 
siRNA depletion of Tpx2 from mouse oocytes results in meiotic progression defects 
with progression from meiosis I and oocyte maturation severally impaired (Brunet et 










1.4.4.3 Other molecular functions of the DAZ family 
An interaction between the C-terminal region of mDazl and the transporter 
protein dynein light chain (Figures 1.30 and 13.1), a component of the dynein-
dynactin motor complex, suggested that mDazl may be involved in mRNA transport 
and localisation (Lee et al., 2006). In support of this, Dazl-bound mRNAs were 
shown to aggregate in sub-cellular foci in some transfected somatic cells (Lee et al., 
2006). The presence of TIA-1 in these foci suggested they may represent stress 
granules, sites of mRNA storage that can be induced by cellular stress or the over 
expression of RNA-binding proteins (reviewed in (Anderson and Kedersha, 2009, 
Buchan and Parker, 2009)). Interestingly, heat shock was recently shown to induce 
Dazl positive stress granules in early spermatocytes (Kim et al., 2012), the formation 
of which was reduced in Dazl-KO animals, suggesting that DAZL may play a role in 




Figure 1.30 - DAZ family interacting proteins. Schematic representation 
of DAZ family domains structure depicting interactions described in 
vertebrate models. From (Brook et al., 2009). 
 




DAZ family members also interact with PUMILIO-2 (PUM-2) (Moore et al., 
2003, Urano et al., 2005) and for human DAZ this interaction is mapped to the 
region that bridges the RRMs and the DAZ motif (Figures 1.30 and 13.1) (Moore et 
al., 2003). Pumilio proteins have well characterised roles in translation as part of 
multi-protein repressor complexes ((Wickens et al., 2002, Urano et al., 2005) 
reviewed in (Quenault et al., 2011)), suggesting that DAZ proteins may function to 
repress mRNAs in germ cells. Alternatively, interaction with PUM-2 may repress the 
ability of DAZ family members to stimulate translation, as the region bound by 
PUM-2 overlaps with the PABP-binding site in mDazl. Consistent with this latter 
hypothesis Ringo mRNA is translational repressed in fully grown X. laevis oocytes 
and is bound by Pum-2, Xdazl and ePABP and becomes translational active when 
Pum-2 dissociates during maturation. However, whilst it is clear that Pum-2 
represses Ringo mRNA translation, it remains unclear whether its subsequent 
translation requires Dazl (Padmanabhan and Richter, 2006).  
Another translation regulator DAZAP-1 (DAZ associated protein-1) has been 
shown to interact with both human DAZ and DAZL protein. This widely expressed 
protein (Dai et al., 2001) was first shown to interact in a Y2H screen using DAZ as a 
bait protein (Tsui et al., 2000a). The X. laevis homolog of DAZAP-1, proline-rich 
RNA binding protein (Prrp), has been implicated in mRNA localisation (Zhao et al., 
2001) and both the X. laevis and human homologues can stimulate translation of 
reporter mRNAs in tethering assays (Smith et al., 2011). Interestingly, translational 
stimulation by DAZAP-1, like that of DAZL, is sensitive to poly(A) tail length 
raising the possibility that DAZAP-1 may contribute to the ability of DAZL to 
stimulate translation. In keeping with this idea deletion of the DAZAP-1 binding site 
reduces the ability of Dazl to stimulate translation  (Collier et al., 2005b) and to bind 
polysomes (Tsui et al., 2000b), however this deletion also impacts PABP1 binding 
(Collier et al., 2005b). Thus the role, if any, of DAZAP-1 in promoting the ability of 












Figure 1.31 - DAZ family functions in gametogenesis. Schematic 
representation of proposed DAZ (orange circle represents generic DAZ family 
member) family functions in the cytoplasm. The multiple functions proposed for 
DAZ family are likely to be dependent on protein partners with which they interact 
in different multi-protein complexes, a common functional feature of 3’UTR 
binding proteins. DAZ proteins can activate the translation of specific mRNAs a 
function that appears to require interaction with PABP. Interaction with dynein 
has been proposed to promote mRNA transport and pumilio-2 (Pum2) repression 
of mRNAs bound by this family. Family members have also been associated with 
relief of miRNA mediated degradation (miRISC) and with regulating poly(A) tail 
length. In C. elegans the latter may involve interaction with CPEB3. From 












Zebrafish DAZL has recently been shown to abrogate micro RNA (miRNA) 
mediated degradation of reporter mRNAs by miR-430 when injected into somatic 
cells (Takeda et al., 2009). These reporter mRNAs contained the 3’UTRs of nanos1 
and tdrd7 which are only expressed in PGCs, in part due to their degradation in 
somatic cells by miR-430, suggesting that Dazl may permit their expression in PGCs 
by relieving miR-430 action. Whilst the mechanism of de-repression remains 
unclear, the authors noted that binding of zDazl induced polyadenylation of reporter 
mRNAs independently of miR-430 action. Whether this reflects protection of 
poly(A) tail by DAZL recruited PABP remains to be determined but C. elegans daz-
1 was shown to interact with the CPEB homolog, Cpb-3, suggesting the potential for 
a more direct role in cytoplasmic polyadenylation (Hasegawa et al., 2006). Such a 
role is supported by their partially overlapping expression patterns during worm 
meiotic progression although the subcellular distribution of Dazl and, at least, 
CPEB1 does not significantly overlap in mouse spermatocytes and these protein do 
not appear to interact (Reynolds et al., 2007). In keeping with this lack of interaction 
in mice, CPEs and Dazl binding sites overlap in target mRNAs such as Sycp3 
(Reynolds et al., 2007) suggesting these proteins are not simultaneously bound and 
CPEB1-mediated activation of target mRNAs (i.e. Dazl mRNA) in mouse oocytes 
has been shown to occur prior to their Dazl-mediated activation (Chen et al., 2011).  
Other interacting partners such as DAZAP-2 (Tsui et al., 2000a) and DAZ 
interacting protein-1 (DZIP-1) and DZIP-2 have been demonstrated to interact with 
both human DAZ and DAZL proteins (Moore et al., 2003, Moore et al., 2004a). 
However no information exists regarding the functionality or possible roles of these 
interactions but as DZIP1 and DZIP2 are not RNA binding proteins the functions of 












1.5 – Aims 
Understanding the molecular mechanisms involved in mammalian germ cell 
development would progress our knowledge of clinically relevant research areas 
such as sub-fertility, infertility, aneuploidy, embryo development, and germ cell 
cancers.  
The identification of the DAZ family in patients with spermatogenic defects, 
together with the data from animal models provides evidence that this family plays 
important roles in gametogenesis. Previous work in the laboratory has shown that 
DAZL fulfils this critical role at least in part by regulating the translation of specific 
mRNAs and has provided a molecular model for DAZL function showing that it acts, 
at least in X. laevis oocytes, by recruiting PABP, a translation initiation factor. This 
allows formation of an alternative closed-loop mRNA conformation which brings the 
ends of the mRNA into functional proximity and drives efficient recruitment of 
ribosomes (Collier et al., 2005b).  
However, mammals encode additional members of both DAZ and PABP 
families, suggesting the potential for an additional layer of complexity. With this in 
mind, it was hypothesised that DAZL recruits one or more PABP family member for 
its function in promoting the translation of specific mRNAs during mammalian 
gametogenesis. To investigate this hypothesis three main questions were addressed: 
1 – What is the expression pattern of Pabp1 and Pabp4 in mouse gonads and are 
they co-expressed with Dazl during male and/or female mouse gametogenesis. If so, 
at what stages does co-expression occur and does this correspond to times associated 
with Dazl phenotypes?  
2 - Do the members of the PABP family that are present alongside Dazl at 
specific germ cell stages in mouse also retain the ability to interact with Dazl? 
3 – Do putative mutations in human DAZL associated with reproductive 
phenotypes affect the function of DAZL in activating translation, and if so, do these 













































































Unless otherwise stated: 
1 – Oligonucleotides were purchased from Eurogentec.  
2 – Centrifugations: 
 - Up to 2 ml volumes were performed in an Eppendorf 5417R - fixed angle 
rotor centrifuge.  
 - Over 2ml volume were performed in a Sigma-Aldrich 6K15 – swing out 
bucket rotor centrifuge.  
3 – Overnight incubation is considered approximately 16hrs. 






Company Location Country 
Abcam Cambridge UK 
Adobe Systems Europe Ltd Maidenhead UK 
Ambion Austin, TX USA 
Biotium Hayward, CA USA 
Applied Biosystems  Carlsbad USA 
BD Biosciences Oxford UK 
Bio-Rad  Hemel Hempstead UK 
Carl Zeiss Ltd Welwyn Garden UK 
Cell Path Hemel Hempstead UK 
Clontech Guilford UK 
Clontech Mountain View USA 
CovaLAB Cambridge UK 
EmbiTech San Diego, CA USA 
Eppendorf  Cambridge UK 
Eurogentec Seraing Belgium 
Finnzymes Espoo Finland 
GE Healthcare Amersham UK 
Harvard Apparatus Kent UK 
Hoefer Holliston, MA USA 
Invitrogen  Paisley UK 
Melford Ipswich UK 
Merk Hertfordshire UK 
Millipore Billerica USA 
MP Biomedicals UK Cambridge UK 
Nanodrop Technologies Inc Wilmington USA 
Narishige  London UK 
New England Biolabs Hitchin UK 
Novagen Nottingham UK 
Pang UK Suffolk UK 
Perkin-Elmer Beaconsfield UK 
Pharmacia Uppsala Sweden 
Photometrics Ltd Tuscon, AZ USA 
Promega Southampton UK 
Qiagen Crawley UK 
Roche  Welwyn Garden UK 
Sigma-Aldrich Gillingham UK 
Vector Laboratories Peterborough UK 
Stratagene Cedar Creek USA 
 
 Table 2.1 - Suppliers. 
 




2.2 Buffers and solutions  
2.2.1 DNA/RNA techniques 
6 x DNA loading buffer 
-0.03% bromophenol blue 
-0.03% xylene cyanol FF 
-30% glycerol 
-60 mM EDTA 
-10 mM Tris-HCl (pH 7.6) 
 
TAE agarose gel running buffer   
-90 mM Tris-HCl (pH 8.3)  
-90 mM acetic acid 
-2 mM EDTA  
 
2.2.2 Protein techniques  
NuPAGE Transfer buffer (pH 7.4)  
-25 mM Tris-base 
-200 mM glycine 
-20% methanol 
 
PBS (Phosphate buffered saline) (pH 7.4) 
-137 mM NaCl 
-6.5 mM Na2HPO4  
-2.7 mM KCl 
-1.5 mM KH2PO4 
 
PBS-T (PBS-Tween-20) (pH 7.4) 








Phospho co-Immunoprecipitation (co-IP) buffer (pH 7.4) 
-20 mM Hepes (pH 7.6) 
-10 mM KCl 
-1.5 mM MgCl2 
-150 mM NaCl 
-0.5% Triton-X-100 
-10 mM sodium pyrophosphate 
-1 mM (Dithiothreitol) DTT 
-1 protease inhibitor cocktail tablet (Roche) 
-10 nM Calyculin A 
 
Phospho-Radio-Immunoprecipitation Assay (RIPA) buffer (pH 7.4) 
-50 mM Tris-base  
-150 mM NaCl 
-1 mM EDTA 
-1% NP40 
-0.2% SDS 
-10 mM sodium pyrophosphate 
-25 mM β-glycerophosphate 
-0.5% sodium deoxycholate 
-100 mM sodium orthovanadate 
-5 mM sodium fluoride 
-1 mM DTT 
-1 complete protease inhibitor cocktail tablet (Roche) 
-10 nM Calyculin A 
 
Protein binding buffer  
-50 mM Tris (pH 8) 
-1.5 mM MgCl2 
-150 mM NaCl 
-0.5 mM DTT 
-0.05% Triton-X-100 




Pull-down wash buffer 
-50 mM Tris (pH 8) 
-1.5 mM MgCl2 
-200 mM NaCl 
-0.5 mM DTT 
-0.1% Triton-X-100 
 
Protein purification lysis buffer (on ice) 
-20 mM Tris-HCl (pH 8) 
-150 mM NaCl 
-10 mM Imidazole 
-1 complete protease inhibitor cocktail tablet, EDTA free (Roche) 
-1 x BugBuster solution (Novagen) 
-1 mM DTT 
-25 units/ml benzonase 
-1000 units/ml lysozyme 
 
His-column protein purification wash buffer (on ice) 
-300 mM NaCl 
-50 mM Tris-HCl (pH 8) 
-20 mM Imidazole 
-1 mM DTT 
-1 complete protease inhibitor cocktail tablet, EDTA free (Roche) 
 
His-column protein purification elution buffer (on ice) 
-300 mM NaCl 
-50 mM Tris-HCl (pH 8) 
-250 mM Imidazole 
-1 mM DTT 
-1 complete protease inhibitor cocktail tablet, EDTA free (Roche) 
 
 




Strep-column protein purification wash buffer (on ice) 
-300 mM NaCl 
-50 mM Tris-HCl (pH 8) 
-1 mM DTT 
-1 complete protease inhibitor cocktail tablet, EDTA free (Roche) 
 
Strep-column protein purification elution buffer (on ice) 
-150 mM NaCl 
-50 mM Tris-HCl (pH 8) 
-1.5 mM MgCl2 
-30% glycerol 
-2.5 mM D-desthiobiotin 
-1 mM DTT 
-1 complete protease inhibitor cocktail tablet, EDTA free (Roche) 
 
4 x Sample Loading Buffer 
-20% Glycerol 
-200 mM 2-mercaptoethanol 
-4% SDS 
-0.2% Bromophenol blue 
-100 mM Tris-HCl (pH 6.8) 
 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) running 
buffer (pH 8.8) 
-25 mM Tris-base 
-250 mM Glycine 
-0.1% SDS  
 
20 x SSC (Sodium Chloride / Sodium Citrate buffer) (pH 7.0) 
-3 M NaCl 
-0.3 M Na3C6H5O7.2H2O 
 




TBS (Tris-buffered saline) (pH 7.4) 
-10 mM Tris-base 






Tris-HEPES Running Buffer (pH 8) 
-100 mM Tris-base 
-100 mM Hepes (pH 7.6) 
-3.5 mM SDS  
 
2.2.3 Bacterial Techniques  
Luria Broth (LB)  
-10 g/l NaCl 
-10 g/l Bacto-tryptone 
-5 g/l Yeast extract  
 
Luria Broth (LB) agar  
-10 g/l NaCl 
-10 g/l Bacto-tryptone 
-5 g/l Yeast extract 
-15 g/l Difco agar  
 
TE (pH 7.5) 
-10 mM Tris-HCl 
-1 mM EDTA 
 
LiOAc/1x TE 
-50 ml 10 x TE  
-50 ml 10x (1M) LiOAc  




40% PEG/ 0.1 M LiOAc/1xTE/ (50 ml) 
-40 ml of 50% Polyethylene glycol (PEG) 3350  
-5 ml 10x TE 
-5 ml 10x (1M) LiOAc 
 
2.2.4 Yeast techniques  
Z Buffer  
-60 mM Na2HPO4  
-40 mM NaH2PO4.H2O 
-10 mM KCl 
-1 mM MgSO4.7H2O 
-39 mM 2-mercaptoethanol 
 
Minimal Yeast Plates (pH 5.8) 1L 
-6.7 g Yeast nitrogen base without amino acids  
-20 g Agar  
-100 ml of the appropriate sterile 10X amino acid dropout solution  
-5% Glucose 
- 200 mg arginine HCl  
- 300 mg isoleucine  
- 300 mg lysine HCl  
- 200 mg methionine  
- 500 mg phenylalanine  
- 2000 mg threonine  
- 300 mg tyrosine  
- 200 mg uracil  
- 1500 mg valine  
*Add appropriate selection markers (below) 
L-Adenine hemisulfate salt 100 mg/ 50ml  
L-Histidine HCl monohydrate 100 mg/ 50ml  
L-Leucine 500 mg/ 50ml  




L-Tryptophan 100 mg/ 50ml 
 
YPD medium  
20 g/L Difco peptone  
10 g/L Yeast extract  
20 g/L Agar (for plates only) 
 
2.2.5 Xenopus techniques  
Marc's Modified Ringers (MMR) buffer  
-100 mM NaCl 
-2 mM KCl 
-5 mM HEPES 
-1 mM MgCl2 
-2 mM CaCl2 
-0.1% penicillin streptomycin  
 
2.3 Bacterial work  
2.3.1 Bacterial strains 
 The following strains of chemically competent Escherichia coli (E. coli) were 
utilised. 
 
Function Strain Genotype Supplier
Plasmid propagation XL1-Blue 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac 
[F´ proAB lacIqZ∆M15 Tn10 (Tetr)] 
Stratagene 
Recombinant protein expression BL21(LysS) 
E. coli B, F-, dcm, ompT, hsdS(rB-mB-), gal(DE3) 
 [pLysS Camr] 
Invitrogen 
 
 Table 2.2 - E. coli strains used. 
 
2.3.2 Bacterial growth 
 Bacteria were grown in Luria Bertani (LB) agar plates containing the 
appropriate antibiotics at 37ºC. Liquid cultures were grown in LB medium in a 
shaking incubator (250 rpm) at 37ºC. Plates were stored at 4ºC. 




Antibiotic Final concentration 
Ampicillin             (Amp) 100 μg/ml 
Kanamycin           (Km) 25 μg/ml 
Chloramphenicol  (Chp) 34 μg/ml 
 
 Table 2.3 - Antibiotic concentrations. 
 
2.3.1.1  Quick transformations 
 Chemical competent E. coli cells, prepared by Bill Richardson, were stored at 
-80ºC and thawed on ice. Per transformation 50-100 ng of plasmid DNA was added 
to 10 l of cells, and incubated at 4ºC (on ice) for 2 minutes. The transformation mix 
was heat shocked for 45 seconds at 42ºC, and then incubated on ice for 2 further 
minutes. 250 l of LB medium was added to the transformation mix prior to 
incubation at 37ºC for 60 minutes. 100 l of the transformation mix was plated in LB 
agar plates containing the appropriate selection antibody ( Table 2.3). Plates were 
incubated overnight at 37ºC.  
 In all transformations a no plasmid DNA control was performed in parallel to 
test the antibiotic selection.  
 
2.3.1.2 Standard transformations  
Transformation of chemical competent E. coli cells with ligation products 
followed the same principal as quick transformations apart from the following; 5-10 
ng of DNA was added to 50 l of cells and incubated for 30 minutes on ice, before a 
45 second heat shock at 42ºC and then incubated on ice for 2 further minutes. 450 l 
of LB medium was added to the transformation mix prior to incubating the cells at 
37ºC for 60 minutes. 100l and 400l were plated onto LB agar plates containing the 
appropriate selection antibody (Table 2.3).  
 




2.4 General nucleic acid techniques  
2.4.1 Plasmid DNA propagation and purification  
Plasmid DNA was propagated in Escherichia coli (E. coli) (see 2.5), and 
purified using mini, midi or maxi QIAquick Prep kits (Qiagen) according to 
manufacturer’s instructions.  
 
2.4.2 Restriction digestion of DNA  
Restriction digests were performed with restriction enzymes from Roche, 
New England BioLabs or Promega using appropriate buffers and according to the 
manufacturer’s instructions. The final volume of enzyme never comprised more than 
10% of the reaction volume. Digests were carried out to linearise DNA to confirm 
authenticity of plasmids after purification (see 2.4.1), for cloning (see 2.4.6), or in 
vitro transcription (see 2.4.14). 
 
2.4.3 Agarose gel electrophoresis  
1-2% agarose gels were routinely used for DNA/RNA visualisation. Agarose 
was dissolved in TAE by heating in a microwave until boiling, after cooling down, 
Gel-Red (Biotium) was added to a final concentration of 1/10 000. 6 x DNA loading 
buffer (see 2.2.1) was added to samples before loading. Gels were run at 25-100 volts 
in TAE buffer and visualized using a trans-illuminator (Geneflash). DNA band sizes 
were determined using a 100bp or 1kb DNA bench-top ladder (Promega), following 
manufacturer’s instructions. 
 
2.4.4 Gel purification of DNA fragments 
Linearised DNA fragments from restriction digests (see 2.4.2), were run on 1-
2% agarose gels (see 2.4.3). Following identification by UV light, the desired 
fragments were extracted with a sterile razor blade and purified using a QIAquick 
Gel Purification Kit (Qiagen) according to the manufacturer’s instructions.  
 
 




2.4.5 Purification of PCR products 
Polymerase chain reaction products (PCR) (see 2.5) were purified using a 
QIAquick PCR product purification kit (Qiagen) according to manufacturer’s 
instructions.  
 
2.4.6 Plasmid de-phosphorylation 
When performing DNA cloning, after restriction digest (see 2.4.2), linearised 
DNA fragments from the vector backbone plasmids were de-phosphorylated, to 
prevent self-ligation, using Shrimp Alkaline Phosphatase (Fermentas) according to 
manufacturer’s instructions. The enzyme was heat inactivated at 65°C for 10 minutes 
before ligation with insert DNA (see 2.7)  
 
2.4.7 DNA ligations  
Ligation of DNA fragments, after gel purification (see 2.4.3.1), was 
performed at room temperature for 2 hours, for compatible ends or overnight at 16C 
for blunt ends, using a T4 DNA ligase (Stratagene) according to manufacturer’s 
instructions. Different molar ratios of vector back-bone to insert (1:1; 1:3 and 1:5) 
were utilised. Two controls were performed: one with no insert and another with no 
ligase.  
 
2.4.8 Quantification of nucleic acids 
DNA and RNA was quantified by measuring its absorbance at 260nm using a 
Nanodrop ND-1000 (Nanodrop Technologies Inc.) spectrophotometer. 
 
2.4.9 DNA phenol/chloroform extraction 
Plasmid DNA was purified by adding an equal volume of 
phenol:chloroform:isoamyl alcohol (25:24:1; pH 7.8), followed by vortexing and 
centrifugation (14,000 rpm, 2 minutes). The aqueous phase (top layer) was collected. 
The same procedure was repeated and the final supernatant ethanol precipitated (see 
2.4.1.3). 




2.4.10 Ethanol precipitation of DNA  
DNA was mixed with 0.1 volumes of 3 M NaOAc (pH 5.2) and 2.5 volumes 
of 100% ethanol (ice cold), vortexed and incubated for 30 minutes at -20°C. The 
DNA was spun down at 14,000 rpm for 30 minutes at 4°C and the supernatant 
removed. The DNA pellet was washed twice with 80% ethanol (ice cold) and spun 
down at 14,000 rpm for 10 minutes. The supernatant was removed and the resultant 
pellet left to dry at room temperature for 10 minutes followed by resuspension in 
distilled water. 
 
2.4.11 DNA sequencing  
All plasmids used were sequenced at the technical services facility in the 
MRC Human Genetics Unit, Edinburgh. Results were analysed using the program 
vector NTI (Invitrogen) or BioEdit 7.0.0 (Ibis Therapeutics). 
 
2.4.12 RNA extraction  
RNA was extracted from tissues and cells using Tri-Reagent (Ambion) 
following manufacturer’s instructions.  
 
2.4.13 Ethanol precipitation of RNA  
RNA was precipitated by mixing with 0.05 volumes of 3 M NaOAc (pH 5.2) 
and 2.5 volumes of 100% ethanol. This solution was vortexed and incubated at -20°C 
for 1 hour. RNA was pelleted by centrifugation at 14,000 rpm for 30 minutes at 4°C 
and the supernatant removed. The pellet was then washed twice with 80% ice cold 
ethanol, left to dry at room temperature for 2 minutes, followed by resuspension in 
nuclease-free water. 
 
2.4.14 In vitro transcription  
 mRNAs for micro-injections or cell-free translation were transcribed in vitro. 
Prior to transcription, plasmids were linearised by restriction enzyme digestion (see 
2.4.2) at the 3’ end of the template sequence and purified using the QIAquick PCR 
kit (Qiagen) (see 2.4.5). 




 50µl Reaction Mix:  
-1x transcription buffer (Stratagene) 
-30 mM DTT 
-1 mM ATP 
-1 mM CTP 
-1 mM UTP 
-7 mM m7G cap analogue (New England Biolabs) 
-100 units RNasin (Promega) 
-0.5 - 2 µg/µl linearised DNA template 
-4 units T7 or SP6 RNA polymerase (Stratagene) 
Transcription reactions were incubated at 37°C for 5 minutes in the absence 
of GTP to allow optimal capping of transcripts, followed by addition of 1 mM of 
GTP and a further incubation of 120 minutes at 37°C. In order to destroy the original 
DNA template 2.5 units of RQ1 RNase-free DNase (Promega) was added to the 
reaction mix and incubated for 30 minutes at 37°C.  
Following two acid phenol:chloroform:isoamylalcohol (25:24:1) (Ambion) 
extractions (see 2.4.7), the purified RNA was passed over a Chroma Spin-100 
DEPC-H20 column (Clontech) to remove unincorporated cap analogue, nucleotides 
and partially transcribed RNA products. Finally the RNA was ethanol precipitated 
(section 2.4.8) and resuspended in nuclease-free water (Ambion). 
 
2.5 Polymerase chain reaction (PCR)  
2.5.1 Polymerase chain reaction (PCR)  
Unless otherwise stated PCR reactions were carried out with a Bio-X-Act 
Long High-Fidelity polymerase (Bioline). 
50 µl Reaction Mix: 
-50 ng of DNA template 
-1x PCR reaction buffer (Bioline)  
-5 mM MgCl2  
-1 mM dNTPs 
-5 pM forward primer  




-5 pM reverse primer 
-3 units of Bio-X-Act long high-fidelity polymerase (Bioline)  
 
Reactions were incubated in a Dyad PCR machine (Bio-Rad) using the 
following program: 
1) 5 minutes                              95°C  
2) 1 minute                               95°C  
3) 30 seconds                            50-65°C  (according to the Tm of the primer +3º) 
4) 1 minute (per kb)                  68°C  
     *2-4 repeated 24 times 
5) 10 minutes                            68°C  
 
2.5.2 Reverse transcription PCR (RT-PCR)  
cDNA was prepared from RNA retrieved from tissues (see 2.4.10) using a 
First Strand cDNA Synthesis AMV Kit (Roche) with Poly(dT) and random primers 
according to manufacturer’s instructions. Intron-spanning gene specific primers (see 
Table 2.9) were used in a PCR reaction (see 2.5) to detect and amplify desired 
transcripts.  
25 µl Reaction Mix: 
-1-2 μg of RNA  
-5 μl 5 x Reaction Buffer  
-2.5μl 40 mM sodium pyrophosphate 
-2.5 μl dNTP mix  
-0.5 μg primer/μg RNA of poly(dT) primer  
-0.5 μg primer/μg RNA of random primer  
-40 units RNasin® Ribonuclease Inhibitor  
-30 units AMV RT  
Reactions were incubated in a Dyad PCR machine (Bio-Rad) using the 
following program: 
1) 10 minutes                            25°C  
2) 60 minutes                            42°C  
3) 5 minutes                              99°C  




cDNA samples were then subjected to PCR (previous section).  
 
 
2.5.3 Site directed mutagenesis  
Specific mutations were created in DNA templates using a QuikChange® II 
XL Site-Directed Mutagenesis Kit (Stratagene), following manufacturer instructions. 
Briefly, two oligonucleotide primers containing the desired mutation, each 
complementary to opposite strands of the original DNA vector, were extended by 
PCR with a Pfu Turbo DNA polymerase. The final PCR product contained parental 
template and the newly synthesised mutated plasmid containing staggered nicks. This 
was then subjected to Dpn I endonuclease treatment (target sequence: 5´-Gm6ATC-
3´), which specifically targets methylated and hemimethylated DNA and digested the 
parental DNA template. The DNA vector containing the desired mutations was then 
transformed into competent E. Coli. The mutagenesis technique will be discuss 
further in Chapter 5.  
 
2.6 Yeast work  
2.6.1  Yeast strains used 
Yeast-two hybrid assays were performed with Saccharomyces cerevisiae (S. 
cerevisiae) strain L40ura- (MATa,ura3-52, leu2-3,112, his3, trpΔ1, ade2, Δgal4, 
lys:(lexAop)-HIS3, ura3:(lexAop)-LacZ) (Zhang et al., 1999). 
 
2.6.2  Growth of yeast strains 
Yeast was grown in YPD agar plates or YPD medium at 30C. Yeast 
transformed with plasmids were grown at 30C on minimal media supplemented 
with amino acids apart from those used for selection. 
 
2.6.3  Yeast transformations  
A single colony of L40ura- was used to inoculate 5 ml of YPD media and 
incubated overnight at 30C with shaking at 250 rpm. The following morning 50 ml 
of YPD media was inoculated with 1 ml of the overnight culture and incubated with 




shaking at 30C until OD600 was between 0.4-0.6. A transformation mix was 
prepared with 50 l 0.1 M LiOAc/1 x TE and 6 l of salmon sperm carrier DNA 
(Clontech) with 1 g of each plasmid to be transformed. 1 ml of yeast culture was 
used per transformation. This was prepared by spinning down the yeast culture in a 
1.5 ml Eppendorf at 7,000 rpm. The supernatant was removed and the yeast pellet 
washed with 1 ml of water followed by 1 ml of 0.1 M LiOAc/1xTE. The 
transformation mix was added to the washed pellet together with 300 l of 40% 
PEG/0.1 M LiOAc/1 x TE and incubated at 30C for 30 minutes, prior to heat shock 
at 42C for 15 minutes. Finally the transformed yeast was pelleted at 7,000 rpm, 
resuspended in 400 ul of distilled water and 200 ul plated onto selective media YPD 
plates. Plates were incubated for 3 days at 30C. 
 
2.6.4 β-galactosidase assay 
Two-hybrid protein-protein interactions were detected by β-galactosidase 
assay. Colonies from transformed yeast were streaked onto 2 mm Whatman filter 
paper, placed on a selective media plate and grown over night at 30C. The filter 
papers were removed from the plates and fast frozen twice in liquid nitrogen for 15 
seconds and thawed at room temperature. These were then placed into Petri dishes 
containing two Whatman filter papers soaked with Z-buffer (see 2.2.4) supplemented 
with 100 μg/ml X-gal. The Petri dish was sealed with parafilm and incubated at 30C 
and colour changes monitored.  
 
2.7 General protein work  
2.7.1 Protein extraction 
 All protein samples were prepared with phospho-RIPA buffer (pH 7.4) (see 
2.2.2), apart from samples used for co-immunoprecipitation, which were prepared in 
co-IP buffer (see 2.2.2). All the procedures were conducted on ice to minimise 
protease activity.  
 
 




2.7.1.1 From tissues  
 Mouse organs were snap frozen in cryovials using liquid nitrogen immediately 
upon collection. Tissues were homogenised in phospho-RIPA buffer, using the 
minimal volume required to submerge the tissue, using a Qiagen TissueLyser 
homogeniser (Qiagen) (25Hz, 2 minutes) followed by 10 minute incubation on ice. 
The homogenised solutions were then centrifuged at 14,000 rpm for 10 minutes at 
4°C to pellet debris. The supernatant was collected and stored at -20°C for future 
applications.  
 
2.7.1.2 From cultured mammalian cells 
 Cultured cells were washed twice with 0.5 ml/ cm2 of ice cold PBS and 
collected in 0.5-1 ml of ice cold PBS using a cell scrapper. Cells were pelleted at 
1000g for 5 minutes at 4°C. The cell pellet was then re-suspended in phospho-RIPA 
buffer followed by “aggressive pipetting”. Cells were left on ice for an extra 5 
minutes to allow complete cell lysis. The homogenised solution was then centrifuged 
at 14,000 rpm for 10 minutes at 4°C.  The supernatant was recovered and stored at -
20°C for future applications.  
 
2.7.2 Bradford assay  
 Protein concentrations were quantified using Bradford Protein Assay Reagent 
(Bio-Rad). 1 μl of protein sample was added to 99 μl of water and 900 μl of Bradford 
Reagent in a spectrophotometer microcuvette. Using a Genequant Pro 
spectrophotometer (GE Healthcare) the 595 nm absorbance was read and the 
concentration of the sample calculated using a standard curve generated with bovine 
serum albumin (0-20 μg).  
 
2.7.3 Polyacrylamide gel electrophoresis (PAGE)  
SDS-polyacrylamide gel electrophoresis was performed using 10% 
acrylamide, 4-12% NuPAGE MOPS (Invitrogen), or 8-16% Tri-HEPES-SDS gels 
(ThermoScientific). Samples were mixed with 4 x sample loading buffer (see 2.2.2) 




and boiled at 95°C for 10 minutes before loading alongside pre-stained or unstained 
protein Benchmark ladders (Invitrogen). Gels were run until the loading dye reached 
the bottom of the gel. 
 
2.7.3.1 10% acrylamide gels 
The separating gel (0.375 M Tris, 3.5 mM SDS, 10-12% [v/v] 
acrylamide/bisacrylamide [29:1], 4.4 mM ammonium persulphate APS, 6.7 mM 
TEMED, pH 8.8) was poured into the apparatus and allowed to polymerise before 
addition of the stacking gel (0.125 M Tris, 3.5 mM SDS, 4% 
acrylamide/bisacrylamide [29:1], 4.4 mM APS, 6.7 mM TEMED, pH 6.8) with an 
appropriate comb to form the desired number/size of wells. Gels were run in SDS-
PAGE running buffer (25 mM Tris, 250 mM glycine, 0.1% SDS; pH 8.8) at 100-
150V.  
 
2.7.3.2 4-12% NuPAGE Invitrogen gels 
Pre-cast gels purchased from Invitrogen were run using NuPAGE MOPS 
SDS Running Buffer (50 mM MOPS, 50 mM Tris, 0.1% SDS, 1 mM EDTA; pH 7.7) 
(Invitrogen) at 100-200V. 
 
2.7.3.3 8-16% Tris-HEPES-SDS ThermoScientific gels 
Pre-cast gels bought from ThermoScientific were run with Tris-HEPES 
Running Buffer (100 mM Tris-Base, 100 mM Hepes, 3.5 mM SDS; pH 8) at 150-
200V.  
 
2.7.4 Staining protein gels  
 Proteins resolved by SDS-PAGE were visualised using GelCode Blue 
(ThermoScientific). Following electrophoresis, gels were washed three times for 10 
minutes in 150 ml of water then incubated overnight in sufficient GelCode Blue stain 
to give full immersion at 4°C on a rocking platform. Excess stain was removed the 
following day by repeated 20 minute washes in 200 ml water at room temperature on 
a rocking platform.  




2.7.5 Western blotting  
In the following section, all manipulations were performed with the minimal 
volume required to submerge the gel or the membrane. Washes were performed in an 
abundant volume of TBS-T at room temperature on a rocking platform.  
 
2.7.5.1 Transfer 
 After electrophoresis the gel was incubated in 100 ml of NuPAGE transfer 
buffer (see 2.2.2) for 10 minutes. The gel, together with an Immobilon-P membrane, 
previously hydrated in 25 ml of 100% methanol and incubated for 10 minutes in 100 
ml of NuPAGE transfer buffer (Millipore), was “sandwiched” between 6 sheets of 
Whatman filter paper soaked in NuPAGE Transfer Buffer. Proteins were transferred 
at 100 mA for 60 minutes using a V20-SDB semi-dry blotter (SCIE-PLAS).  
 
2.7.5.2 Blocking, antibody incubation and detection 
Unless otherwise stated, the membrane was blocked in 5 % (w/v) skimmed 
milk in TBS-T for 1 hour at room temperature on a rocker.  
Primary antibodies were diluted (see 2.15.2 Table 2.7) in 5 % (w/v) skimmed 
milk in TBS-T and incubated for 1 hour at room temperature or overnight at 4C on a 
rocking platform. After primary antibody incubation, the membrane was washed 3 
times for 5 minutes in TBS-T. The membrane was then incubated for 1 hour at room 
temperature with secondary antibody conjugated to HRP diluted (see 2.15.2 Table 
2.8) in 5 % skimmed milk in TBS-T. The membrane was washed 3 times in TBS-T 
for 10 minutes and incubated in enhanced chemiluminescence solution (ECL) (GE 
Healthcare) according to manufacture’s instructions. Finally membranes were blotted 
dry and exposed to ECL Hyperfilm (GE Healthcare) and developed using Exograph 
compact x4 X-ray processor (XoGraph Imaging Systems). 
 
2.7.6 Immunoprecipitation (IP)  
 100 μl of 50 % protein G sepharose beads slurry (GE Healthcare) was washed 
3 times in 1 ml of ice cold phospho-RIPA buffer (beads were pelleted at 2,500 rpm, 1 




minute at 4oC between washes). This slurry was then added to 1 mg of protein lysate 
in a final volume of 1ml made up with phospho-RIPA buffer containing 1 µg of the 
relevant antibody and tumbled overnight at 4oC on a rotor. Antibody bound beads 
were washed 5 times with 1 ml of ice cold phospho-RIPA buffer (beads were 
pelleted at 2,500 rpm, 1 minute at 4oC between washes). The stringency of the 
washes was varied by adjusting the NaCl concentration (150 mM-600 mM) 
according to the antibody used and is explained in detail in the appropriate results 
sections. The beads were collected using a Pierce spin cup (ThermoFisher) (2,500 
rpm, 1 minute at 4oC), and eluted in sample loading buffer (see 2.2.2) by heating to 
75C for 10 minutes. Beads were pelleted at 14,000 rpm for 1 minute and the 
supernatants run on a SDS-PAGE gel and submitted to western blot analysis.  
 
2.7.7 In vitro translation using cell free extracts 
In vitro synthesis of proteins in cell-free extracts was used to verify the size 
of protein products from plasmid constructs.  
 
2.7.7.1 Rabbit reticulocyte lysate  
Nuclease treated rabbit reticulocyte lysate (RRL) (Promega) is a commonly 
utilised in vitro translation system that is favoured due to its ability to synthesise 
relatively large proteins and its low background due to absence of endogenous 
mRNAs. The RRL system was used according to manufacturer’s instructions with 90 
minute incubations at 30°C. 
50 µl RRL reaction mix: 
-2 μg of RNA  
-1 μl amino acid mixture minus methionine (1 mM)  
-2 μl of [35S]-methionine (1,200 Ci/mmol at 10 mCi/ml) (MP Biomedical)  
-35 μl of rabbit reticulocyte lysate (Promega)  
-Nuclease free water to a final volume of 50 μl  
 
35S-labelled proteins were run at 150V on NuPAGE 4-12 % Bis-Tris pre-cast 
gels (see 2.7.3.) with a pre-stained protein ladder (BioLabs). For non-radiolaballed 




proteins to test antibody specificity, the amino acid mixture minus methionine and 
the [35S]-methionine was substituted with 1 ul of complete amino acid mixture (1 
mM).  
 
2.7.7.2 Transcription and Translation (TnT)  
TnT is a modified rabbit reticulocyte lysate that contains a bacteriophage 
polymerase, providing a one step system that both transcribes and translates mRNAs. 
TnT reactions were performed with the T7 Quick TNT system (Promega) according 
to manufacturer’s instruction. 
50 µl TnT reaction mix: 
-1 µg of DNA plasmid  
-1 μl of 1 mM [35S]-methionine at 10 mCi/ml  
–40 μl TnT® T7 Quick Master Mix. 
-Nuclease free water to a final volume of 50 μl  
 
TnT expressed proteins were run at 150V on NuPAGE 4- 12% Bis-Tris pre-
cast gels (Invitrogen) with a pre-stained protein ladder (BioLabs) as described in 
section  2.7.3.2.  
 
2.8 Recombinant protein generation  
2.8.1 His-Strep recombinant protein induction and 
purification 
Single transformed E. coli colonies (section 2.3.3) were used to inoculate 5 
ml LB liquid cultures containing the appropriate antibiotic and grown overnight at 
37ºC. 0.5 ml of the overnight culture was used to inoculate 200 ml of fresh LB media 
with appropriate antibiotics and was grown at 37ºC (aerated at 250 rpm) until OD600 
~ 0.4. Recombinant protein induction was achieved by addition of 200 μl of 1 M 
iopropyl-β-D-thio-galactoside (IPTG) for 4 hours at 22°C. Cells were collected by 
centrifugation at 4,700 rpm for 30 minutes at 4ºC. Cell pellets were lysed by addition 
of 10 ml of protein purification lysis buffer (see 2.2.2) and incubated at room 




temperature on a turn-wheel for 30 minutes prior to removal of cell debris by 
centrifugation at 4,700 rpm for 20 minutes at 4ºC. 
1 ml of Ni-NTA agarose beads (Qiagen) was added to a Bio-Rad Poly-Prep 
chromatography column and washed twice by addition 10 ml of His-column protein 
purification wash buffer (see 2.2.2) and allowed to drain by gravity flow. The cleared 
lysate was passed over the column containing the washed beads. The flow through 
was collected and passed over the column for a second time. The column was 
washed three times with 10 ml His-column protein purification wash buffer and 
bound proteins eluted with 10 ml of His-column protein purification elution buffer 
(see 2.2.2).  
Bio-Rad Poly-Prep chromatography columns containing 1 ml of Strep-Tactin 
Superflow agarose beads (Novagen) were washed twice with 10 ml of Strep-column 
protein purification wash buffer (2.2.2) and allowed to drain by gravity flow. The 
eluate from the Ni-column was passed over the pre-washed Strep-column with the 
flow-through being reapplied. The column was washed three times by addition of 10 
ml of Strep-column protein purification wash buffer. Prior to elution, columns were 
capped to allow a 5 minute incubation (at 4ºC) with 1 ml of Strep-column elution 
buffer (see 2.2.2). Eluates were collected by gravity flow in 0.5 ml volume fractions. 
Following each 0.5 ml collection, an extra 0.5 ml of Strep-column protein 
purification elution buffer was added to the column, up to a total of 4 ml (8 samples 
of 0.5 ml). Samples were quantified (section 2.8.2) and stored at -80ºC. 
 
2.8.2 Quantification of induced purified proteins 
 Two different dilutions of each eluate and four different concentrations of a 
BSA standard (250-1000ng/μl) were run on a SDS-PAGE gel and stained with 
SYPRO Ruby (Invitrogen) following manufacturer’s instructions. Protein 
concentrations were calculated using ImageQuant software (GE Healthcare) after 
scanning the gel with a 488 nm excitation laser (Typhoon Variable Mode Imager), by 
comparison with the known BSA concentrations.  
 




2.9 Pull-down assays  
50 μl of glutathione sepharose 4B beads (GE Healthcare) were washed twice 
in 1 ml of binding buffer (see 2.2.2), followed by an incubation with 1 ml of 1 μg/μl 
BSA for 30 minutes at room temperature on a rotating wheel. Beads were pelleted at 
2,500 rpm at 4ºC for 1 minute and washed two times in 1 ml of binding buffer. 3 
pmol of GST proteins (GST and GST-hDAZL (Abnova #H00001618-P01)) were 
added to the beads and the volume increased to 1 ml with binding buffer (see 2.2.2) 
before incubation for 1 hour at 4ºC on a rotating wheel. Beads were spun down at 
2,500 rpm at 4ºC for 1 minute and the supernatant containing unbound proteins 
removed. 30 pmol of purified His-PABP-Strep proteins (see 2.8.1) in binding buffer 
(see 2.2.2) was added to the beads in a total volume of 1 ml. The samples were 
tumbled for 1 hour at 4ºC on a rotating wheel. Finally, beads were transferred to a 
Pierce SpinCup (ThermoFisher) and washed five times with 1 ml of pull-down wash 
buffer (see 2.2.2), pelleting at 2,500 rpm for 1 minute at 4oC between washes. 30 μl 
of sample loading buffer was added to the samples before heating at 75C for 5 
minutes and eluates collected by spinning the columns at 14,000 rpm for 1 minute. 
The recovered samples were run on a SDS-PAGE gel and subject to western blot 
analysis. 
 
2.10 Histological analysis  
2.10.1 Fixation, embedding and sectioning 
 Tissues were fixed either in Bouin’s or 4% NBF in 20x the volume of the 
tissue. After fixation, tissues were washed twice with, and stored in, 70% ethanol 
until being processed. Tissues were embedded in paraffin wax by the histology core 
facility in the CRH on a Leica TP1050 processor (Leica Microsystems). 
 Paraffin embedded tissues were sectioned (5 μm) using a Leica RM2135 
microtome. Sections were floated on a 50°C water bath and mounted on electrostatic 
charged glass slides (Merck - BDH #406/0179/00) and dried overnight at 50°.  
 




2.10.2 De-waxing and re-hydration 
 Paraffin fixed tissues mounted on slides were subject to de-waxing and re-
hydration. Slides were de-waxed by two 5 minutes washes in a xylene bath and then 
re-hydrated in baths with decreasing concentrations of ethanol starting at 100%, 95% 
and finally 70% for 20 seconds each. Slides were then washed in running tap water 
for 30 seconds. At this point the sections were ready for staining or 
immunohistochemical (IHC) analysis.  
 
2.10.3 Haematoxylin and eosin staining of tissues  
 In serial sections of tissues, every tenth section was submitted to H&E to assess 
tissue and cell morphology. The in between sections were used for IHC if the 
histology was satisfactory.   
 Following de-waxing and re-hydration (see 2.10.2), sections were immersed in 
a haematoxylin bath for 5 minutes to stain the nuclei of cells blue. The slides were 
then washed in running tap water for 30 seconds and immersed on 1% acid alcohol 
(1 % HCl, 70 % ethanol) for 5 seconds to remove non-specific cytoplasmic staining. 
Slides were washed in running tap water followed by a 30 second immersion in 
Scott’s tap water bath (20 mM KCl2; 160 mM MgSO4) and washed again in running 
tap water. In order to stain the cytoplasm, the slides were immersed in Eosin bath for 
30 seconds, giving the cytoplasm a distinct pink colour. After washing the slides one 
last time in tap water, they were dehydrated by immersion in a series of increasing 
concentrations of ethanol (70 %, 80 %, 95 % 2x 100 %) for 20 seconds each. Finally 
the slides were incubated twice for 5 minutes in xylene and mounted in Pertex (Cell 
Path) with a glass cover slip.  
 
2.10.4 Immunohistochemistry  
2.10.4.1 General principle 
 Immunohistochemistry was used to visualise the expression of proteins in 
tissues using antibodies specific for target proteins. Detection is achieved by a 
second antibody conjugated to HRP (chromogenic DAB detection) or fluorescent 




detection tag (Immunofluorescence) (Figure 2.1). 
 All the IHC was carried out following the following steps:  
-Antigen retrieval (not applicable for PABP1) 





-Dehydration and xylene wash 
-Mounting with cover slip 
 Two separate washes of 5 minutes were performed between each one of the 
previous steps in 400 ml of TBS on a rocking platform at room temperature. 
 
Figure 2.1 - IHC detection systems. Illustration of DAB and 
immunofluorescence detection systems for Immunohistochemistry (IHC). 
Adapted from - http://www.leinco.com/immunohistochemistry 
 
 Dewaxed and de-hydrated sections (see 2.10.2) were submitted to an antigen 
retrieval step, with the exception of PABP1 antibody which did not require an 
antigen retrieval step. Antigen retrieval uncovers possible hidden antigen sites by 
breaking cross-links between proteins formed due to formalin fixation. For this, the 
slides were boiled for 5 minutes in 0.01 M citrate buffer (pH 6.0) in a pressure 
cooker and then left to stand in the citrate buffer for 20 minutes. Subsequently slides 
were incubated in 30 % hydrogen peroxide in methanol bath on a rocking platform 
for 30 minutes to block any endogenous peroxidase present in the tissues (this step 




was only applied for the chromogenic and the tyramide fluorescence detection 
systems). The slides were washed in tap water followed by two washes with TBS. 
Samples were then incubated with 100 μl blocking solution (5 % v/v serum from the 
animal species used to raise secondary antibody, 5 % w/v BSA in TBS) for 1 hour at 
room temperature. This minimizes the non-specific binding of the antibodies to the 
tissue. After blocking, sections were incubated with the primary antibody diluted in 
blocking solution (see 2.15.2 Table 2.7) and incubated over night at 4°C. The 
following morning slides were washed twice with TBS and incubated with the 
secondary antibody (see 2.15.2 Table 2.8) diluted in blocking solution for one hour at 
room temperature. The slides were then washed twice for in TBS. The following 
steps were dependent on the detection system used. 
 
2.10.4.2 Chromogenic DAB detection  
 In this detection system, the secondary antibody is conjugated to biotin, which 
binds streptavidin conjugated to horseradish peroxidase (HRP) that when catalyses 
the 3, 3’diaminobenzidinetrahydrochloride (DAB) substrate and gives a brown 
colour.  
 After the secondary antibody incubation and subsequent TBS washes (see 
2.10.4.1), the slides were incubated with 100 μl of 1 μg/ml streptavidin-HRP (Dako 
Labs) for 30 minutes at room temperature. Slides were washed two times for 5 
minutes in a TBS bath. DAB solution was diluted in the provided buffer (ImmPACT 
DAB kit - Vector Lab) according to manufacturer’s instructions. 100 μl of DAB 
solution was added to the tissue section. Incubation periods with DAB solution vary 
depending on the antibody and the tissue, therefore each slide was prepared 
individually and colour change monitored under a light microscope for between 30 
seconds to 1 minute. DAB reaction was stopped by washing slides in tap water. The 
tissue sections were then counter-stained with haematoxylin, dehydrated and 
mounted (see 2.10.3).  
 Sections were examined on a Provis AX70 (Olympus Optical) light microscope 
fitted with a Canon DS6031 camera (Canon Europe) and images analysed using 
Adobe Photoshop CS2 (Adobe Systems Europe Ltd) and AxioVS40 v4.8 (Carl Zeiss 







2.10.4.3.1 Direct detection 
 In this detection system the secondary antibody is conjugated with a 
fluorescent marker (see Figure 2.1), thus following incubation with the secondary 
antibody the slides were washed twice in 400 ml bath of TBS-T for 5 minutes in a 
rocking platform at room temperature, and counter-stain applied (see DAPI counter 
staining 2.10.4.3.3).  
 
2.10.4.3.2 Tyramide signal amplification detection  
 The tyramide signal amplification (TSA) system (Perkin Elmer) is used to 
enhance detection in IHC. Tyramide is a phenolic compound activated by HRP that 
works as an amplification reagent, by covalently binding to tyrosine residues of 
adjacent proteins. Activation only occurs immediately adjacent to sites at which HRP 
is bound (Figure 2.2). 
 
 
Figure 2.2 - Tyramide signal amplification (TSA) diagram. Illustration of 
TSA; a – standard HRP conjugated detection; b – TSA. B – biotin label; SA 
– streptavidin; HRP Horseradish peroxidase; T – tyramide. Adapted from - 
http://www.perkinelmer.com/pages/020/staticpages/tsasystems.xhtml 
 
 Following incubation with the appropriate peroxidase-conjugated secondary 
antibody (see 2.10.4.1), slides were washed twice for 5 minutes in a TBS bath. Slides 




were then incubated for 10 minutes at room temperature with the fluorescein 
tyramide signal amplification (TSA) diluted 1:50 in the TSA buffer provided with 
the TSA Kit (Perkin Elmer). Slides were finally washed in TBS-T for 5 minutes and 
counter-staining with DAPI. 
 
2.10.4.3.3 Fluorescent counter-staining with DAPI   
 Following direct or TSA immunofluorescence detection nuclei were visualised 
by DAPI fluorescent stain. After washing slides in TBS-T, sections were stained by a 
10 minute incubation at room temperature in 100 μl of DAPI (diamidino-2-
phenylindole) (Sigma) diluted 1:1000 in TBS. The slides were then washed in a 
TBS-T bath for 1 minute and mounted using PermaFluor (ThermoScientific) and a 
glass cover slip.  
 Fluorescent images were captured using a Zeiss LSM 710 Meta Axiovert 100M 
confocal microscope (Carl Zeiss Ltd). DAPI signal was detected with a laser 
emission at 409-480 nm and excitation at 405 nm. Alexa-488 was obtained with 
emission at 490-539 nm and excitation at 488 nm. Finally alexa-546 was obtained 
with emission at 549-670 nm and excitation at 546 nm.  
 All images were analysed in Adobe Photoshop CS2 (Adobe Systems Europe 
Ltd).  
  
2.11  In situ proximity ligation assay 
This technique allows the detection of endogenous protein interactions in 
tissue samples prepared for microscopy. Briefly, target proteins are detected with 
primary antibodies (raised in different species) which are themselves detected with 
oligonucleotide labelled secondary antibodies (PLA probes). The PLA probes are 
ligated through the addition of complementary oligonucleotides and amplified by 
rolling-circle amplification. Ligation only occurs when the two PLA probes are in 
close proximity of less than 40 nm. The result is a several hundred-fold increase in 
the number of oligonucleotides which are detectable through hybridization of 
fluorescence labelled oligonucleotides complementary to the amplified sequence. As 
each amplified PLA signal can be visualised as an individual fluorescent dot, this 




allows the localization of specific protein-protein interactions, within tissues and 
cells (Soderberg et al., 2006).  
Until the addition of the PLA probed secondary antibodies, the PLA 
procedure follows the same protocol as previously described for IHC (see 2.10.4.1). 
All solutions, buffers and enzymes describe hereafter are provided as part of a PLA 
kit (OLink biosciences) and were used following manufactures instruction. All 
described TBS-T washes represent two 400 ml bath washes in TBS-T for 5 minutes 
at room temperature on a rocking platform. Each incubation was performed in 100 μl 
volumes, covering the entire tissue at 37°C on a humidity incubator. 
After primary antibody incubation and the following TBS-T washes, the 
sections were incubated with secondary antibodies, PLA probes for 2 hours. The 
slides were then washed twice in TBS-T followed by incubation with the 
hybridization solution for 15 minutes. After a 1 minute wash with TBS-T, slides 
were incubated with the Duolink ligation solution for 15 minutes, and washed twice 
for two minutes in TBS-T. Sections were then incubated with the PLA polymerase 
enzyme solution for 90 minutes. After two washes with TBS-T, the slides were 
incubated with Duolink detection solution for 60 minutes, washed for 2 minutes in 
TBS-T and incubated with DAPI (see 2.10.4.3.3) for 10 minutes at room 
temperature. Finally, slides were prepared for mounting by a serial bath washes in 
solutions of decreasing concentration of SSC (2 x SCC; 1 x SSC; 0.2 x SSC and 0.02 
x SSC) for 2 minutes each. Slides were then mounted using PermaFluor 
(ThermoScientific) and a glass cover slip.  
 Fluorescent images were captured using a Zeiss LSM 710 Meta Axiovert 100M 
confocal microscope (Carl Zeiss Ltd). Confocal microscopy specifications are 












2.12 Cell culture techniques  
2.12.1 Cell culture  
 HeLa (human cervical carcinoma) cells were kept at 37C in 5% CO2 in 
Dulbecco's Modified Eagle Medium (DMEM) (Invitrogen) supplemented with 10% 
fetal calf serum (FCS) (Perbio). Cells were “passaged” by washing twice with PBS 
and incubation with 1 ml/cm2 10% trypsin-PBS (Sigma) to detach cells from the 
flask. Trypsinised cells were collected and vigorously pippeted to declump cells. A 
small number of cells, 1.5 x 104 per cm2 was used to seed new cultures.  
 Cell counting was performed in a 0.1 mm depth, 1/400 mm2 Neubauer 
haemocytometer (Hawksley Crystallite). 10 μl of trypsonised cells suspension was 
applied into the Neubauer haemocytometer. The number of cell per ml was 
calculated by averaging the number of cells in four different 1 mm2 squares 
multiplied by 104.  
 
2.12.2 DNA transfection  
Cells were split in a 1.8 x 104/cm2 ratio, 16 hours prior transfection to achieve 
70% confluency at the point of transfection. Lipofectamine™ 2000 Transfection 
Reagent (Invitrogen) was used to transfect cells, according to manufacturer 
instructions. Briefly, for a 6 well plate (9.4cm2/well), 2 μg of plasmid DNA was 
incubated with 1.5 ml of serum-free DMEM (Invitrogen) and mixed with a solution 
of 1.5 ml DMEM with 10 μl of Lipofectamine. This mix was incubated for 20 
minutes at room temperature to allow formation of transfection complexes and added 
to the cells, prior to incubation for 6 hours. The medium was then changed to DMEM 
supplemented with 10% FCS and cells incubated overnight. The following morning 
cells were subject to for microscopy analysis, or cell extracts made for western blot 
analysis or immunoprecipitation.  
 
2.12.3 siRNA transfection 
 1.2 x 105 cells were seeded per well in 12 well-plates and grown over night in 
DMEM supplemented with 10% FCS. The following morning, cells were transfected 




with 5 nM of the required siRNAs (Qiagen) (Table 2.4) using Hiperfect reagent 
(Qiagen) according to manufacturer instructions (Burgess et al., 2011). Cells were 
incubated in OPTIMEM (Invitrogen) for 48 hours after which they were collected in 
1 ml of ice cold PBS and stored at -80C until required.  
 
siRNA Catalogue No Target sequence 
Hs_PABPC1_4 SI00676662 CGGGCTCGGAACACACATTA 
Hs_PABPC4_8 SI04179861 AGGGAAGGCCTCCATATTATA 
 
 Table 2.4 - siRNA; sequences of human PABPs siRNAs. (Burgess et al., 
2011). 
 
2.13 Xenopus laevis oocyte techniques  
Animals were housed at the QMRI Xenopus laevis (X. laevis) facility in a 12 
hour light/dark regime with water temperature between 15-18°C. All procedures 
followed the regulations imposed by the UK Home Office (Animal Act, 1986 
[Scientific Procedures]). 
 
2.13.1 Oocyte preparation  
a  b  
Figure 2.3 - Xenopus laevis oocytes. a - Xenopus laevis ovary containing 
oocytes at varied stages of development wrapped in connective tissue, 
containing blood vessels. From - 
http://ibmmsrvlakitu.unibe.ch/sigel/xenopus.html; b - Xenopus laevis 
oocytes. Animal pole, dark brown hemisphere; and the vegetal pole, cream 
colour. From - http://www.xenopus.com/links.htm 
 
Oocytes for micro-injections were collected from adult female X. laevis. 
Animals were culled by submersion in a lethal dose of anaesthetic (500 ml 8g/L of 4-
aminobenzoic acid (Sigma) for 30 minutes). Once the animal failed in the 




responsiveness test (failed to right when turned over), an intra-cardiac injection of 
0.4 ml Phenobarbital was given. Death was confirmed by decapitation and 
exsanguination by removing the heart. The ovary lobes (Figure 2.3-a) were removed 
and washed several times in 20 ml of MMR (see 2.2.5), until the MMR remained 
clear. Oocytes were collected manually by “scrapping”, or by collagenase treating 
the ovary.  
 
2.13.1.1 Oocyte “scraping”  
To release oocytes from the ovary, the ovaries were gently pulled open with 
scissors, and with the aid of a metallic bacterial inoculation loop, oocytes were 
carefully scrapped off the connective tissue under a Leica MZ6 (Leica) dissecting 
microscope. 
 
2.13.1.2 Collagenase treatment  
Ovaries were gently opened and incubated twice for 1 hour at room 
temperature in 25 ml of 2.5 mg/ml collagenase B (Roche) in 1x MMR on a turn-
wheel. In between incubations, oocytes were washed 5 times in 1x MMR. Finally the 
oocytes were allowed to recover in 1x MMR solution at 18ºC overnight, before being 
injected in the following morning.  
 
2.13.2 Oocyte micro-injection  
Oocytes were sorted under a Leica MZ6 (Leica) dissecting microscope and 
stage VI oocytes selected for micro-injection based on size (1200–1300 μm) and 
appearance (Figure 2.3-b) and kept in 1x MMR solution at 18ºC. Stage VI X. laevis 
oocytes were micro-injected using a PLI-100 Harvard Apparatus micro-injector and 
a Narishige Micromanipulator under a Leica MZ6 dissecting microscope. Between 
30 and 50 oocytes were selected per experimental point, depending on the condition 
of the oocytes. RNA was injected at the mid-line to avoid nuclear damage, and each 
injection delivered approximately 50 nl of in vitro transcribed RNA (see 2.412). 
Oocytes were incubated at 18C in 1x MMR until harvested (Figure 2.4).  
 




Figure 2.4 - Micro-injections. Schematic representation of the micro-injection 
strategy. Plasmid DNA linearised and transcribed in vitro. mRNAs were micro-
injected into stage VI oocytes to produce proteins and/or measure translation rates.  
 
2.13.3 Tethered function assays  
Oocytes were initially injected with 50 nl of RNA encoding MS2-fusion 
proteins at a concentration of 1 μg/μl, and incubated at 18C in MMR for 6 hours. 
Each oocyte was then injected with a solution containing luciferase (5 ng/μl) and β-
galactosidase (20 ng/μl) reporter mRNAs and incubated overnight at 18C in 1x 
MMR (Figure 2.5). The following morning, before collecting the oocytes, any 
necrotic or unhealthy oocytes were discarded. The remaining oocytes were pooled in 
groups of 5, to reduce the effect of variation between individual oocytes, and 
homogenised in 200 μl of lysis buffer (Tropix). Both assays, luciferase and β-
galactosidase, were performed in duplicate for each pool of 5 oocytes and were done 
using a Monolight 3010 Luminometer (Pharmingen). For the luciferase assay 100 l 
of luciferase assay reagent (Promega) was added to 5 μl of oocyte extract and 
assayed immediately. -galactosidase activity was assayed using 2.5 l of oocyte 
lysate and 100 μl of a 1/100 dilution of Galacton-Plus (Tropix) in Galacto Reaction 




Buffer Diluent (Tropix). Samples were incubated at room temperature in the dark for 
45 minutes before mixing with 100 μl of Accelerator II Reaction Substrate (Tropix) 
and assay.  
Luciferase values were normalised against -galactosidase activity which 
acted as a co-injection control. 
 
Figure 2.5 - Tethered function assay. A- Schematic representation of the tethered 
function assay. A fusion between the MS2 coat protein and human DAZL (MS2-
DAZL), binds the MS2 binding sites within the 3’UTR of a luciferase reporter mRNA 
(Luc-MS2), tethering DAZL to the RNA. The effects of DAZL on translation are 
measured by luciferase assay. B– Cartoon of the reporters used for the tethered 
function assay. β-galactosidase reporter mRNA is used as an co-injected control. 
*Adapted from (Gray et al., 2000). 
 
2.13.4 Radio-labelling of newly synthesised 
proteins in oocytes  
In order to assess the expression of MS2-fusion in a sub-population (circa 5) 
of injected oocytes (see 2.13.2) they were incubated overnight in 10 l/ml of in vitro 
labelling grade 35[S]-methionine (50 mCi/l) (GE Healthcare). After 16 hours, 
oocytes were collected and washed in 1x MMR to remove any non-internalised 35[S]-
methionine. Oocytes were lysed in 10 l of TE per oocytes. 10 ml of TE was 
supplemented a priori with a protease inhibitor cocktail tablet (Roche). Lysates were 
cleared twice by centrifugation at 14,000 rpm at 4C for 5 minutes with the 
supernatant collected to a new 1.5 ml tube. 10 l of cleared supernatant, the 
equivalent to 1 oocyte, was mixed with 10 l 2 x sample loading buffer (see 2.2.2) 
and boiled for 5 minutes at 95C, cooled for 5 minutes on ice and run at 150 V on a 




NuPAGE 4- 12 % Bis-Tris pre-cast gel (Invitrogen) with a pre-stained protein ladder 
(BioLabs).  
The gel was fixed by being submerged three times for 10 minutes in fixing 
solution (40 % methanol, 10 % acetic acid) followed by a 30 minute incubation in 5 
% glycerol Enlightening solution (Perkin-Elmer). The gel was dried for 2 hours at 
80C in a Bio-Rad 583 Gel Drier and then placed on an exposing cassette with a 
Kodak BioMax MR film overnight at -80C. The following morning the cassette was 
placed vertically for 30 minutes at room temperature to thaw, and the film processed 
in an Exograph compact X4 X-ray processor (XoGraph Imaging Systems). 
 
2.14  Mouse work 
2.14.1 Mouse husbandry and welfare 
Animals were maintained in the Biomedical Research Facility at Little 
France, University of Edinburgh on a 12 hour light/dark regime, with humidity 
maintained at 55% and temperature between 20 and 25°C as specified in the Animal 
Act, 1986 (Scientific Procedures). Food and water were available ad libitum. All 
procedures were undertaken according to the UK Home Office regulations. Animals 
were culled by inhalation of rising concentration of carbon dioxide and subsequent 
cervical dislocation (Schedule 1 method). Setting up of timed matings (see 2.14.2) 
was carried out under my direction by facility staff. Neonates were culled by 
decapitation (Schedule 1 method). Unless otherwise stated, mice were wild-type 
C57BL/6. 
 
2.14.2 Time matings 
To assess fetal gonad development timed matings with individual pairs were 
set up. Females were examined for post-copulatory vaginal plugs with the morning 
of discovery being designated as 0.5 days post-coitum (0.5dpc), since mice mate 
during the middle of their dark period (overnight). Following Schedule 1 culling 
pregnant dams were placed in a supine position to allow removal of the intact uterus 
through the abdomen. Embryos were removed from the amniotic sacs, decapitated 
and immersed in PBS. Up to 13.5dpc the entire embryo was fixed. For embryos older 




than 13.5dpc the fetal gonads were removed, washed once in 1 ml of ice cold PBS, 
and fixed.  
 
2.14.2.1 Sex genotyping 
To determine the sex of the fetus, DNA was prepared from the head (11.5dpc 
and 13.5dpc) or tail (15.5dpc) which was snap frozen and stored at -80°C upon 
collection. The tissue was processed by immersion in 25 μl of TE-T (TE with 1% 
Tween -20) and 2 μl of 10 mg/ml proteinase K (Sigma) for 2 hours at 55°C to allow 
proteinase activity. Proteinase K was then denatured by boiling the sample at 95°C 
for 10 minutes. The digested tissue was spun at 7,000 rpm for 5 minutes at 4°C and 
the supernatant transferred into a fresh 1.5 ml tube. 10 μl of supernatant was diluted 
in 90 μl of distilled water and used for PCR.  
 
PCR Mix: 
-2 μl of the DNA  
-10 μl of Biomix Red Mix (Bioline) 
-0.2 μl of 100 mM each forward primer (Table 2.5) 
-0.2 μl of 100 mM each reverse primer (Table 2.5) 
 
Reactions were run in a Dyad PCR machine (Bio-Rad) using the following 
program: 
1) 3 minutes                              94°C  
2) 45 seconds                            94°C  
3) 50 seconds                            63°C  
4) 1 minute                                72°C  
     *2-4 repeated 40 times 
5) 5 minutes                              72°C  
 
 PCR products were run on a 2% agarose gel with a 100 bp ladder (NEB). 
Male fetuses generate 2 bands (225 and 370bp) and females, a single band (370bp). 
 
 




Name Location 5’ primer 3’ primer size 
Zfy Y 5'TGGCATCTGTCTCCTGACT 3’GCCACATGCTTCTTGAGTTC 225bp 
Xist X 5'T GCTCCACTTGAGACGGAAC 3'TCGGCCACTACTATGAGCAG 370bp 
 
Table 2.5 - Primers for sex genotyping. Location refers to the chromosome 
encoding the amplified sequence.  
 
2.15  Antibodies 
2.15.1 In-house antibodies  
Two different polyclonal antibodies specific for mouse PABP1 (PABP1) 
were raised in rabbits using two different peptides (Marshal – 
AQKAVNSATGVPTV; VINPY - PVINPYQPAPPSGY). 
One PABP4 antibody was raised in rabbits immunised against a peptide 
sequence present in both mouse and human PABP4 (KKEAAQKVGTVAAATS). 
Antibodies were raised by Covalab lab. 
Polyclonal sera from immunised rabbits was affinity purified by other 
members of the laboratory before use and stocks stored at -20°C in 20% glycerol 
PBS solution with 0.05% sodium azide.  
Concentrations of the affinity purified antibodies were calculated by Bradford 
assay (see 2.7.2).  
 
Antibody Concentration 
Marshal 112.6 μg/μl 
VINPY 56.3 ng/μl 
Anti-PABP4 240 ng/μl 
 
 Table 2.6 - In-house antibody concentrations. 
 
2.15.2 Commercial antibodies 
Several commercial antibodies were used in this project. Details on the 
suppliers, species raised in and dilutions for specific assays are detailed in Table 2.7 








Protein Raised in Supplier TSA DAB IF WB 
 α - LH subunit 
(R20 – GSU) 
Rabbit McNeilly Lab*1   1/1000  
β - LH subunit 
(518 B7) 
Mouse  Dr. J. F. Roser*1   1/5000  
DAZL Mouse Serotec – MCA2336  1/250 1/20 1/200 
DAZL Goat Everest – EB06857 Not Specific 
DAZL Abcam No longer available  1/100   
GAPDH-HRP Mouse Abcam -Ab9484    1/1,000 
GST Goat Abcam – ab6613    1/1,000 
IgG Mouse Sigma - I5381     
IgG Rabbit Sigma - I5006     
IgG Goat Perbio – 31402     
His-6 Mouse Sigma – H1029    1/1,000 
PABP1 (VINPY) Rabbit Gray Lab *2  1/1000  1/5,000 
PABP1 (Marshal) Rabbit Gray Lab  1/10,000 1/5,000 1/500 1/10,000
PABP4 Rabbit Gray Lab *2 1/7,500 1/2,000 1/1,000 1/2,500 
PABP4 Rabbit Abnova – 8761-D01P Not Specific 
PABP4 Rabbit Bethyl – IHC-00561  1/250  1/1,000 
Strep-Tag Mouse Novagen – 71590-3    1/1,000 
T7-Tag Mouse Novagen – 69522-3    1/10,000
 
Table 2.7 - Primary antibodies. *1 - (Pope et al., 2006) *2 - (Burgess et al., 2011); 
TSA –tyramide signal amplification; IF – Immunofluorescence; WB – Western blot. 
 
Anti-Species Raised in Conjugated Supplier IHC Western blot 
Goat Chicken Biotin SantaCruz - sc2984 1/500  
Goat Chicken HRP SantaCruz - sc2953  1/20,000 
Mouse Donkey Alexa-488 Invitrogen - A21202 1/200  
Mouse Goat Biotin Vector - E0433 1/500  
Mouse Goat HRP Pierce - 31444  1/20,000 
Rabbit Goat Alexa-546 Invitrogen - A11035 1/200  
Rabbit Goat Biotin Vector - E0432 1/500  
Rabbit Goat HRP Sigma - A0545  1/150,000 
 










Oligo Sequence Restriction sites
I.P1-F1 CAT GCA GAA TTC ATC AAC CCC TAC CAG CCA GCA CC EcoRI 
I.P1-R1 CAT GCA CAT ATG TTA GAC AGT TGG AAC ACC AGT GGC AC NdeI 
I.tP-F1 CAT GCA GAA TTC AAC CCC TAC CAA CCA GCA TCT TCC EcoRI 
I.tP-R1 CAT GCA CAT ATG TTA AAC AGT TGG GAC ACC AGA GGT ACT GC NdeI 
I.P4-F1 CAT GCA GAA TTC GCC ATC TTA AAT CAG TTC CAG CCT GC EcoRI 
I.P4-R1 CAT GCA CAT ATG TTA AGA GGT AGC AGC AGC AAC AGT GCC C NdeI 
mB-F2 ATG GAG ACC GAG TCC CGG GCG C  
mB-R2c TCA AAA TAA ACT CCT TAC TTT AAT TGG CTC AGG C  
mB-F2RE CAT GCA GGA TCC CAT GGA GAC CGA GTC CCG GGC GC BamHI 
mB-R2cRE CATGCACTCGAGTCAAAATAAACTCCTTACTTTAATTGGCTCAGGC XhoI 
c85a-F CTCGAGTCTACTGCAAATCATGAAACTCCAAACTCAACC  
c85a-R GGTTGAGTTTGGAGTTTCATGATTTGCAGTAGACTCGAG  
a97t_c98g-F CTGCAAATCCTGAAACTCCAATGTCAACCATCTCCAGAGA  
a97t_c98g-R TCTCTGGAGATGGTTGACATTGGAGTTTCAGGATTTGCAG  
a178g_t179c-F CCAAGGCTATATTTTACCAGAAGGCAAAGCCATGCCAAACACTGTTTTT  
a178g_t179c-R AAAAACAGTGTTTGGCATGGCTTTGCCTTCTGGTAAAATATAGCCTTGG  
a412g-F AGCTGGGCCCTGCAATCGGGAAACAAAATTTATGTG  
a412g-R CACATAAATTTTGTTTCCCGATTGCAGGGCCCAGCT  
hD+t –F GAATTCGATTTAGCCTCGATGTCTACTGCAAATCCTGAA  
hD+t – R TTCAGGATTTGCAGTAGACATCGAGGCTAAATCGAATTC  
hD.P6H+T-F GGA ATT CGA TTT AGC CTC GAT GTC TAC TGC AAA TCA TGA AA  
hD.P6H+T-R TTT CAT GAT TTG CAG TAG ACA TCG AGG CTA AAT CGA ATT CC  
3G9xD-F CCTTGAGTGATTTTTCCCCTTTTCATAGGAGTC  
3G9xD-R GGAACTCACTAAAAAGGGGAAAAGTATCCTCAG  
MmPABP1CDS-F GTG CCA CTG GTG TTC CAA CTG TCG TCG AC SalI 
MmPABP1CDS-R GGA TCC TAT GAA CCC CAG CGC CCC CAG CTA CCC BamHI 
MmPABP4CDS-F TGT ACA TAT GAA CGC TGC AGC CAG CAG C BsrGI 
MmPABP4CDS-R GCA CTG TTG CTG CTG CTA CCT CTG TCG AC SalI  
MmPABP5CDS-F GGA TCC TAT GAG TGG GGA GCC TAA TAC TGC BamHI 
MmPABP5CDS-R GGC AAG CTA GGC ACA GGT GGG TCG AC SalI 
hDexp.F CAT GCA TCT AGA ATG TCT ACT GC AAA TCC TG XbaI 
HDexp.R CAT GCA GGA TCC TCA AAC AGA TTT AAG CAT TGC CCG BamHI 
   
Table 2.9 - Oligonucleotides. Name, corresponding sequence and restriction 





















2.16  Plasmids 
All plasmids were sequence verified (see 2.4.9). The primers involved in the 




pGEM-T-easy-mPabp1c * pGEM-T-easy-hDAZL-N10C (no ATG) * 
pGEM-T-easy-mtPabpc * pGEM-T-easy-hDAZL-I37A (no ATG) * 
pGEM-T-easy-mPabp4.001c * pGEM-T-easy-hDAZL-R115G(no ATG) * 
pGEM-T-easy-mPabp4.002c * pGEM-T-easy-hDAZL (ATG) * 
pGEM-T-easy-mPabp4.003c * pGEM-T-easy-hDAZL-P6H * 
pGEM-T-easy-mPabp4.004c * pGEM-T-easy-hDAZL-N10C * 
pGEM-T-easy-mPabp5               pGEM-T-easy-hDAZL-I37A * 
pGEM-T-easy-mBoll * pGEM-T-easy-hDAZL-R115G * 
pGEM-hDAZL pGEM-hGDF9 
pGEM-T-easy-hDAZL-P6H (no ATG)    pGEM-T-easy-xATG-hDAZL 
YEAST TWO-HYBRID  
pACT-hDAZL BTM-mPabp1 (RRM 1-4)            
pGAD-hDAZL BTM-xPabp1c                              
pGAD-hDAZ                             BTM-hPABP1c                            
pACT-mDazl                             BTM-mtPabpc                              
pGAD-xDazl                              BTM-htPABPc                              
pGAD-hBOLL                            BTM-mPabp5                               
pACT-mBoll * BTM-mPabp4.001c * 
pACT-IRP                                   BTM-mPabp4.002c * 
BTM-KnDB  BTM-mPabp4.003c * 
BTM-mPabp1c                             BTM-mPabp4.004c * 
pACT-hPAIP                                 BTM.xPabp4c 
plexA-MS2                                  BTM-hDAZL
PROTEIN EXPRESSION 
pET52b(+)-mPabp1 * pET52b(+)-mPabp5 * 
pET52b(+)-mPabp4.001 * pGEX 
pET52b(+)-mPabp4.002 * pCGN 
pET52b(+)-mPabp4.003 * pCG.hDAZL * 
pET52b(+)-mPabp4.004 * pEGFP-C1 
REPORTER ASSAY 
pMSPN pLG.MS2 
pMS2-hDAZL  pMS2.U1A 
pMS2-hDAZL-P6H (no ATG) * pLuc.hGDF9.3’UTR 
pMS2-hDAZL-N10C (no ATG) * pLuc.hGDF9.3’UTR.∆hDAZL * 
pMS2-hDAZL-I37A (no ATG) * pCSFV-lacZ 
pMS2-hDAZL-R115G (no ATG) *  
 








2.16.1 pGEM constructs 
All pGEM-T-easy clones represent intermediate cloning steps, unless 
otherwise stated.  
 
pGEM-T-easy-mPabp1c was obtained by PCR generation of a fragment containing 
the C-terminal region of mouse Pabp1 open reading frame (ORF) (mPABP1c, amino 
acids 396-633) from the IMAGE clone (#6816124), using the oligonucleotide 
primers I.P1-F1 and I.P1-R1 (see Table 2.9). The resulting fragment and pGEM-T-
easy were digested with EcoRI and NdeI prior to ligation. 
 
pGEM-T-easy-mtPabpc containing the C-terminal region of mouse tPabp ORF 
(mtPABPc, amino acids 396-628) was generated following the strategy described for  
pGEM.Teasy-mPabp1c, but from the IMAGE clone #6704229 and using the primers 
I.tP-F1 and I.tP-R1.  
 
pGEM-T-easy-mPabp4 isoforms (001-004) containing the C-terminal region of the 
mouse Pabp4 splice variants (mPabp4c, starting at amino acid 395 until the end of 
the ORF), numbered according to the ENSEMBL predictions. These fragments were 
generated by RT-PCR from day 15 mouse testes RNA (see 2.4.2) using primers I.P4-
F1 and I.P4-R1. The resulting PCR fragments were cloned into pGEM-T-easy using 
EcoRI and NdeI.  
 
pGEM-T-easy-mPabp5 which contains the complete ORF of mouse PABP5. Gift 
from Ross Anderson (University of Edinburgh, unpublished). 
 
pGEM-T-easy-mBoll contains the ORF of mouse Boule obtained by RT-PCR (see 
2.4.1) with primers mB-F2 and mB-R2c from day 15 mouse testes RNA (see 2.4.2). 
This PCR fragment was cloned into pGEM-T-easy using BamHI and XhoI. 
 
pGEM-hDAZL containing the hDAZL ORF minus the endogenous start codon has 
been previously described (Collier et al., 2005b).  





pGEM-T-easy-hDAZL-P6H (no ATG) contains the hDAZL mutant P6H ORF minus 
the endogenous start codon and was generated using the XL site directed 
mutagenesis kit (Stratagene) following manufacturer’s instructions. pGEM- hDAZL 
was used as a PCR template with the mutation oligonucleotides c85a-F and c85a-R..  
pGEM-T-easy-hDAZL-N10C (no ATG) contains the hDAZL mutant N10C ORF 
minus the endogenous start codon and was generated as described for pGEM-T-easy-
hDAZL-P6H (no ATG) but using the oligonucleotides a97t_c98g-F and a97t_c98g-
R. 
 
pGEM-T-easy-hDAZL-I37A (no ATG) contains the hDAZL mutant I37A ORF 
minus the endogenous start codon and was generated as described for pGEM-T-easy-
hDAZL-P6H (no ATG) but using the oligonucleotides a178g_t179c-F and 
a178g_t179c-R. 
 
pGEM-T-easy-hDAZL-R115G (no ATG) contains the hDAZL mutant R115G ORF 
minus the endogenous start codon and was generated as described for pGEM-T-easy-
hDAZL-P6H (no ATG) but using the oligonucleotides a412g-F and a412g-R. 
 
pGEM-T-easy-hDAZL (ATG) contains the hDAZL ORF and was generated as 
described for pGEM-T-easy-hDAZL-P6H (no ATG) but using the oligonucleotides 
hD+t-F and hD+t-R, to introduce a functional start codon. 
 
pGEM-T-easy-xATG-hDAZL contains the hDAZL ORF with a functional start 
codon. It was generated by digesting pGEM-T-easy-hDAZL (ATG) with EcoRI to 
liberate the hDAZL ORF which was ligated into EcoRI digested ATG-pGEM 
(Gorgoni et al., 2011), a pGEM-T.easy plasmid with mutated upstream ATGs. This 
plasmid was used for target reporter assays (see chapter 5). 
 
pGEM-T-easy-hDAZL-P6H contains the hDAZL P6H mutant ORF with a functional 
start codon. It was generated following the same principle as pGEM-T-easy-hDAZL-
P6H (no ATG) but using the oligonucleotides hD.P6H+T-F and hD.P6H+T-R. The 




resulting PCR product was digested with EcoRI and cloned into ATG-pGEM 
(Gorgoni et al., 2011) with mutated upstream ATGs, previously digested with EcoRI. 
This plasmid was used for target reporter assays (see chapter 5). 
 
pGEM-T-easy-hDAZL-N10C contains the hDAZL N10C mutant ORF with a 
functional start codon cloned into ATG-pGEM (Gorgoni et al., 2011). It was 
generated following the procedure described for pGEM-T-easy-hDAZL (ATG) from 
the initial template pGEM-T-easy-hDAZL-N10C (no ATG). The result of this PCR 
and ATG-pGEM were digested with EcoRI and ligated. This plasmid was used for 
target reporter assays (see chapter 5). 
 
pGEM-T-easy-hDAZL-I37A contains the hDAZL I37A mutant ORF with a 
functional start codon in ATG-pGEM (Gorgoni et al., 2011). It was generated 
following the procedure described for pGEM-T-easy-hDAZL (ATG) from the initial 
template pGEM-T-easy-hDAZL-I37A (no ATG). The result of this PCR and ATG-
pGEM were digested with EcoRI and ligated. This plasmid was used for target 
reporter assays (see chapter 5). 
 
pGEM-T-easy-hDAZL-R115G contains the hDAZL R115G mutant ORF with a 
functional start codon in ATG-pGEM (Gorgoni et al., 2011). It was generated 
following the procedure described for pGEM-T-easy-hDAZL (ATG) from the initial 
template pGEM-T-easy-hDAZL-R115G (no ATG). The result of this PCR and ATG-
pGEM were digested with EcoRI and ligated. This plasmid was used for target 
reporter assays (see chapter 5). 
 
pGEM-hGDF9 containing the human GDF9 3’UTR was obtained by PCR 
amplification from the IMAGE clone #2978938 with primers 5’hGDF9 and 
3’hGDF9, and blunt cloned into pGEM-T-easy (SP6 promoter). This unpublished 
plasmid was a gift from Dr B. Collier (MRC Human Genetics Unit, Edinburgh). 
 




2.16.2  Y2H vectors 
pACT.mBoll containing the complete ORF of mBoll fused to the activation domain 
of GAL4 was obtained by retrieving the complete ORF of mBoll from pGEM-T-
easy-mBoll, using the restriction sites BamHI and XhoI. The mBoll ORF was cloned 
into the pACT backbone obtained from pACT.hDAZL (Ruggiu and Cooke, 
2000)previously digested with the same enzymes. Sequence analysis showed that the 
construct was out of frame. To correct this, the plasmid was digested with BamHI 
and then “filled in” with Klenow and religated.  
 
BTM-KnDB containing the lexA DNA binding domain was a gift from D. Bernstein, 
University of Wisconsin-Madison. 
 
BTM-mPabp1c containing the C-terminal region of mouse Pabp1 (mPABP1c, amino 
acids 396-633) fused to the lexA DNA binding domain was generated by digesting 
pGEM-T-easy-mPabp1c with EcoRI and NdeI. The fragment corresponding to 
mPabp1c was then cloned into BTM-KnDB (gift from D. Bernstein, University of 
Wisconsin) previously digested with the same restriction enzymes. 
 
BTM-mtPabpc containing the C-terminal region of mouse tPabp (mtPABPc, amino 
acids 396-628) fused to the lexA DNA binding domain was generated as described 
for BTM-mPabp1c but starting with pGEM-T-easy-mtPabpc. 
 
BTM-mPabp4.001c containing the C terminal region of mouse Pabp4.001 (mPabp4c, 
amino acid 395 – 660) fused to the lexA DNA binding domain was generated as 
described for BTM-mPabp1c but starting with pGEM-T-easy-mPabp4.001c.  
 
BTM-mPabp4.002c containing the C terminal region of mouse Pabp4.002 (mPabp4c, 
amino acid 395 – 615) fused to the lexA DNA binding domain was generated as 
described for BTM-mPabp1c but starting with pGEM-T-easy-mPabp4.002c. 
 




BTM-mPabp4.003c containing the C terminal region of mouse Pabp4.003 (mPabp4c, 
amino acid 395 – 631) fused to the lexA DNA binding domain was generated as 
described for BTM-mPabp1c but starting with pGEM-T-easy-mPabp4.003c. 
 
BTM-mPabp4.004c containing the C terminal region of mouse Pabp4.004 (mPabp4c, 
amino acid 395 – 644) fused to the lexA DNA binding domain was generated as 
described for BTM-mPabp1c but starting with pGEM-T-easy-mPabp4.004c. 
 
BTM-hDAZL containing the complete ORF of hDAZL fused to the lexA DNA 
binding domain was generated by digesting pGEM-T-easy-hDAZL(ATG) with 
EcoRI and BamHI. The resulting fragment was then cloned into BTM-KnDB (gift 
from D. Bernstein, University of Wisconsin), previously digested with the same 
restriction enzymes. 
 
pACT-hDAZL, and pACT-mDazl containing the ORFs of mouse and human DAZL 
fused to the GAL4 activation domain have been previously described (Ruggiu and 
Cooke, 2000). 
 
pGAD.hBOULE, pGAD-xDazl (Collier et al., 2005b) and pACT.IRP  (SenGupta et 
al., 1996) containing respectively the complete ORF of human BOLL, X. laevis Dazl 
and IRP fused to the activation domain of GAL4 have been previously described. 
 
BTM-Ct contains the C-terminal region of X. laevis PABP1 and has been previously 
described (Gray et al., 2000) BTM-hCt and BTM-tCt contain C-terminal region of 
human PABP1 and tPABP respectively fused to the LexA DNA binding domain and 
were a gift from Joel Smith (University of Edinburgh). 
 
lexA.MS2 containing the ORF of the MS2 coat protein fused to the DNA binding 
domain of lexA has been previously described (SenGupta et al., 1996). 
 
pACT.hPAIP contains the ORF of human PAIP1 fused to the GAL4 activation 
domain and has been previously described (Gray et al., 2000).  




pGAD.hDAZL, pGAD.hDAZ contains the ORFs of human DAZL and DAZ fused to 
the activation domain of GAL4 and were a gift from Joel Smith (University of 
Edinburgh, unpublished). 
 
BTM-PABP4Ct containing the C-terminal region of X. laevis PABP4 fused to the 
lexA DNA binding domain, has been previously described (Gorgoni et al., 2011).  
 
BTM-mPabp1(RRM1-4) and BTM-mPABP5 contains RMM1-RRM4 of mouse 
Pabp1 and the ORF of mouse Pabp5, respectively, fused to the lexA DNA binding 
domain, and were gifts from Ross Anderson (University of Edinburgh, unpublished). 
 
2.16.3 Expression plasmids 
pCGN is a mammalian expression vector that produces N-terminal T7 tagged 
proteins and has been previously described (Tanaka and Herr, 1990). 
 
pEGFP-C1 is a commercial plasmid (Clontech), containing a GFP mut1 variant 
(Cormack et al., 1996) followed by a multiple cloning site.  
 
pET52b(+) is a commercial plasmid (Merckmillipore), used for expression of 
proteins with an N-terminal Strep•Tag II and a 10X•His•Tag at the C-terminus. 
 
pET52b(+)-mPabp1 is a bacterial expression vector containing the ORF of mPabp1 
with a N-terminal Strep•Tag II and a 10X•His•Tag at the C-terminus. It was created 
by PCR of the mPabp1 ORF from the IMAGE clone (#6816124), using the 
oligonucleotides MmPABP1CDS-F and MmPABP1CDS-R. The PCR product and 
pET52b(+), were digested with BamHI and SalI prior to ligation. 
 
pET52b(+)-mPabp4.002 is a bacterial expression vector containing the ORF of 
mPabp4.002 with an N-terminal Strep•Tag II and a 10X•His•Tag at the C-terminus. 
It was created by PCR generation of a fragment from the IMAGE clone #277091, 




using the oligonucleotides MmPABP4CDS-F and MmPABP4CDS-R. The PCR 
product and pET52b(+) were digested with BsrGI and SalI prior to ligation. 
 
pET52b(+)-mPabp4.001 is a bacterial expression vector containing the ORF of 
mPabp4.001 with an N-terminal Strep•Tag II and a 10X•His•Tag at the C-terminus. 
It was created by digesting the fragment containing the splice variant region of 
mPabp4.001 from the plasmid pGEM-Teasy-mPabp4.001c using the enzymes NsiI 
and StuI. This fragment was cloned into the pET52b(+)-mPabp4.002 that was 
previously digested with the same enzymes (to replace the corresponding fragment 
from mPabp4.002). 
 
pET52b(+)-mPabp4.003 is a bacterial expression vector containing the ORF of 
mPabp4.003 with an N-terminal Strep•Tag II and a 10X•His•Tag at the C-terminus. 
It was generated as described for pET52b(+)-mPabp4.001 but using pGEM-T-easy-
mPabp4.003c as a template. 
 
pET52b(+)-mPabp4.004 is a bacterial expression vector containing the ORF of 
mPabp4.004 with an N-terminal Strep•Tag II and a 10X•His•Tag at the C-terminus. 
It was generated as described for pET52b(+)-mPabp4.001 but using pGEM-T-easy-
mPabp4.004c as a template. 
 
pET52b(+)-mPabp5 is a bacterial expression vector containing the complete ORF of 
mPabp5 with an N-terminal Strep•Tag II and a 10X•His•Tag at the C-terminus. It 
was generated as described for pET52b(+)-mPabp1 but using the IMAGE clone 
#125979 as a template and the oligonucleotides MmPABP5CDS-F and 
MmPABP5CDS-R. 
 
pCG.hDAZL is a mammalian expression vector containing the ORF of hDAZL with 
an N-terminal T7 tag. It was created by PCR of the hDAZL ORF from the pGEM-T-
easy-hDAZL(ATG) using oligonucleotides hDexp.F and h.Dexp.R, which introduce 
XbaI and BamHI restriction sites. The PCR product and pGCN was digested with 
XbaI and BamHI prior to ligation. 





pGEX is a bacterial expression vector containing the glutathione S-transferase, 
provided by GE Healthcare.  
 
2.16.4  Reporter assay plasmids 
pLG-MS2 containing the luciferase ORF reporter with 3 MS2 binding sites on its 
3’UTR has been previously described (Gray et al., 2000). 
 
pMSPN containing the ORF of the MS2 bacteriophage coat protein has been 
previously described (Wilkie et al., 2005). 
pCSFV-lacZ containing the lacZ gene with the classical swine fever virus IRES  has 
been previously described (Smith et al., 2011). 
 
pMS2-U1A containing the ORF of the MS2 bacteriophage coat protein fused to the 
U1A ORF has been previously described (Gray et al., 2000).  
 
pMS2-hDAZL has been previously described (Collier et al., 2005a). This plasmid 
contains the MS2 coat protein fused to the hDAZL in which the hDAZL ATG is 
absent. This plasmid was used in tethered function assays.  
 
pMS2-hDAZL-P6H containing the MS2 coat protein fused to the hDAZL mutant 
P6H was generated by liberating the ORF of hDAZL-P6H from pGEM-T-easy-
hDAZL-P6H(no ATG) using XhoI and BamHI. This fragment was cloned to 
pMSPN, previously digested with the same enzymes. This plasmid was used in 
tethered function assays. 
 
pMS2-hDAZL-N10C containing the MS2 coat protein fused to the hDAZL mutant 
N10C was generated as described for pMS2-hDAZL-P6H but using pGEM.Teasy-
hDAZL-N10C(no ATG) as a template. This plasmid was used in tethered function 
assays. 
 




pMS2-hDAZL-hDAZL-I37A containing the MS2 coat protein fused to the hDAZL 
mutant I37A was generated as described for pMS2-hDAZL-P6H but using pGEM-T-
easy-hDAZL-I37A(no ATG) as a template. This plasmid was used in tethered 
function assays. 
pMS2-hDAZL-R115G containing the MS2 coat protein fused to the hDAZL mutant 
R115G was generated as described for pMS2-hDAZL-P6H but using pGEM-T-easy-
hDAZL-R115G (no ATG) as a template. This plasmid was used in tethered function 
assays. 
 
pLuc.hGDF9.3’UTR containing the luciferase reporter gene fused to the 3’UTR of 
hGDF9 was a gift from Dr Collier (MRC Human Genetics Unit, Edinburgh, 
unpublished). hGDF9 3’UTR was digested from pGEM- hGDF9 with SalI and PstI 
and cloned into pUC19Luc (Reynolds et al., 2007), previously digested with the 
same enzymes. 
 
pLuc.hGDF9.3’UTR.ΔhDAZL contains the luciferase reporter gene fused with the 
3’UTR of hGDF9 in which the most striking DAZL binding site has been mutated 
using the XL site directed mutagenesis kit (Stratagene) following manufacturer’s 
instructions. pLuc.hGDF9.3’UTR was used as a template with the mutation 
oligonucleotides 3G9xD-F and 3G9xD-R. 
 
2.17 Statistical analysis 
 Statistical analysis was performed using GraphPad (GraphPad Software Inc). 






















Investigating potential interactions 















During gametogenesis, gene expression is highly dependent on post-
transcriptional regulation, in part due to long intervals of transcriptional quiescence. 
Therefore an important mechanism of gene regulation in germ cells is the activation 
of stored silent mRNAs by RNA-binding proteins (Seydoux and Braun, 2006, 
Kimble and Crittenden, 2007, Paronetto and Sette, 2009). In many cases such 
mRNAs are stored with short poly(A) tails.  
Reports from several labs have shown that DAZL family members, which are 
crucial for germ cell development, are mRNA-specific regulators of translation 
(Maines and Wasserman, 1999, Maegawa et al., 2002, Collier et al., 2005b, 
Reynolds et al., 2005, VanGompel and Xu, 2011). Two models have been proposed 
for their ability to stimulate translation. Collier et al. in 2005 presented a model 
based on work in Xenopus laevis (X. laevis) oocytes in which Dazl proteins act by 
directly recruiting PABP proteins to mRNAs circumventing the requirement for a 
long poly(A) tail in promoting the closed–loop conformation. An alternative model 
emerged from work in zebrafish suggesting that DAZL enhances mRNA translation 
and stability by suppressing micro RNA (miRNA) induced deadenylation (Takeda et 
al., 2009).  
Interestingly, both mouse and human DAZL can stimulate the translation of 
reporter mRNAs in X. laevis oocytes and show a conserved ability to interact with X. 
laevis PABP proteins, suggesting that this mechanism may be utilised in mammals. 
However, mammals encode additional members of both the DAZ and PABP 
families, adding to the complexity of possible DAZL-PABP interactions that may 
drive mRNA-specific translational activation during mammalian gametogenesis 
(Kleene et al., 1994, Saxena et al., 1996, Reijo et al., 2000, Saxena et al., 2000, 
Blanco et al., 2001, Feral et al., 2001, Kimura et al., 2009), necessitating an 
understanding of their relative expression patterns. 
Previous work has provided insight into the expression of Dazl in mouse 
gonads. At 12.5 days post coitum (12.5dpc), prior to germ cell sex differentiation, 
Dazl transcripts can already be observed. In oogonia, these increase by 14.5dpc, 
coinciding with the time that the first this initiates meiosis (13.5-14.5dpc) (Seligman 




and Page, 1998). Dazl protein is present in the cytoplasm of oocytes throughout 
oogenesis  increasing during oocyte maturation (Ruggiu et al., 1997, Chen et al., 
2011). In male germ cells, Dazl protein can be observed from fetal prospermatogonia 
through primary spermatocytes (Ruggiu et al., 1997, Reijo et al., 2000, Anderson et 
al., 2007). However, despite this reasonably comprehensive characterisation, 
important information on Dazl expression is still missing for both sexes during 
specific phases of mammalian germ cell proliferation and differentiation.  
Characterisation of PABP1 (the prototypical PABP) expression is in contrast 
surprisingly sparse in part due to a lack of PABP-specific antibodies. However in 
adult mouse testes, where it has been most intensely characterised, northern blot 
analysis on single cell suspensions from seminiferous tubules has shown that Pabp1 
mRNA is restricted to the pachytene spermatocytes and round spermatids (Kleene et 
al., 1994).  
 This chapter explores the possibility that mammalian DAZL proteins regulate 
translation initiation by interacting with the translation initiation factor PABP1, as in 
proposed to occur in X. laevis (Collier et al., 2005b). Hence, their precise expression 
patterns in mammalian gonads, the extent of their colocalisation within developing 
germ cells and their ability to interact will be determined.  
 
3.2 Results 
3.2.1 Dazl in mouse adult testes 
 12 tubule stages (I-XII) have been identified by Russel et al. (Figure 3.1) in 
adult testis, but Dazl expression has only been examined in stages III-IV, VII and X 
(Ruggiu et al., 1997). Therefore, information on important phases such as the mitosis 
to meiosis transition in stage V –VII tubules, and the zygotene progression in stages 
XI-XII is missing. Hence, to gain a more comprehensive characterisation of Dazl 
expression, an anti-DAZL antibody was optimised for fixed tissue (Appendix 1) and 
applied to adult mouse testes sections with the 12 tubule stages of spermatogenesis 
being identified based on cell phase and morphology. The 12 stages represent the 
developmental progression and differentiation that occurs during adult 
spermatogenesis, starting with spermatogonia which are germ cell stem cells 




committed to a male differentiation pathway, through mitosis and meiosis until 16th-
phase haploid spermatids are released into the lumen of the seminiferous tubules.  
 
Figure 3.1 - Staging diagram for mouse spermatogenesis. Diagram depicting the 
different phases of spermatogenesis in adult mouse. Tubule stages are described in 
roman numerals I-XII. The progression of germ cell types within these tubules is 
described by letters or numbers. m-In – mitotic A spermatogonium into intermediate 
spermatogonium; In-m - mitotic intermediate spermatogonium into B 
spermatogonium; B – B spermatogonium; B-m – mitotic B spermatogonium into 
preleptotene spermatocyte; PL – preletotene  spermatocyte; L – leptotene  
spermatocyte; Z – zygotene  spermatocyte; P – pachytene  spermatocyte; D – 
diplotene spermatocyte; m1-m2 – transition between meiosis I and II; 1-16 – stages 
of spermatids, 1-8 round spermatids, 9-16 elongating spermatids (Lahn et al., 2002), 
although stages 7-9 can be considered transitional stages. Stage II and III are 
grouped together due to an inability to precisely distinguishing them by light 
microscopy. From Russel et al. 1990. 
 
 Figures 3.2 to 3.5 show the results of the Dazl immunostaining in the 12 
different developmental stages, with the last panel in Figure 3.5 showing a no 
primary antibody negative control.  
 Dazl expression was detected in A spermatogonia (Figure 3.4 – stage X), 
intermediate spermatogonia (Figure 3.2 – stage II/III), B spermatogonia (Figures 3.2 
and 3.3 – Stages IV and VI) and preleptotene spermatocytes (Figures 3.3 and 3.4 – 
stages VI - VIII). Surprisingly there was a clear decrease in Dazl levels in leptotene 
cells at stage IX (Figure 3.4). This decrease became more evident at stage X, when 
Dazl was essentially undetectable in leptotene cells (Figure 3.4). At Stage XI (Figure 




3.5), with progression of early spermatocytes into zygotene phase, Dazl expression 
was restored and continued through the zygotene phase in stage XII tubules. Dazl 
expression was observed through the entire pachytene phase from stage I to stage X 
(Figures 3.2 -3.4). At diplotene phase in stage XI, there was a considerable decrease 
in Dazl expression (Figure 3.5). With progression of cell cycle into the meiosis I to 
meiosis II transition at stage XII, Dazl expression decreased even further to levels 
just above background (Figure 3.5). Dazl was not detected in round or elongating 
spermatids at any stage (Figures 3.2 to 3.5). As expected, Dazl was not detected in 
Sertoli cells, somatic cells within the tubules that support the developing  germ cells 
(Cooke et al., 1996). In the absence of primary antibody, immunostaining was only 
present in the Leydig cells between the tubules, suggesting that the observed pattern 
in germ cells is specific for Dazl (Figure 3.5 – Neg).  
 A representative montage of individual cells from each phase of development 
was constructed (Figure 3.6) using Adobe Photoshop and collated into a 
spermatogenesis developmental diagram based on the table of Russell 1990. This 
representation allowed periods of strong Dazl expression during mouse 
spermatogenesis to be clearly discerned. These results show that Dazl is present in 
the cytoplasm of all observed spermatogonia (A, intermediate and B) and continues 
through early meiotic cells including preleptotene, but decreases at leptotene in stage 
IX tubules and is undetectable in stage X leptotene cells. Through zygotene (stages 
XI and XII) Dazl expression resumes and is very robust throughout pachytene but 
starts to decrease again at diplotene (stage XI). Finally by anaphase of the meiosis I 
to meiosis II transition (m1-m2) Dazl was almost completely absent. Where observed 
Dazl was cytoplasmic but nuclear expression was also observed in B spermatogonia 
(stage V-VI), as described (Ruggiu et al., 1997).  
 In conclusion, this detailed characterisation showed that Dazl is expressed 
during mitosis and meiosis, but undergoes a surprising reduction at leptotene before 
recovering during zygotene and is most robustly expressed during pachytene. Levels 
of Dazl diminish during the meiosis I to meiosis II transition and Dazl is absent from 
post-meiotic germ cells. 













Figure 3.2 - Dazl is expressed in mouse adult testes – stages I to IV. IHC 
with DAB detection using an anti-DAZL antibody (1/250 dilution) in adult mouse 
testes detects Dazl expression. Germ cell types are marked. Tubule stages 
indicated in roman numerals. x100 magnification. 













Figure 3.3 - Dazl is expressed in mouse adult testes – stages V to VII. IHC 
with DAB detection using an anti-DAZL antibody (1/250 dilution) in adult 
mouse testes detects Dazl expression. Germ cell types are marked. 
Tubule stages indicated in roman numerals. x100 magnification. 













Figure 3.4 - Dazl is expressed in mouse adult testes – stages VIII to X. IHC 
with DAB detection using an anti-DAZL antibody (1/250 dilution) in adult 
mouse testes detects Dazl expression. Germ cell types are marked. 
Tubule stages indicated in roman numerals. x100 magnification. 










Figure 3.5 - Dazl is expressed in mouse adult testes – stages XI and XII. IHC 
with DAB detection using an anti-DAZL antibody (1/250 dilution) in adult 
mouse testes detects Dazl expression. Germ cell types are marked. 
Tubule stages indicated in roman numerals. Stage XI and XII x100 
magnification. Neg – negative control; L – Leydig cell; Neg – x40 
magnification.  





























Figure 3.6 - Montage of individual cells representing the stages of mouse 
spermatogenesis immunostained for Dazl. Tubule stages indicated by roman 
numerals I - XII. Ais – isolated A spermatogonium; Apr – proliferating A 
spermatogonium; m-In - A spermatogonium into intermediate 
spermatogonium; In-m - intermediate spermatogonium into B 
spermatogonium; B – B spermatogonium; B-Im - B spermatogonium into 
preleptotene spermatocyte; Pl – preletotene  spermatocyte; L – leptotene  
spermatocyte; Z – zygotene  spermatocyte; P – pachytene  spermatocyte; D – 
diplotene spermatocyte; m1-m2 – transition between meiosis I and II; 1-16 – 











3.2.2 Pabp1 in mouse adult testes 
Pabp1 mRNA has been shown to be present in pachytene spermatocytes and 
round spermatids (Kleene et al., 1994, Gu et al., 1995), however it is not clear to 
what extent this reflects the expression of Pabp1 protein, as PABP1 mRNA is subject 
to robust translational control. Thus, in order to gain an understanding of Pabp1 
expression during mouse spermatogenesis, the efficacy of two anti-PABP1 
antibodies, recently generated within the lab, for IHC was investigated (Appendix 2). 
One of these antibodies (Marshall) had been shown to be PABP1-specific by western 
blotting and immunofluorescence in cultured cell lines (Burgess et al., 2011). As 
both antibodies gave similar results (Appendix 2), subsequent experiments were 
performed with Marshall, described subsequently as anti-PABP1 antibody.  
Anti-PABP1 antibody was applied to adult testis sections and tubule stages 
identified based on cell morphology. In stage I-IV tubules (Figure 3.7), Pabp1 was 
present in the cytoplasm of round and elongating spermatids, but no expression was 
observed in pachytene spermatocytes. Pabp1 was not detected in any of the 
spermatogonial phases in stages I-VI (or in any other tubule stages, Figures 3.8 to 
3.10). Pabp1 was also robustly expressed in round spermatids within stage V-VII 
tubules (Figure 3.8) and to a lesser extent in elongating spermatids at these stages. 
Pabp1 was absent in pachytene cells at stage V (Figure 3.8), but started to be visible 
in stage VI pachytene cells and was abundant in the cytoplasm of pachytene cells by 
stage VII. No Pabp1 expression was observed in early spermatocytes in these or any 
later stages, until pachytene spermatocytes in stage VI. In stages VIII-X (Figure 3.9) 
Pabp1 was present in all pachytene spermatocytes and spermatids (round and 
elongating) but not in the spermatozoa in the lumen of the tubules (stage VIII). In the 
last two stages, XI and XII, Pabp1 was expressed in late pachytene and diplotene 
spermatocytes (stage XI), secondary spermatocytes (stage XII) and elongating 
spermatids (stage XI and XII) but not in early zygotene spermatocytes (Figure 3.10). 
Pabp1 was absent from the Sertoli and Leydig cells at all stages and as the no 
primary antibody control (Figure 3.11) did not show immunostaining the observed 
pattern  appeared  to  dependent  on  the  PABP1  antibody.  Lastly,  Pabp1  was not  
 













Figure 3.7 - Pabp1 is expressed in mouse adult testes – stages I to IV. 
IHC with DAB detection using an anti-PABP1 antibody (1/5000 
dilution) in adult mouse testes detects Pabp1 expression. Germ 
cell types are marked. Tubule stages indicated in roman 
numerals. x40 magnification.













Figure 3.8 - Pabp1 is expressed in mouse adult testes – stages V to 
VII. IHC with DAB detection using an anti-PABP1 antibody (1/5000 
dilution) in adult mouse testes detects Pabp1 expression. Germ 
cell types are marked. Tubule stages indicated in roman 
numerals. x40 magnification. 













Figure 3.9 - Pabp1 is expressed in mouse adult testes – stages VIII to 
X. IHC with DAB detection using an anti-PABP1 antibody (1/5000 
dilution) in adult mouse testes detects Pabp1 expression. Germ 
cell types are marked. Tubule stages indicated in roman 
numerals. x40 magnification. 












Figure 3.10 - Pabp1 is expressed in mouse adult testes – stages XI, 
XII and efferent ducts. IHC with DAB detection using an anti-PABP1 
antibody (1/5000 dilution) in adult mouse testes detects Pabp1 
expression. Germ cell types are marked. Tubule stages indicated 
in roman numerals. x40 magnification. 






Figure 3.11 - Negative control for PABP1 antibody in mouse testes. 
Negative control for IHC with DAB detection for the PABP1 
antibody in mouse testes performed with no primary antibody.. 
x20 magnification.  
 
 
observed in spermatozoa within the efferent ducts (Figure 3.10), although the ciliated 
epithelium cells of the efferent ducts did express Pabp1, providing a positive control 
for immunostaining. 
The twelve stages were subsequently compiled to form a Russel et al.-like 
staging diagram (Figure 3.12) (Russell et al., 1990)showing that Pabp1 expression 
starts in the cytoplasm of germ cells at pachytene spermatocytes within stage VI-VII 
tubules. A peak of Pabp1 expression can be observed between phase 4 and 9 
spermatids. Nonetheless, PABP1 expression appears robust from pachytene stage VII 
until the phase 9-10 spermatids. As the spermatids undergo nuclear elongation and 
condensation, Pabp1 levels diminish gradually with no Pabp1 being observed by the 
















































Figure 3.12 - Pabp1 expression during mouse spermatogenesis. Tubule stages 
are described in roman numerals I-XII. A – isolated A spermatogonium; Apr – 
proliferating A spermatogonium; m-In – A spermatogonium into intermediate 
spermatogonium; In-m - intermediate spermatogonium into B 
spermatogonium; B – B spermatogonium; B-Im – B spermatogonium into 
preleptotene spermatocyte; Pl – preletotene spermatocyte; L – leptotene  
spermatocyte; Z – zygotene  spermatocyte; P – pachytene spermatocyte; D – 
diplotene spermatocyte; m1-m2 – transition between meiosis I and II; 1-16 – 
stages of spermatids, 1-8 round spermatids, 9-16 elongating spermatids.











3.2.3 Colocalisation of Dazl and Pabp1 in adult 
mouse testes 
An in vivo interaction between DAZL and PABP1 in mammalian 
gametogenesis would require the simultaneous presence of both proteins in the 
cytoplasm of the same cells. The previous data (Figure 3.6, 3.12 and 3.13) show that 
both proteins appear to be present in the cytoplasm of pachytene spermatocytes from 
stage VI until the meiosis I to meiosis II transition at stage XII.  
To formally verify their co-localisation, dual immunofluorescence (IF) was 
performed with fluorescently labeled secondary antibodies. Since previous 
optimization showed that anti-DAZL and anti-PABP1 antibodies work best in 4% 
NBF and Bouin’s fixed tissues respectively (Appendix 1 – Figure A1.2 and 
Appendix 2 – Figure A2.2), intiatial dual IF was performed on tissues fixed with 
either of the fixatives (data not shown). Subsequent analysis was undertaken in 4% 
NBF fixed tissues. In the absence of the PABP1 primary antibody, Dazl was detected 
in spermatogonia and most stages of spermatocytes, including pachytene (Figure 
3.14-a), consistent with previous results. Pabp1 was detected in round and elongating 
spermatids in all tubules but only in some pachytene stages (Figure 3.14-b), when the 
Dazl antibody was omitted. When both primary antibodies were present (Figure 
3.14-c), merged images showed that Pabp1 and Dazl did not colocalise in stage III 
pachytene spermatocytes but did colocalise in the cytoplasm of pachytene 
spermatocytes in stage V-VI and VII tubules (Figure 3.14c). In stage VII, where both 
proteins are more strongly expressed, colocalisation results in a more yellow colour 
than in stage V-VI tubules where the pixels remain green-yellow due to weaker 
PABP1 expression at this stage.  
These results, together with the individual DAB expression patterns (Figures 
3.6, 3.12 and 3.13), support the conclusion that Dazl and Pabp1 are present together 
in the cytoplasm of pachytene spermatocytes from stage VI-VII (Figure 3.14) until 
the meiosis I to meiosis II transition at stage XII (summarized in Figure 3.15).  
 
 






Figure 3.13 - Dazl (a) and Pabp1 (b) are co-expressed in the cytoplasm of 
stage 7 pachytene spermatocytes until the meiosis 1 to meiosis 2 transition. 
Diagrams of spermatogenic developmental were assembled based on the Russel 
et al diagram (Figure 3.1) following IHC with DAB detection with a DAZL (Figure 
3.6) and PABP1 (Figure 3.12) primary antibodies. More detailed descriptions are 
provided in the legends of Figure 3.6 and 3.12.  
 
 




a)  b)  
c)  
Figure 3.14 - Stage specific Dazl and Pabp1 colocalisation. Adult testes 
were used for dual-IF was used to detect co-expression of Dazl (green) 
and Pabp1 (red) in adult mouse testes using fluorescently labelled 
secondary antibodies. a and b represent negative controls, for 
secondary antibodies, preformed with only one primary antibody: a – 
Anti-DAZL primary antibody; b – Anti-PABP1 primary antibody; nuclear 
counterstain (DAPI) – blue. Pachytene spermatocytes showing 
expression of both proteins are identified by orange arrows (Stage V-VI 
and VII), green arrow identifies pachytene spermatocytes only 
expressing Dazl. Specific cell types are indicated. Tubule stage is 



























Figure 3.15 - Staging diagram summarising the expression and co-expression 
of Dazl and Pabp1 during mouse spermatogenesis. Adaptation of the Russel 
et al diagram for mouse spermatogenesis, showing periods of Dazl (green) 
and Pabp1 (red) expression. Ais - isolated A spermatogonium; Apr - 
proliferating A spermatogonium; m-In - A spermatogonium into 
intermediate spermatogonium; In-m - intermediate spermatogonium into B 
spermatogonium; B - B spermatogonium; B-Im - B spermatogonium into 
preleptotene spermatocyte; PL - preletotene spermatocyte; L - leptotene  
spermatocyte; Z – zygotene  spermatocyte; P – pachytene  spermatocyte; 
D – diplotene spermatocyte; m1-m2 – transition between meiosis I and II; 
1-16 – stages of spermatids, 1-8 round spermatids, 9-16 elongating 
spermatids. 









3.2.4 Expression of Dazl and Pabp1 in pre-pubertal 
testis 
Several mRNA targets have been proposed to be translationally regulated by 
Dazl during mammalian spermatogenesis (Venables et al., 2001, Jiao et al., 2002, 
Reynolds et al., 2005, Reynolds et al., 2007, Zeng et al., 2008). To date only two, 
Mvh and Sycp3 (Reynolds et al., 2005, Reynolds et al., 2007), have been validated 
with Mvh and Sycp3 protein levels being decreased by 4-5 and 7 days post-partum 
(dpp) respectively in outbred Dazl knockout mice (Dazl-KO). Because this analysis  
was carried out during the first wave of spermatogenesis, expression of Dazl and 
Pabp1 was assessed during this timeframe to determine whether they are present 
within the same cells at times when decreased translation of target mRNAs is 
observed in Dazl-KO mice (Reynolds et al., 2005, Reynolds et al., 2007). 
Three developmentally relevant time points were chosen: 3 dpp prior to the 
initiation of meiosis (when the only germ cells present are prospermatogonia); early 
meiosis (10 dpp, when spermatogonia, preleptotene and leptotene spermatocytes are 
present); and mid-meiosis (12 dpp when spermatogonia, preleptotene/leptotene and 
zygotene/pachytene spermatocytes are present) (Bellve et al., 1977). Germ cells were 
identified by the morphology of their nuclei.  
Despite significant general background within the lumen, weak Pabp1 
expression can be observed in the cytoplasm of prospermatogonia at 3 dpp (Figure 
3.16-a). At 10 dpp, weak Pabp1 expression can be observed in the cytoplasm of 
spermatogonia (Figure 3.16-b). Finally, at 12 dpp, Pabp1 expression is observed in 
the cytoplasm of spermatogonia and early spermatocytes (preleptotene and leptotene) 
(Figure 3.16-c). No immunostaining was observed in the absence of primary 
antibody. These results indicate that Pabp1 expression can be detected in early stages 
of spermatogenesis, during differentiation of spermatogonia and early spermatocytes 
overlapping with the period when Mvh and Sycp3 expression is reduced in the Dazl-
KO mouse.  
 





Figure 3.16 - Pabp1 is expressed in pre-pubertal mouse testes. IHC using a 
PABP1 antibody in pre-pubertal mouse testis aged a – 3 dpp; b – 10 dpp; c – 12 
dpp. Black arrows indicate prospermatogonia; arrowheads indicate 
spermatogonia; green arrowheads indicate early meiotic germ cells. Germ cells 
were identified by characteristically large circular nucleus. In comparison, the 
somatic cells have narrow elongated nuclei. Red * - peritubular cell with no Pabp1 
expression.  x40 magnifications. insets – negative control with no primary 
antibody. 





Figure 3.17 - Dazl is expressed in pre-pubertal mouse testes. IHC using a 
DAZL antibody in pre-pubertal mouse testis aged a – 3 dpp; b – 10 dpp; c – 
12 dpp. Black arrows indicate prospermatogonia; arrowheads indicate 
spermatogonia; green arrowheads indicate early meiotic germ cells. Germ 
cells were identified by characteristically large circular nucleus. In 
comparison, the somatic cells have narrow elongated nuclei. x40 
magnifications. insets – negative control with no primary antibody. 




The presence of Dazl within these germ cells was confirmed showing that 
Dazl was strongly expressed at 3 dpp in prospermatogonia (Figure 3.17-a), 
decreasing with differentiation at 10 dpp (Figure 3.17-b) and was further reduced by 
12 dpp (Figure 3.17-c). Thus, Pabp1 and Dazl are both present during germ cell 
development in male pre-pubertal mice, consistent with the model that DAZL may 
utilise PABP1 to stimulate translation of mRNAs such as Scyp3 and Mvh (Collier et 
al., 2005b, Reynolds et al., 2005, Reynolds et al., 2007). 
 
3.2.5 Expression of Dazl and Pabp1 during female 
fetal gametogenesis 
In adult male mice, Dazl and Pabp1 colocalise during meiosis at the late 
pachytene phase. A similar colocalisation in females would occur during fetal 
development, as meiosis is initiated at 13.5 dpc in females concomitant with the 
germ cells being surrounded by somatic cells to form germ cell cysts (12.5 and 13.5 
dpc) (Tam and Snow, 1981, Bendel-Stenzel et al., 1998, McLaren, 2003). This event 
marks the beginning of germ cell sexual differentiation when they become 
committed to sex specific pathways and differences arise between sexes (Haston et 
al., 2009, Kerr and Cheng, 2009). Male germ cells do not enter meiosis but undergo 
mitotic arrest. In keeping with this sex specific difference, meiotic progression is 
impaired in 15.5 dpc oogonia and germ cells are lost by 4 dpp in outbred Dazl-KO 
mice (Ruggiu et al., 1997, Saunders et al., 2003, Lin et al., 2008).  
Therefore the expression patterns of Dazl and Pabp1 were examined during 
fetal germ cell development in females both prior to and at the initiation of meiosis 
(12.5 dpc and 13.5 dpc respectively) and at 15.5 dpc when all germ cells have left 
interphase and are engaged in prophase I (Di Carlo et al., 2000). Importantly, Figure 
3.18-a reveals that Dazl protein is already present in the PGCs of 12.5dpc fetal 
ovaries. This is consistent with reports that Dazl mRNA is present as early as 14.5 
dpc (Seligman and Page, 1998) and with recent reports that that PGCs in inbreed 
Dazl-KO C57BL/6 fail to respond to feminising or masculinising cues in developing 
gonads, which leads to the proposal that Dazl may serve as a so-called “licensing 
factor” for entry into oogenic or spermatogenic pathways (Gill et al., 2011). At 13.5 




dpc (Figure 3.18-b) PGCs continued to express significant levels of Dazl as they start 
to organize into clusters surrounded by developing granulosa cells, known as germ 
cell cysts (McLaren, 2003). By 15.5 dpc highly dense germ cell cysts can be 
observed, expressing high levels of Dazl (Figure 3.18-c).  
Unfortunately, Pabp1 expression could not be assessed at 12.5 dpc due to 
scarcity of the tissue but was examined at 13.5 and 15.5 dpc (Figure 3.19). At 13.5 
dpc, Pabp1 was expressed throughout the developing ovary, and it was possible to 
ascertain that this included the cytoplasm of the differentiating PGCs (Figure 3.19-a) 
which express Dazl (Figure 3.18-b). At 15.5dpc (Figure 3.19-b), Pabp1 remained 
diffusely expressed including in the cytoplasm of oogonia, although appeared less 
abundant than at 13.5 dpc. This reduced expression was consistently observed.  
In conclusion, these results show that Dazl and Pabp1 are both present in the 
cytoplasm of PGCs at 13.5 dpc, the period when XX PGCs commit to a female 
differentiation pathway and initiate meiosis, with Pabp1 levels declining once 
meiosis is initiated. The presence of both proteins during this timeframe raises the 
possibility that the reported requirement for Dazl at this stage (Lin et al., 2008, Gill 
et al., 2011)) may reflect its role in stimulating mRNA-specific translation (Collier et 
al., 2005b, Reynolds et al., 2005, Reynolds et al., 2007). 
 
 
3.2.6 Expression of Dazl and Pabp1 in fetal male 
gonads 
During fetal development, inbred male Dazl-KO mice develop phenotypes 
(Lin and Page, 2005, Lin et al., 2008) and male germ cells enter into a sexual 
dimorphic mitotic arrest. It was of interest to determine the expression of Dazl and 
Pabp1 in male fetal gonads and whether their expression varies significantly to that 










Figure 3.18 - Dazl is expressed in fetal female germ cells. IHC analysis using 
a DAZL antibody in fetal mouse ovaries: a – 12.5 dpc; b – 13.5 dpc; c – 
15.5 dpc; insets - negative control performed with no primary antibody. 
Arrowheads indicate germ cells which can be identified by their 
distinctive big round nuclei with diffuse chromatin and low nuclear to 
cytoplasm ratio, compared to the developing somatic cells which have 
smaller and more elongated nuclei: black – primordial germ cells; green - 
oogonia. x40 magnifications. 




Figure 3.19 - Pabp1 is expressed in fetal female germ cells. IHC analysis using a 
PABP1 antibody in fetal mouse ovaries: a – 13.5 dpc; b – 15.5 dpc; insets - 
negative control performed with no primary antibody. Arrowheads indicate 
germ cells which can be identified by their distinctive big round nuclei with 
diffuse chromatin and low nuclear to cytoplasm ratio, compared to the 
developing somatic cells which have smaller and more elongated nuclei: 
white – primordial germ cells; green - oogonia. x40 magnifications. 




Therefore, Dazl and Pabp1 expression were examined in fetal male gonads at 
the developmental times previously studied in females. At 12.5 dpc, similarly to 
females, PGCs were dispersed throughout the developing testis and robustly 
expressed Dazl (Figure 3.20-a). No Dazl expression was observed in the surrounding 
somatic cells, comprising the future Sertoli and Leydig cells. At 13.5 dpc (Figure 
3.20-b), fetal testes start to show clear morphological differences compared to age-
matched ovaries. At this time point PGCs are already organized within the 
developing seminiferous tubules and continue to express Dazl. As expected, Dazl 
negative cells can be also observed within the tubules, representing developing 
somatic Sertoli cells. At 15.5 dpc, the seminiferous tubules were highly populated 
with Dazl positive germ cells (Figure 3.20-c) although the more peripheral cells, 
likely the precursors of the somatic Sertoli cells, or somatic cells outside the tubules, 
were negative.  
In contrast to Dazl, Pabp1 is widely expressed within the developing 13.5 dpc 
testes (Figure 3.21-a) including in the cytoplasm of the Dazl expressing PGCs and 
the surrounding somatic cells. At 15.5 dpc, Pabp1 is observed in the cytoplasm of 
cells including the prospermatogonia (Figure 3.21-b). This diffuse staining is 
dependent on primary antibody since no signal is detected in the negative controls 
performed with no primary antibody (Figure 3.21-insets).  
In conclusion, during mouse testes development, Dazl and Pabp1 are both 
present within PGCs at 13.5 dpc. However, by 15.5 dpc in prospermatogonial cells, 
Pabp1 expression is dramatically reduced. Pabp1 levels also decline during this time 
in female mice but to a much lesser extent. Regarding Dazl expression no significant 
difference is observed between ages or sexes during the three time points analysed. 
 





Figure 3.20 - Dazl is expressed in fetal male germ cells. IHC analysis using 
a DAZL antibody in fetal mouse testes: a – 12.5 dpc; b – 13.5 dpc; c – 
15.5 dpc; insets - negative control performed with no primary antibody. 
Arrowheads indicate germ cells which can be identified by their 
distinctive big round nuclei with diffuse chromatin and low nuclear to 
cytoplasm ratio, compared to the developing somatic cells which have 
smaller and more elongated nuclei: black – primordial germ cells; green 
- prospermatogonia. x40 magnifications. 




Figure 3.21 - Pabp1 is expressed in fetal male germ cells. IHC analysis 
using a PABP1 antibody in fetal mouse testes: a – 13.5 dpc; b – 15.5 
dpc; insets - negative control performed with no primary antibody. 
Arrowheads indicate germ cells which can be identified by their 
distinctive big round nuclei with diffuse chromatin and low nuclear to 
cytoplasm ratio, compared to the developing somatic cells which 
have smaller and more elongated nuclei: black – primordial germ 
cells; green - prospermatogonia. x40 magnifications. 




3.2.7 Dazl and Pabp1 expression in adult female 
gonads 
 At birth, oocytes are arrested at the diplotene stage of meiosis I, and only 
those surrounded by granulosa cells in primordial follicles survive atresia (Pepling, 
2006). Subsequently, subpopulations of primordial follicles are activated progressing 
through primary, secondary and antral phases (Eppig, 2001), prior to A meiotic 
maturation and ovulation (Lee et al., 1996, Richards, 2005).  
Although the outbred Dazl-KO mice show no germ cells by 4 dpp (Saunders 
et al., 2003), recent work using morpholino knockdown has shown that Dazl is also 
required for the translational activation of mRNAs during oocyte maturation (Chen et 
al., 2011). Thus, to assess whether Dazl may utilise Pabp1 to activate translation in 
developing oocytes, their expression was investigated in adult mouse ovaries.  
 IHC analysis in adult mouse ovaries showed strong Dazl immunostaining in 
the cytoplasm of oocytes of primordial and primary follicles (Figure 3.22), which 
started to decrease in secondary follicles with antral follicles appearing to contain 
little Dazl. This reduction of Dazl in growing oocytes may appear at odds with its 
function during maturation but Chen et al. 2011 have shown that Dazl mRNA 
translation is activated during maturation. Dazl was also detected in the granulosa 
cells and the cells of the corpus luteum, only in the presence of primary antibody, 
despite being regarded as germ cell specific protein (Figure 3.22 - a and b).  
 




Figure 3.22 - Dazl is expressed in oocytes of primordial and primary follicles. IHC 
analysis of Dazl expression in adult mouse ovaries using an anti-DAZL 
antibody. a, b and c - Dazl expression in mouse adult ovaries. d – negative 
control performed with no primary antibody. a – x10 magnification; b – x20 
magnification; c – x40 magnification; d – x20 magnification.  
 
Similar investigation of Pabp1 expression (Figure 3.23) showed that it was 
expressed in a variety of cell types within the ovary and to varying extents. As 
observed for Dazl, there was significant Pabp1 expression in the cytoplasm of 
oocytes in primordial and primary follicles, which decreased in secondary follicles 
and was extremely low in the oocytes of antral follicles. Pabp1 was also robustly 
expressed in the granulosa cells and to a lesser extent in corpus luteum cells.  
In summary, in adult mouse ovaries, Dazl and Pabp1 show similar temporal 
expression within oocytes, both peaking in the oocytes of primordial and primary 
follicles, and diminishing as oogenesis progresses. Due to the small window of 
oocyte maturation, 10-20 hours, it was not possible to assess expression in maturing 
oocytes within the sections. This would require super-ovulation of mice and/or in 
vitro maturation of oocytes.  
 





Figure 3.23 - Pabp1 is highly expressed in oocytes and granulosa 
cells of primary and primordial follicles and corpus luteum. IHC 
analysis of Pabp1 expression in mouse adult ovaries using an 
anti-PABP1 antibody. a and b – expression of Pabp1 in mouse 
adult ovaries; c - no primary antibody control. a and b - x40 
magnifications; c - x20 magnification.




3.2.8 Interactions between mammalian DAZL and 
PABP1 
Previous work within the laboratory has shown that Dazl can stimulate 
translation in X. laevis oocytes by interacting with the C-terminal portion of X. laevis 
PABP1 and/or ePABP (xPABP1 and xePABP) (Collier et al., 2005b). The 
observation that Dazl and Pabp1 colocalise during specific stages of male and female 
gametogenesis in mouse suggests that this mechanism of action may be conserved in 
mammals. Thus the ability of murine Dazl (mDazl) and Pabp1 (mPabp1) to interact 
was investigated using a variety of in vitro and in vivo approaches.  
 
3.2.9 In situ proximity ligation assay 
Since colocalisation within the same cells does not establish a physical 
interaction, an in situ proximity ligation assay (PLA) was established to probe the 
ability of endogenous mDazl and mPabp1 to interact.  
PLA technology (Soderberg et al., 2006) extends the ability of FRET 
(reviewed in (Weibrecht et al., 2010)) to study protein-protein interactions within  
cells by detecting those between endogenous proteins. As described in section 2.11 
and in Figure 3.24, PLA uses primary antibodies (raised in different species) to 
detect endogenous proteins in situ and secondary antibodies conjugated to unique 
short DNA strands. When these secondary antibodies are in close proximity (0 < 40 
nm) the two PLA probes can be ligated by addition of complementary 
oligonucleotides. Once hybridised to the PLA probes these oligonucleotides form a 
circle which can be amplified several-hundred fold via rolling circle amplification. 
The amplified sequence is then hybridized with complementary fluorescent 
oligonucleotide probes. This results in a high concentration of a fluorescent signal for 
each single molecular interaction, detectable as distinct spots by fluorescence 
microscopy, thus even transient or weak interactions can be detected by PLA. 
 
 




Figure 3.24 - In situ proximity ligation assay. Schematic representation of the 




3.2.10 Optimisation of the in situ proximity ligation 
assay with anti-α and anti-β LH subunits in 
mouse pituitary 
As PLA is a relatively new and specialised technique, validation and 
optimisation was performed with a well-established interaction prior to using this 
technique to assess potential Dazl-PABP1 interactions.  
Luteinizing hormone (LH) is produced by the anterior pituitary gland and is 
an important regulator of reproduction both in males and females. LH is a 
heterodimeric glycoprotein composed of α and β subunits, which are non-covalently 
associated. The α and β subunits only heterodimerise in more peripheral regions of  
the anterior pituitary following a gonadotrophin releasing hormone (GnRH) stimulus 
from the hypothalamus (Pope et al., 2006). These properties make this interaction 
within the mouse pituitary attractive for optimising PLA, as the absence of subunit 
interactions in the posterior pituitary, provides a negative control.  




The initial steps of the PLA protocol are in common with IHC. Sections from 
mouse pituitary are antigen retrieved, blocked and incubated with both anti-α and 
anti-β LH subunit antibodies (Table 2.7) (Pope et al., 2006). After this, a specific 
OLink in situ proximity ligation assay protocol is followed (described in section 
2.11). 
Three variations of the method were tested to optimize the assay. In the first 
instance, the supplied OLink protocol was followed exactly. This included a final 
wash with 70% ethanol (EtOH), prior to mounting the slides with the provided 
OLink Biosciences media containing an Alexa Fluor 488 counterstain (#80100) and 
sealing the cover slip with nail varnish. This (Figure 3.25-a) resulted in a very weak 
signal in the anterior but not posterior pituitary, with localisation of this signal 
suggesting it was specific.  In the second, the final 70% EtOH wash was omitted 
enhancing the signal in the anterior pituitary (Figure 3.25-b). No fluorescence signal 
was observed in the posterior pituitary. Lastly, an extra incubation with DAPI 488 
counterstain was introduced before the serial washes with SSC buffer (see 2.11). 
This was followed by a 70% EtOH final wash and mounting with a cover slip using 
PermaFluor solution (ThermoScientific). This change in mounting media produced a 
signal pattern (Figure 3.25-c) identical to the one observed with the provided OLink 
Biosciences mounting media and of similar strength (Figure 3.25-a); however, the 
use of PermaFluor made the slides more durable and avoided the poor image quality 
and evaporation of mounting media sometimes associated with using nail varnish as 
a sealant.  
As including a DAPI 488 incubation and excluding the 70% EtOH wash both 
appeared to enhance the signal quality, a final experiment was performed with both 
protocol modifications (i.e. incubation with DAPI 488 counterstain; no 70% EtOH 
wash; cover slip mounted with PermaFluor). A montage of a mouse pituitary using 
this modified PLA protocol (Figure 3.26) showed a robust positive signal for LH 
heterodimerisation in the peripheral regions of the anterior pituitary. This pattern was 
not observed without anti-α LH subunit antibody (Figure 3.26 - inset) and  resembles 
that described in the literature (Pope et al., 2006), indicating that the optimised PLA 
protocol is a viable technique to assess in situ interactions between two proteins. 
 







Figure 3.25 - Optimisation of the in situ PLA for α and β LH subunits in 
mouse pituitary. In situ PLA protocol suggested by the manufacturer was 
optimised for mouse pituitary fixed sections, using an anti-α (1/1000) and an anti-β 
(1/5000) LH sub-unit primary antibodies. Three different steps for in situ PLA 
protocol optimization: a – as per manufacturer instructions; b – no 70% EtOH wash 
before mounting with Olink biosciences #80100; c – slide incubated with DAPI 
counter staining followed by mounting with PermaFluor. Red – Interaction of α and 





























Figure 3.26 - In situ PLA for α and β LH subunits in mouse pituitary. In situ 
PLA with α (1/1000) and β (1/5000) LH subunit primary antibodies performed in 
mouse pituitary fixed sections. Protocol followed manufacturer but including 
previous optimisation steps: incubated with DAPI, no 70% EtOH wash and 
mounted with PermaFluor. insets – negative control, in situ PLA with no α-subunit 
primary antibody, incubated with DAPI, no 70% EtOH wash and mounted with 
PermaFluor. Red – Interaction of α and β LH subunits. Blue – nuclear counter 
stain by DAPI. 









3.2.11 In situ proximity ligation assay with anti-Dazl 
and anti-PABP1 antibodies in mouse testes 
After optimisation of the PLA protocol with the LH subunits, this technique 
was used to assess potential interactions between Dazl and Pabp1 in mouse adult 
testes.  
Given the expression patterns of Pabp1 and Dazl as summarised in Figure 
3.13 and 3.15, any interaction in adult males is only likely to occur in the cytoplasm 
of spermatocytes between stage VI pachytene spermatocytes until the meiosis I to 
meiosis II transition (stage XII). However, PLA with anti-PABP1 (Marshall) and 
anti-DAZL antibodies produced a strong signal within Leydig cells and occasional 
weak foci in the seminiferous tubules (Figures 3.27-a). Increasing the amount of 
primary antibodies only diminished rather than enhanced the signal (Figure 3.27-b) 
and higher magnification images (Figure 3.28-a) showed that the signal obtained 
within the seminiferous tubules is within the early spermatocytes, a stage when 
Pabp1 is not expressed (see section 3.2.2), suggesting it does not represent a genuine 
interaction. Moreover, omitting either the anti-DAZL (Figure 3.27-c and 3.28-b) or 
anti-PABP1 (Figure 3.27-d) antibody confirmed the lack of specificity. 
It is possible that the lack of specificity was due to cross-reaction of the 
secondary mouse antibody with mouse testis proteins. Therefore, a newly available 
anti-DAZL antibody (Everest #EB06857) raised in goat was tested to establish 
whether it could be used for PLA (Figure A1.5 - Appendix 1). However, the pattern 
observed with this antibody was not consistent with the findings described earlier in 
this chapter nor with previous literature on Dazl mRNA or protein expression 
(Niederberger et al., 1997, Ruggiu et al., 1997). Thus it was unsuitable for use in 
PLA. 
In conclusion, although these results show that the proximity ligation assay 
proved to be a powerful technique to investigate in situ interaction of proteins, it 
could not be applied to study the DAZL-PABP1 interaction with the available 
antibodies.  
 




Figure 3.27 - In situ PLA in mouse testes with DAZL and PABP1 antibodies. In 
situ PLA performed in mouse testes using an anti-DAZL and an anti-
PABP1 antibody following previously optimised PLA protocol. a –anti-
DAZL (1/20) and anti-PABP1 (1/500) as optimised for dual 
immunofluorescence; b – anti-DAZL (1/10) and anti-PABP1 (1/250); c – 
negative control with no DAZL primary antibody; d – negative control 
with no PABP1 primary antibody Red – Interaction. Blue – nuclear 
counterstain by DAPI. * - Fluorescent signal within the seminiferous 
tubules. Each image represents a 4 x 4 montage of x40 magnification 
images. 
 





Figure 3.28 - In situ PLA in mouse testes with DAZL and PABP1 antibodies. 
Magnifications of 3.26 b (3.27 – a) and c (3.27 – b) figures. a – using 
1/10 dilution of anti-DAZL and anti-PABP1 (1/250) primary antibody; b – 
negative control with no DAZL primary antibody; Red – Interaction. 
Blue – nuclear counterstain by DAPI. x40 magnifications. 
 
 




3.2.12 In vitro interaction between DAZL and PABP1  
The yeast-two hybrid (Y2H) assay takes advantage of the ability of the DNA 
binding domain and the activation domain of transcription factors to be physically 
separated but to function when brought into proximity. Thus by expressing these 
domains as fusions with other proteins, protein-protein interactions can be assessed 
by transcriptional activation of reporter genes (in this case LacZ; Figure 3.29; (Fields 
and Song, 1989). Activation of the lacZ reporter is detected by a colorimetric assay. 
 
Figure 3.29 - Yeast two-hybrid assay schematic. Two fusion proteins are 
expressed in yeast. One has a transcription factor DNA binding domain 
(DB) fused to a “bait” protein (PABP) whilst the other contains an 
transcription activation domain (AD) fused to a “prey” protein (DAZL). If 
the “bait” protein interacts with the “prey” protein, the AD is brought into 
proximity of the DB, at the upstream activation sequence (UAS) of a LacZ 
reporter gene inducing its transcription. LacZ encodes β-galactosidase, 
which cleaves the substrate X-gal producing blue-pigmented colonies. In 




Thus, in order to assess whether mammalian DAZL and PABP1 interact, a 
directed Y2H approach was undertaken using the C-terminal region from mouse and 




human PABP1 fused to the lexA DNA-binding domain and mouse and human 
DAZL genes as GAL4-activation domain fusions. The C-terminal region of X. laevis 
PABP1 served as a positive control (Collier et al., 2005b) and iron regulating protein 




Figure 3.30 - DAZL-PABP interactions are conserved in mammals. Yeast two-
hybrid assay between DAZL and the C-terminus of vertebrate and 
mammalian PABP family members using qualitative β-Gal filter assays. IRP 
and MS2 represent negative controls. Blue plaques indicate a positive 
interaction. ND – not done. 
 
This showed that both the mouse and human DAZL proteins retained the 
ability to interact with X. laevis, mouse and human PABP1. No interactions were 
observed with the negative controls. This result indicates that the DAZL-PABP1 
interaction is maintained in multiple mammals as well as non-mammalian 
vertebrates, with its evolutionary conservation supporting its biological relevance. 
Furthermore, a second mammalian specific family member, tPABP, both from 
mouse and human was also able to interact with Dazl (Figure 3.30). tPABP is a germ 
cell specific protein that is only expressed in round spermatids (Kimura et al., 2009). 
 
3.2.13 Human DAZL and PABP1 interact in HeLa cells 
To confirm the interaction between mammalian PABP1 and DAZL by 
coimmunoprecipitations (co-IPs), cultured mammalian cells were transfected with a 
Dazl expressing plasmid because DAZL is only expressed in germ cells for which 




cell lines are not available. HeLa cells were chosen as they are easily cultured and 
transfected and express endogenous PABP1.  
 
 
Following optimisation of the transfection protocol (Appendix 3), HeLa cells 
were transfected with a vector expressing hDAZL (pCG-hDAZL). 24 hours post-
transfection cell extracts were prepared and subjected to immunoprecipitation with 
the anti-PABP1 antibody. Since both DAZL and PABP1 are RNA-binding proteins, 
RNase1 which cleaves after all 4 bases, was added to the co-IP to eliminate spurious 
RNA-mediated interactions (Figure 3.31-c). Co-immunoprecipitating (co-IP) 
proteins were detected by western blotting (Figure 3.31). To reduce non-specific 
binding of DAZL, washes were performed with a buffer containing 450 mM NaCl. 
Under these high stringency conditions (Figure 3.32) DAZL could be directly 
immunoprecipitated and was co-precipitated by the anti-PABP1 antibody, but not by 
the control antibody (anti-rIgG) indicating that these proteins interact. 
     
              
Figure 3.31 -  Schematic representation of co-immunoprecipitation (Co-IP). a - 
antibody bound to protein-A beads tumbled with cell extract, (b) in the 
presence of RNase1 which cleaves RNA molecules, including poly(A) 
sequences (c). Antibody binding to the specific protein of interest it is raised 
against retains this protein with the beads, and in permissive conditions its 
protein binding partners are also retained (d). Repeated washes remove 
unbound proteins. Finally bound proteins are eluted from the beads and 
analysed by western blot (e). 





Figure 3.32 - DAZL-PABP1 interaction in HeLa cells. Immunoprecipitation (IP) 
with anti-DAZL (D), anti-mouse IgG (mIgG), anti-PABP1 (P1) and anti-rabbit 
IgG (rIgG), from HeLa cell extracts transfected with hDAZL. IPs were western 
blotted against DAZL. Ipt represent 1% input of the material used for each 
IP. IPs were washed with 450mM NaCl. Mouse and rabbit IgG work as IP 
negative controls. 
 
To confirm this interaction, the reverse co-IP was also performed. At low salt 
concentrations PABP1 was co-immunoprecipitated by Dazl but also by the control 
antibody (mIgG). However, following high salt washes (600 mM NaCl) PABP1 was 
significantly enriched by the anti-DAZL antibody compared to the mIgG control 
(Figure 3.33). These results validate those obtained by Y2H providing further 
evidence that mammalian DAZL and PABP1 can interact.  
 
Figure 3.33 - Co-immunoprecipitation of PABP1 and DAZL. Immunoprecipitation 
(IP) with anti-DAZL, anti-mouse IgG (mIgG), anti-PABP1 and anti-rabbit IgG 
(rIgG), in HeLa cell extracts transfected with hDAZL. IPs were western blotted 
for PABP1 and DAZL. Immunoprecipitating antibodies are shown along the 
top and western blotting antibodies on the side of panels Ipt represent 0.5% of 
the material used for each IP. Different NaCl concentrations of the washing 
solutions: 1 – 300mM; 2 - 450mM; 3 – 600mM.  Mouse and rabbit IgG are IP 
negative controls.  
 
 




3.2.14 Interaction between endogenous Dazl and 
Pabp1 in adult mouse testes extracts 
To test whether the DAZL-PABP1 interaction is recapitulated with the 
endogenously expressed mouse proteins, co-IPs were performed using adult mouse 
testes extracts treated with RNase1. Immunoprecipitation was conducted using the 
anti-PABP1 antibody or rabbit immunoglobulin G (rIgG) to control for non-specific 
interactions. Western blotting for Dazl demonstrated that the anti-PABP1 antibody 
but not rIgG efficiently co-IP murine Dazl (Figure 3.34). 
 
 
Figure 3.34 - Endogenous Dazl-Pabp1 interactions. Immunoprecipitation 
(IP) with anti-PABP1 (P1) and anti-rabbit IgG (rIgG) as a negative 
control, in mouse adult testes extracts. IPs were western blotted for 
PABP1 and DAZL. Ipt represent 1% of the material used for each IP. IPs 
were washed with 200mM salt.  
 
 
These results show that endogenous mouse Dazl can interact with the 
translation initiation factor Pabp1. Taken together with their colocalisation in a 
subset of male and female germ cells, these data suggest that the Dazl-Pabp1 











This chapter examined whether DAZL may recruit PABP1 to fulfil its role in 
promoting mRNA-specific translation during mammalian gametogenesis. To this end 
the ability of these proteins to interact was established, and the extent of their 
colocalisation in adult and fetal male and female germ cells investigated. In so doing, 
this also provided insight into the expression of Pabp1 within mouse tissues and 
extended our understanding of the expression pattern of Dazl.  
 
3.3.1  Dazl expression in adult, pre-pubertal and 
fetal mouse gonads  
Despite the earliest phenotypes associated with loss of Dazl function 
occurring between 14.5 and 15.5 dpc (Lin and Page, 2005, Lin et al., 2008), Dazl 
expression in fetal ovaries prior to 17.5 dpc or in fetal testes had not been examined, 
although its mRNA was known to be present as early as 11.5 dpc in developing 
testes (Lin and Page, 2005). Consistent with the spectrum of phenotypes that arise 
during fetal development and after birth, Dazl expression in germ cells was initiated 
prior to morphological sex differentiation (at 13.5 dpc) (Figures 3.18 and 3.20) and 
could still be detected at the end of meiosis I in both sexes. In females, Dazl was 
present till the dictyate stage of oogenesis, declining significantly after the secondary 
follicle stage (Figure 3.22). Dazl levels are still low in fully grown oocytes (Nishi et 
al., 1999) but increase again during oocyte maturation (Chen et al., 2011). 
Interestingly, Dazl levels also declined in males, but to undetectable levels, in 
leptotene spermatocytes (stage IX-X) but recovered by zygotene ( stages XI-XII), 
consistent with a recent independent report (Kim et al., 2012). This indicates that 
Dazl may have additional functions after the described leptotene/zygotene arrest in 
males (Schrans-Stassen et al., 2001, Saunders et al., 2003) up until the meiosis I to 
meiosis II transition in stage XII spermatocytes (Figure 3.6) when expression ceases.  
Whilst Dazl appeared restricted to the cytoplasm of female germ cells at all 
stages examined, it was possible to observe some apparently nuclear Dazl in mitotic 
spermatogonia (Figures 3.2, 3.3 and 3.6), in agreement with previous reports (Ruggiu 




et al., 1997, Reijo et al., 2000). Consistent with this sub-cellular distribution, 
Drosophila Boule has a biphasic sub-cellular localisation translocating to cytoplasm 
just prior to the onset of the phenotype. However, eliminating it from the nucleus 
does not perturb entry into meiosis suggesting that its critical role is cytoplasmic 
(Cheng et al., 1998). Mouse Dazl has described roles in the erasure and re-
establishment of the imprinting methylation status of germ cells (Haston et al., 2009, 
Navarro-Costa et al., 2010), but these roles may well be indirect (i.e. through 
regulation of mRNAs required for these processes) and it is difficult to conclude with 
certainty from DAB stained tissues that Dazl is nuclear in the absence of additional 
evidence e.g. confocal analysis of cells from disaggregated testes. Nonetheless its 
presence within this compartment would allow for as yet undescribed functions in 
nuclear RNA regulation.  
Although Dazl is widely accepted as a germ cell specific protein (Cooke et 
al., 1996, Reijo et al., 1996b), notably it was also detected in the cytoplasm of 
granulosa cells and particularly within the cells of the corpus luteum. Although 
controversial, similar somatic expression has previously been observed in mouse and 
humans (Ruggiu et al., 1997, Pan et al., 2002, Pan et al., 2008), raising the question 
as to whether they are indeed sites of Dazl expression. In line with this, a specific 
form of Drosophila boule is expressed in the laminar cells of the fly eye (Joiner and 
Wu, 2004, Hoopfer et al., 2008), showing that this family, at least in invertebrates, is 
not germ cell specific.  
 
3.3.2  Pabp1 expression in mouse gonads 
Surprisingly, given the large amount of biochemical information available on 
PABP1 function, its expression pattern in multi-cellular organisms is virtually 
unknown. Thus this work provides the first characterisation of Pabp1 expression, 
focusing on both developing and adult testes and ovary; testis is the only tissue for 
which information regarding its mRNA distribution within different cell types was 
available (Kleene et al., 1994, Gu et al., 1995, Kleene et al., 1998) although PABP1 
mRNA was known to be present in human ovary (Feral et al., 2001).  




In fetal gonads, Pabp1 appeared to be expressed in both the PGCs and 
somatic cells at 13.5 dpc (Figures 3.19 and 3.21), although markers are required to 
further clarify the different cell types as only some could be identified by 
morphology with any certainty. Interestingly, Pabp1 was almost absent in testes by 
15.5 dpc whilst females showed only a small decrease in Pabp1 expression which 
may reflect sex specific differences at this age since female germ cells progress 
through meiosis whilst male germ cells enter mitotic arrest.  
In adults, Pabp1 was found to be expressed in the granulosa and theca cells of 
the ovary but not in the Sertoli and Leydig cells of the testis, despite these being 
considered broadly functionally equivalent. Within the germ cells, Pabp1 was 
abundant in primordial and primary oocytes with a marked decreased after this stage 
(Figure 3.23) and in stage VI-VII pachytene until the last phase of spermatid 
development (Figure 3.12). However, the conclusion that round spermatids express 
Pabp1 is complicated by the presence of tPabp within this stage (Kleene et al., 1994, 
Feral et al., 2001, Kimura et al., 2009), as the peptide used to raise the Pabp1 
antibody is 75% conserved within tPabp (Appendix 2). Nevertheless, several lines of 
evidence argue that Pabp1 is expressed in round spermatids. Firstly, the equivalent 
stage in humans contains Pabp1 mRNA (Feral et al., 2001) secondly, another in 
house Pabp1 antibody (VINPY) raised against a distinct peptide (64% identical to 
tPABP) also detected Pabp1 in round spermatids (Appendix 2), and thirdly, an 
independent Pabp1 antibody raised against an epitope with almost no homology to 
tPabp similarly detected Pabp1 in these cells (Kimura et al., 2009).  
 
 hPABP1-c mtPabp-c htPABP-c xPABP1-c 
mPabp1-c 99% 69% 90% 89% 
hPABP1-c  69% 91% 89% 
mtPabp-c   62% 62% 
htPABP-c    80% 
 
Table 3.1 - Homology between PABP1 and tPABP C terminal regions. 
A tPABP homologue is not present in X. laevis and percentages represent 
amino acid identity. hPABP-c – human PABP C terminal region;  mPabp – 
mouse Pabp; xPabp – X. laevis PABP. 
 
 




While the patterns obtained with our Marshall and VINPY antibodies were 
essentially identical (Appendix 2), they differed from that of Kimura et al., 2009 in 
one aspect. Neither of the in house antibodies detected Pabp1 in spermatogonia in 
adults, consistent with Pabp1 transcripts being restricted to late spermatocytes and 
round spermatids in humans (Kleene et al., 1994, Feral et al., 2001), but Pabp1 was 
apparently detected at low levels at this stage with the Kimura antibody (Kimura et al., 2009). However, 
Kimura et al detected Pabp1 by IF but did not identify tubule stages or use markers for 
spermatogonia, making assessment of this claim difficult from the low magnification 
images (Kimura et al., 2009).  
Another explanation for this apparent difference arises from our comparison 
of PABP1 expression in adults and during the first wave of spermatogenesis, since 
Kimura et al do not state whether adult or pre-pubertal mice were subject to IF with 
PABP1 antibodies. This comparison revealed that although mitotic spermatogonia 
and early spermatocytes do not express Pabp1 during adult spermatogenesis it can be 
detected in prospermatogonia (3 dpp), spermatogonia and early spermatocytes during 
the first wave. While this difference could reflect the presence of cross-reacting 
proteins in pre-pubertal mice, northern and western blot analysis of 5 dpp testes, in 
which the only germ cells are prospermatogonia, both detect Pabp1 (Kimura et al., 
2009). This indicates that Pabp1 expression is surprisingly differentially regulated 
during the first and subsequent waves of spermatogenesis. This unusual difference in 
the waves has also been noted for euchromatin epigenetic marker histone H3 
acetylated at lysine 9 (acetyl H3K9) (Webster et al., 2005). The physiological role of 
this intriguing difference in Pabp1 expression remains unclear but it could be related 
to differentiated spermatogonia arising directly from gonocytes during the first wave 
and from a spermatogonial stem cell population in subsequent waves.  
 
3.3.3 Dazl may activate mRNA-specific translation 
during mammalian gametogenesis by PABP1 
recruitment  
This chapter examined the hypothesis that DAZL proteins may activate the 
translation of specific mammalian mRNAs by recruiting PABPs as described in X. 




laevis oocytes (Collier et al., 2005b). This model is dependent on the ability of Dazl 
to interact with PABPs. Importantly, three independent lines of evidence supported a 
direct RNA-independent interaction between Dazl and the prototypical family 
member, Pabp1, which was found to be expressed in a subset of male and female 
germ cells. Firstly, both murine and human DAZL interacted with PABP1 in an Y2H 
assay (Figure 3.30), secondly DAZL could be immunoprecipitated from transfected 
cell lysates with an anti-PABP1 antibody (Figure 3.32) and thirdly, endogenous 
Pabp1 and Dazl were reciprocally co-IPed from adult mouse testes lysates (Figure 
3.34). While the latter supports the physiological relevance of this interaction, 
controls showing that these proteins do not also pulldown unrelated proteins, would 
further support the specificity of this interaction, although stringent conditions were 
utilised. Conservation of this interaction is consistent with the ability of mouse Dazl 
to interact with X. laevis PABPs and to stimulate the translation of reporter mRNAs 
in stage VI oocytes (Collier et al., 2005b). 
X. laevis oocytes do not, however, contain a tPabp homologue which is 
mammalian specific. The C-terminal regions of murine and human tPABP are 69 % 
and 91 % identical compared to their respective Pabp1 counterparts (Table 3.1). 
Although not verified by a second method, Y2H indicated that tPABP could interact 
with Dazl. However, tPABP is only expressed in round spermatids (Kleene et al., 
1994, Gu et al., 1995, Kimura et al., 2009), which appear to lack Dazl, since it is last 
detected during the meiosis I to meiosis II transition. Therefore it is unlikely that 
DAZL recruits tPABP for its function in promoting translation in vivo. The 
apparently fortuitous interaction of tPabp and Dazl, and the ability of proteins which 
are normally physically separated to interact following lysate preparation (Ohh et al., 
1998) emphasise the importance of directly visualising interacting proteins within the 









3.3.4 Dazl-KO phenotypes and Pabp1 expression 
Dazl null mice present complex phenotypes (summarised in Figure 3.35). On 
an inbred background, abnormal germ cells appear in the fetal gonads of both sexes 
as early as 14.5-15.5dpc (Lin and Page, 2005, Lin et al., 2008). Germ cell survival is 
greatly enhanced on an outbred background with germ cells reaching the pachytene 
spermatocyte phase in males, although apoptotic, leading this to being described as a 
leptotene-zygotene block (Schrans-Stassen et al., 2001, Saunders et al., 2003). In 
outbred females abnormal chromatin condensation is detectable by 17.5 dpc and 
germ cells are absent by 4 dpp (Saunders et al., 2003). Importantly, Pabp1 is present 
within germ cells during the time frames when the various Dazl phenotypes develop 
(summarised in Figure 3.35), with dual IF confirming that Pabp1 and Dazl are both 
present, at the same time, within the cytoplasm of studied germ cells (Figures 3.13 
and 3.15). Thus these results taken together with the interaction data support the 
hypothesis that Dazl activates the translation of specific mRNAs by recruiting Pabp1, 
allowing formation of a closed-loop mRNA conformation.  
 
Figure 3.35 - Dazl and Pabp1 co-expression in mouse gametogenesis. Dazl and 
Pabp1 are both expressed during stages associated with mouse Dazl-KO 
phenotypes. In males co-expression is depicted with two different red lines, 
the bottom one starting after birth until pachytene-meiosis II spermatocytes 
represent the first wave of spermatogenesis, the top representing subsequent 
waves of spermatogenesis which show co-expression only between 
pachytene and meiosis II. *1 - (Lin and Page, 2005, Lin et al., 2008); *2 - 
(Saunders et al., 2003); *3 - (Schrans-Stassen et al., 2001); *4 - (Ruggiu et al., 
1997, Schrans-Stassen et al., 2001, Saunders et al., 2003). 
 




However, the translational activation of Dazl target mRNAs is likely to be 
complex. For instance, Pabp1 is present at 3 and 10 dpc straddling the timeframe 
when Dazl has been shown to function as a translational activator of verified target 
mRNAs, Mvh and Sycp3. In Dazl KO mice, their protein levels decrease at 4-5dpp 
and 7dpp respectively (Reynolds et al., 2005, Reynolds et al., 2007), consistent with 
Pabp1 playing a critical role in this process. But, in subsequent rounds of 
spermatogenesis, Pabp1 expression apparently follows the initial translation of Sycp3 
(Dobson et al., 1994, Yuan et al., 2000) apparently inconsistent with this model. 
However, Sycp3 mRNA is also translationally activated by CPEB1 in both sexes 
(Tay and Richter, 2001) with Sycp3 protein levels being incompletely ablated in both 
Dazl and CPEB1 KO mice (Tay and Richter, 2001, Reynolds et al., 2007). The 
CPEB1 and Dazl binding sites within Sycp3 mRNA overlap suggesting that their 
binding may be mutually exclusive (Tay and Richter, 2001, Reynolds et al., 2007, 
Brook et al., 2009) and interestingly in this regard recent work during oocyte 
maturation has shown that Dazl mRNA translation is initially activated by CPEB1 
and subsequently by itself (Chen et al., 2011). Thus the absence of Pabp1 when 
Sycp3 is initially activated during spermatogenesis in adults may reflect the 
temporality of translational activation by CPEB1 and Dazl, with Dazl maintaining 
























Investigating potential interactions 

























PABP4 is one of the least characterised members of the PABP family. 
However, recent work in X. laevis has shown that this vertebrate specific PABP 
appears to activate global translation in a manner similar to PABP1 (Gorgoni et al., 
2011). Consistent with this, mammalian PABP4 was found to associate with 
polysomes in cell lines (Burgess and Gray 2012) and to activate the translation of a 
reporter mRNA containing the IL-2 3’UTR in cell-free extracts (Okochi et al., 2005). 
To date, little work has been done to assess the temporospatial expression pattern of 
PABP4 in any species, although RT-PCR suggests it is developmentally regulated in 
X. laevis (Gorgoni et al., 2011) and northern blotting suggests that PABP4 mRNA is 
variably expressed in a range of human tissues (Yang et al., 1995). PABP1 mRNA is 
subject to extensive translational control (Burgess and Gray, 2010), and examination 
of the 5’UTR of PABP4 suggests the conservation of at least one of these control 
elements (NK Gray, personal communication), highlighting the importance of 
examining the expression of PABP4 protein directly.  
 As previously discussed, X. laevis Dazl has been shown to interact with two 
PABP family members, the prototypical PABP1 and embryonic PABP (ePABP). It 
has been shown that these interactions underlie the ability of Dazl to promote the 
translation of specific germ cell mRNAs (Collier et al., 2005b). Chapter 3 extends 
these observations by showing that the interaction between PABP1 and DAZL is 
conserved in mammals. Although PABP4 has the C-terminal region that mediates 
PABP1/ePABP-DAZL interactions, the amino acid sequence of this region differs 
considerably between PABPs and thus it remains unclear whether DAZL can also 
utilise PABP4 to activate specific mRNAs. In support of a putative DAZL-PABP4 
interaction, PABP4 transcripts are highly enriched in both human testis and ovary 
(Yang et al., 1995), although it remains to be determined whether PABP4 is 
expressed in germ cells. Therefore, in this chapter, the possibility that Dazl fulfils its 
role in translation activation, in part, by interacting with PABP4 will be scrutinised. 
To this end, the expression pattern of murine Pabp4 within gonads will be 
established, to determine the extent of its colocalisation with Dazl. The ability of 
these proteins to interact will also be examined.  





4.2.1 PABP4 antibody validation 
To date most work on the PABP family has revolved around the archetypical 
PABP1. As a result no PABP4-specific antibodies have been available, leading to a 
lack of information pertaining to its expression pattern.  
Thus to investigate Pabp4 expression in mouse tissues an in house antibody 
was raised against a C-terminal peptide (KKEAAQKVGTVAAATS). This peptide is 
conserved in the four putative mouse Pabp4 splice variants proposed by Ensembl 
(Hubbard et al., 2009), but differs greatly from the equivalent peptide in ePabp and, 
to a lesser extent, Pabp1 and tPabp (Figure 4.1).  
 
 
anti-PABP4  KKEAAQKVGTVAAATS 
mPabp4-001  KKEAAQKVGTVAAATS 
mPabp4-002  KKEAAQKVGTVAAATS 
mPabp4-003  KKEAAQKVGTVAAATS 
mPabp4-004  KKEAAQKVGTVAAATS 
mPabp1      -KEAAQKAVNSATGVP 
mtPabp      -KEAAQKAVGSTSGVP 
mePabp      MESTDRN--------- 
 
Figure 4.1 - Peptide homology corresponding to sequence within the C 
terminal domain of mouse Pabp4 used to raise the anti-PABP4 antibody.  
Peptide homology corresponding to the sequence within the C-terminal region 
of mouse Pabp4 used to raise the PABP4 antibody (blue). Green and red- 
amino-acids either match or vary from the peptide sequence respectively; 
mPabp4.001-004 – putative splice variants of mouse Pabp4 (isoforms 1 to 4); 
mPabp1 – mouse Pabp1; mtPabp – mouse tPabp; mePabp – mouse ePabp. 
 
As a first step to testing the specificity of the anti-PABP4 antibody, HeLa 
cells, which express both PABP1 and PABP4, were transfected with siRNAs found 
to be effective for PABP1 or PABP4-specific knockdown (Burgess et al., 2011). 
Western blotting of the resulting cell extracts with the anti-PABP4 antibody (Figure 
4.2) showed that it appeared to be specific for PABP4 since no protein band was 
detected in the siPABP4 lane, but a protein of the predicted size was detected in 




mock and siPABP1 transfected cell extracts (Figure 4.2 – a). GAPDH served as a 
loading control. Conversely, the PABP1 antibody, used in Chapter 3, failed to detect 
PABP1 in the siPABP1 lane (Figure 4.2 – b), supporting the specificity of both the 
PABP1 and PABP4 antibodies.   
a)  b)  
Figure 4.2 - Anti-PABP4 antibody specifically detects PABP4 in HeLa cells. 
HeLa cells were transfected with 5 nM of siPABP1 (siP1), siPABP4 (siP4) or were 
mock transfected and incubated for 48 hours. a – Anti-PABP4 antibody only 
detects PABP4 in cells transfected with siPABP1 or mock transfected. b - An anti-
PABP1 antibody (Marshall) does not detect any signal following PABP1 
knockdown but still detects PABP1 following PABP4 knockdown or mock 
transfection. GAPDH is used as a loading control. 
 
To investigate the specificity of this antibody for IHC across a range of tissues, the 
PABP4 and PABP1 antibodies were applied to serial sections of whole 15.5 dpc 
mouse embryos, fixed in Bouin’s. Interestingly, this revealed that Pabp4 was widely 
expressed across different mouse tissues but by no means ubiquitous (Figure 4.3). In 
particular Pabp4 showed significant expression in the neopalial cortex (the future 
cerebral cortex), heart, intercostal muscle, liver, Bowman’s capsule in the developing 
kidney, pancreatic primordium, lining of the stomach (Fundic glands) and the lungs. 
Pabp1 was also found not to be ubiquitously expressed and was concentrated in 
several developing organs: the posterior area of the ventricular zone; mesodermic 
condensation (future extrinsic ocular muscle); primordial of follicles of vibrissae, 
Bowman’s capsule in the developing kidney, ovaries,  pancreatic primordium,  lining 
of the stomach (Fundic glands) and the lungs (Figure 4.4). Importantly, while some 
tissues/structures showed expression of both proteins (neopalial cortex, extrinsic 
ocular muscle, kidney, ovary and lining of the stomach), others only showed 
expression of one or other of these PABPs (liver, heart, intercostals muscle, 
ventricular zone, whiskers).  




Figure 4.3 - Pabp4 is not ubiquitously expressed during mouse fetal 
development. IHC on 15.5 dpc female mouse using the anti-PABP4 antibody 
(1/2000 dilution). 1 – ventral zone; 2 – neopalial cortex (future cerebral cortex); 3 
– mesodermal condensation (future extrinsic ocular muscle); 4 – primordial of 
follicles of vibrissae; 5 – atrium; 6 – ventricle; 7 – intercostal muscle; 8 – liver; 9 – 
kidney (Bowman’s capsule); 10 – ovary; 11 – pancreatic primordium; 12 – lining 
of the stomach (Fundic glands); 13 – lung. Inset – negative control performed 
with no primary antibody.  





Figure 4.4 - Pabp1 is not ubiquitously expressed during mouse fetal 
development and has a different expression pattern from PABP4. IHC on 
15.5 dpc female embryo using an anti-PABP1 antibody (1/5000 dilution). 1 – 
ventral zone; 2 – neopalial cortex (future cerebral cortex); 3 – mesodermal 
condensation (future extrinsic ocular muscle); 4 – primordial of follicles of 
vibrissae; 5 – atrium; 6 – ventricle; 7 – intercostal muscle; 8 – liver; 9 – kidney 
(Bowman’s capsule); 10 – ovary; 11 – pancreatic primordium; 12 – lining of the 
stomach (Fundic glands); 13 – lung. Inset – negative control performed with no 
primary antibody. 




These results establish that neither PABP is ubiquitously expressed during 
mammalian development, with sites of concomitant expression of both Pabp1 and 
Pabp4 and sites where they are differentially expressed.  
As this data also supported the efficacy of this antibody in distinguishing 
between Pabp4 and Pabp1, it was optimised for further use on Bouin’s fixed adult 
mouse testes by applying different dilutions (range 1/500 to 1/2000).  
 
Figure 4.5 - Optimisation of the anti-PABP4 antibody for IHC in mouse 
testes. Three dilutions of the PABP4 antibody in mouse testes. a) 1/500; b) 
1/1000; c) 1/2000 diluted in normal goat serum were applied to Bouin’s fixed 
adult mouse testes. d) No primary antibody control. * - Sertoli cell cytoplasm; + - 
germ cells; L – Leydig cells. x20 magnifications. 
 
All dilutions showed a similar pattern of DAB detection with cytoplasmic 
staining in a variety of cell types and stages (Figure 4.5). In all dilutions, Pabp4 
appeared most highly expressed in the germ cells adjacent to the basement 
membrane (spermatogonia and early spermatocytes, a more in depth description is 
provided in section 4.2.2) and in the cytoplasm of the Sertoli cells. Pabp4 was also 
detected at lower levels, particularly at higher antibody concentrations, within later 




germ cell stages excluding spermatozoa, and in the Leydig cells. In the absence of 
primary antibody (Figure 4.5- d) or in the presence of rabbit IgG or normal rabbit 
serum (Figure 4.6; Ross Anderson), immunostaining was not detected in any of these 
cell types suggesting that the observed pattern is dependent on the PABP4 antibody. 
Hereafter, the anti-PABP4 antibody was used as a 1/2000 dilution in normal serum. 
 
a) 
b)  c)  
Figure 4.6 - Additional controls further support the specificity of the anti-
PABP4 antibody. Sections of adult mouse testes immunostained for Pabp4 in 
parallel with additional negative controls. a – anti-PABP4 antibody; b – rabbit 





4.2.2 PABP4 expression in mammalian adult testes 
Following optimisation and validation of the antibody, the cells expressing 
Pabp4 within the testes were analysed in greater detail. In agreement with Figure 4.5, 
Figure 4.7- a recapitulates the previous observed Pabp4 expression pattern with 
markedly stronger expression in the cells adjacent to the basement membrane 
Staging of different tubules according to Russell et al., 1990 (Figure 3.1) (Russell et 
al., 1990) revealed these cells to be B-spermatogonia and early spermatocytes, 




namely preleptotene, leptotene and zygotene spermatocyte cells. Pabp4 expression 
was significantly diminished essentially to background levels in subsequent stages 
(i.e. pachytene, secondary spermatocytes (spermatocyte in metaphase – Figure 4.7)) 
and round and elongating spermatids. 
However, Pabp4 was strongly expressed in the cytoplasm of the Sertoli cells 
which extends from the basement membrane towards the lumen and also weakly in 
the Leydig cells. Its presence in these somatic cells which support germ cell 
development by delivering nutrients, regulating hormone levels and by secreting 
tubular lumen fluid (reviewed in (Russell et al., 1990), reveals that Pabp4 is not 
restricted to the germ cells within the testis. As expected, no expression was 
observed in spermatozoa released into the lumen of the seminiferous tubules (stages 
VII-VIII) (Figure 4.7-a) or in the efferent duct, where sperm are concentrated due to 
testicular fluid reabsorption and undergo maturation (Hermo and Smith, 2011) 
(Figure 4.7- b). However, the ciliated epithelium cells of the efferent ducts express 
Pabp4, providing an internal control for the efficacy of the antibody. Pabp4 may 
contribute to the high rate of protein synthesis in these cells which produce lumicrine 
factors required for sperm transport and maturation (Hermo and Smith, 2011).  
Comparison of the Pabp4 expression to that observed with Pabp1 and Dazl 
revealed that the expression of Pabp4 within the testes is almost reciprocal to that of 
Pabp1, and highly reminiscent of the expression of Dazl within the germ cells (see 










Figure 4.7 - Pabp4 is expressed in germ and somatic cells in mouse adult 
gonads. IHC analysis of mouse adult testes sections with an anti-PABP4 antibody 
(1/2000) in mouse adult testes. a – Pabp4 is robustly expressed in the cytoplasm 
of B-spermatogonia, preleptotene, leptotene, zygotene germ cells and Sertoli 
cells. The weak Pabp4 expression in the cytoplasm of pachytene spermatocytes, 
round spermatids, elongating spermatids and in Leydig cells (L) may represent 
background staining. b – no Pabp4 staining is observed in the spermatozoa within 










b)  c)  
Figure 4.8 - The expression pattern of Pabp4 in adult mouse testes is 
distinct from Pabp1, but significantly overlaps with that of Dazl. IHC of adult 
mouse testes with DAB detection using: a – PABP4 (from Figure 4.7 - a); b – 
PABP1; c – Dazl antibodies. PABP4 and Dazl expression shows an intense peak 
in the cells close to the basement membrane (spermatogonia and early 
spermatocytes), whilst PABP1 expression is stronger in inner germ cells (round 
and elongating spermatids). a and and b - x20 magnification, c – x40 
magnification.  
 
4.2.2.1 PABP4 expression pattern is conserved in 
mammalian testes  
Since this data represents the first analysis of PABP4 expression and taking 
advantage of the conserved nature of peptide used to raise the antibody, PABP4 
expression was also examined in other mammalian species to determine whether the 
observed pattern was recapitulated. Due to tissue availability, expression was 
analysed in adult rat and marmoset testes alongside mouse testes by two different 
detection systems: DAB and immunofluorescence (IF). In contrast to mouse, 
marmoset spermatogenesis progresses with a “helical” organisation within the 
seminiferous tubules, with different spermatogenic stages observed in the same 
tubule section (Millar et al., 2000). In spite of this organisational difference, the 
pattern of Pabp4 expression in marmoset testes was broadly similar to that in mouse, 




with stronger DAB staining in the early germ cells proximal to the basement 
membrane of the tubules and lighter staining in cells closer to the lumen (Figure 4.9). 
However, the cytoplasm of Sertoli cells was not clearly distinguishable, suggesting 
that Pabp4 may not be abundant in these cells in the marmoset.  
 
Figure 4.9 - PABP4 expression is broadly similarly in mouse and marmoset 
testes. a and b – IHC with anti-PABP4 antibody (1/2000); c and d – no primary 
antibody controls. a and c – mouse testes, b and d - marmoset testes. x20 
magnification. 
 
IF with tyramide detection in mouse and marmoset also gave results 
resembling those obtained with DAB detection, with the most intense signal being in 
the outermost germ cells and, in the case of mouse, also the Sertoli cells (Figure 
4.10- a, b and c). The pattern observed in rat (Figure 4.10-b) most strongly resembled 
that obtained for mouse (see figure 4.7) with strong detection of PABP4 in early 
germ cells and in the extended cytoplasm of the Sertoli cells. Together these results 
suggest that PABP4 is predominantly expressed in the early germ cell stages of both 
rodent and primate species, with rodent species also showing significant staining 
within the Sertoli cells.  




Figure 4.10 - IF IHC analysis shows that PABP4 pattern of expression in 
mammalian testes is broadly similar. Immunofluorescent (IF) detection of 
PABP4 (1/7500) in a – mouse; b – rat; and c - marmoset testes. d – rat testes 
negative control with no primary antibody. Red – PABP4, blue – DAPI nuclear 
counterstain. x40 magnifications.  
 
4.2.2.2 Dazl and Pabp4 are predominantly expressed in 
the same germ cell stages in adult mice testis.  
Comparing the expression analysis of Pabp4 with that obtained for Dazl (see 
sections 3.2.1 and 4.2.2.1) supports the hypothesis that Pabp4, like Pabp1, may be 
utilised by Dazl to activate mRNA translation. Indeed the almost distinct patterns of 
Pabp1 and Pabp4 raise the possibility that Dazl may utilise Pabp4 in early germ cells 
and Pabp1 later in spermatogenesis to activate a cascade of mRNAs required for 
these different developmental stages. Thus to confirm that Dazl and Pabp4 co-reside 




within the cytoplasm of the same germ cells, a dual-IF IHC assay with tyramide 
detection was utilised.  
 
a)  b)  c)  
d)  e)  
Figure 4.11 - Pabp4 and Dazl colocalise within the cytoplasm of early germ 
cells in adult mouse testes. Dual immunofluorescence with anti-Dazl and anti-
PABP4 antibodies using tyramide detection  a - anti-PABP4; b - anti-DAZL; c - 
merge of a and b; d and e. e - Colocalisation confirmed using intensity analysis 
software along the arrow shown in d (Zeiss Zen 2007). Red – Pabp4; Green – 
Dazl; Blue –DAPI nuclear counterstain. a, b and c – x40 magnification; d - x100 
magnification.  
 
In agreement with earlier data, both Pabp4 and Dazl expression was highest 
in the cytoplasm of the more peripheral germ cells (Figures 4.11- a and b) with their 
co-expression being confirmed in merged images (Figure 4.11- c). However, 
merging the images did not produce the expected distinctive yellow colour, due to 
the differing relative pixel intensities of the Dazl and Pabp4 signals. Therefore, to 
further confirm that both proteins co-reside within the cytoplasm of cells, a pixel 
intensity analysis was performed using the Zeiss Zen 2007 software focusing on the 
early germ cells where both proteins are highly expressed (Figures 4.11 - d and e). 
To this end, a cross-section of the picture was selected starting from the basement 
membrane towards the lumen and software used to read the pixel intensity for each 




colour through the selected line (Figure 4.11- d). A graph depicting the pixel 
intensity throughout the marked line, with the X axis representing distance (basement 
membrane towards lumen), and Y axis representing pixel intensity is shown (Figure 
4.11- e). This revealed that the expression of both proteins is very low at the 
basement membrane but dramatically increases within the cytoplasm of the first 
germ cell, decreases significantly in the nucleus and increases again in the 
cytoplasm. This nuclear/cytoplasmic variation continued through the analysed 
section with high pixel intensity for both proteins within the cytoplasm, and low 
intensity in the nucleus. These results establish that both proteins are found diffusely 
distributed within the same cellular compartment, the cytoplasm, during early stages 
of spermatogenesis, consistent with the hypothesis that they may interact to activate 
translation of a subset of mRNAs within germ cells. 
 
4.2.2.3 Pabp4 expression in mouse fetal gonads 
The previous sections established that Dazl and Pabp4 are both present within 
the cytoplasm of spermatogonia and early spermatocytes, which represent germ cells 
undergoing mitotic or entering meiosis division, respectively. Thus in order to 
investigate the expression of Pabp4 during the equivalent stages in females, anti-
PABP4 antibody was applied to the gonads of fetal female mice (Dazl - Figure 3.18; 
Pabp4 - Figure 4.12).  
At 13.5 dpc Pabp4 was detected throughout the developing ovary Figure 4.12 
- a. Despite this essentially ubiquitous pattern, Pabp4 could be identified within the 
cytoplasm of primordial germ cells (PGCs) within the germ cell cysts, which also 
express Dazl (Figure 3.18), and in the surrounding somatic cells. At day 15.5 dpc 
(Figure 4.12 - b) expression of Pabp4 was maintained throughout the ovary including 
the cytoplasm of oogonia, the site of Dazl expression.  
 




Figure 4.12 - Pabp4 is widely expressed in female fetal gonads including the 
germ cells. IHC with DAB detection was performed using the anti-DAZL antibody 
at different developmental stages: a – 13.5 dpc; b – 15.5 dpc. Arrowheads indicate 
germ cells: black – PGCss; green - oogonia. x40 magnifications; insets - no 
primary antibody controls.  
 




Figure 4.13 - Pabp4 is widely expressed in male fetal gonads including the 
germ cells. IHC with DAB detection was performed using the anti-DAZL antibody 
at different developmental stages: a – 13.5 dpc; b – 15.5 dpc. Arrowheads indicate 
germ cells: black – PGCs; green – prospermatogonia; * - inter germ cell space; S – 
Sertoli cells. x40 magnifications; insets - no primary antibody control. 
 




 As previously mentioned there is a marked sexual dimorphic status in germ 
cells at these stages of development, with only female gonocytes entering meiosis 
(13.5 dpc). Thus in order to determine whether Pabp4 is differentially expressed in 
males at these stages, 13.5 and 15.5 dpc fetal mouse testes were subject to IHC with 
the anti-PABP4 antibody. Similar to 13.5 dpc ovary, Pabp4 was widely expressed 
within the developing testes (Figure 4.13 - a), including the cytoplasm of PGCs 
within the developing seminiferous tubules, which express Dazl (Figure 3.20 -b) and 
the surrounding intra and intertubular somatic cells. At day 15.5 dpc (Figure 4.13 - 
b), Pabp4 was still expressed very widely, including in the prospermatogonia, but at 
low levels. The strongest expression appeared to be in the spaces between 
prospermatogonia cells (* in Figure 4.13 - b), which may represent early extensions 
of Sertoli cell cytoplasm starting to surround the germ cells (Mendis et al., 2011). 
The absence of immunostaining in the absence of primary antibody (Figure 4.13 
insets) suggests that this expression pattern although widespread was specific. Thus 
Pabp4 appears to be expressed alongside Dazl in the cytoplasm of fetal germ cells of 
both sexes (Figures 3.17 and 3.19), consistent with a potential role in mediating Dazl 
function at these stages.  
 
4.2.2.4 Pabp4 expression in female adult mouse gonads 
Given the phenotypic consequences associated with loss of Dazl function in 
maturing oocytes (Chen et al., 2011), the expression of Pabp4 was also compared to 
that of Dazl in adult ovaries. Pabp4 was strongly expressed in the oocytes of 
primordial, primary and secondary follicles, but became undetectable in oocytes in 
antral follicles. Interestingly, Pabp4 was also expressed in a subset of somatic cells 
including the granulosa and theca cells of the growing follicles (Figure 4.14). 
Granulosa cells are considered functionally equivalent to the Sertoli cells which also 
displayed robust Pabp4 expression (Figure 4.7), whilst theca cells functionally 
resemble Leydig cells. PABP4 was essentially absent from the stroma cells that sit 
between the follicles. 
 
 






Figure 4.14 - Pabp4 expression within adult mouse ovaries. IHC analysis 
using the anti-PABP4 antibody (1/2000) in mouse adult ovaries using: a and b – 
IHC with anti-PABP4 antibody; c - negative control performed with no primary 
antibody. x40 magnifications. In mouse ovaries, Pabp4 is expressed in the 
cytoplasm of primordial, primary and secondary follicles. Pabp4 expression is 
also observed in granulosa and theca cells. 
 
Importantly, the robust expression of Pabp4 within the oocytes of primordial, 
primary and secondary follicles resembles that of Dazl (Figure 3.22), indicating that 
both proteins are present within the cytoplasm of oocytes during early 
folliculogenesis. Interestingly, unlike the pattern observed in male germ cells, where 
Pabp4 and Pabp1 show almost reciprocal expression (Figure 4.8), the expression of 
these PABPs significantly overlapped in oocytes.  




4.2.3 Mouse testes express four different splice-
forms of Pabp4 
 
To date no PABP-specific protein interactions have been described, and the 
finding that Pabp4 and Dazl show striking similarities in their expression during 
male and female germ cell development, provides the potential for these proteins to 
interact in vivo. Ensembl (Hubbard et al., 2009) predicts four different potential 
splice-forms for mouse Pabp4 (mPabp4), created by inclusion and exclusion of 2 
exons (Figure 4.15). Such alternative splicing would generate variation within the 
proline-rich linker that comprises part of the C-terminal region. This region of 
PABP1 is responsible for its interaction with DAZL (Collier et al., 2005b). The 
predicted splice variants, named mPabp4-001, -002, -003 and -004 correspond to 
proteins of 660 amino acids (aa), 615 aa, 631 aa and 644 aa, respectively and appear 
conserved in humans (Hannah Burgess, personal communication), suggesting that 
they may be biological relevant. However, due to differences in nomenclature these 
putative isoforms are named differently: human PABP4-001 (hPABP4-001) 
corresponds to mPabp4.004, hPABP4-002 corresponds to mPabp4.001, hPABP4-003 
corresponds to mPabp4.002 and hPABP4-004 corresponds to mPabp4.003.  
 
Figure 4.15 - Schematic representation of the different mouse Pabp4 
isoforms predicted by Ensembl. Constitutive exons are represented in dark 
blue; alternative exons are represented in light blue and green. Unfilled regions 
represent UTRs. 
 





Figure 4.16 - Mouse testes express 4 different splice forms of Pabp4. 
RT-PCR performed in mouse testes RNA with oligonucleotides that flank 
the predicted variable region of mouse Pabp4.  
 
To determine whether these predicted splice variants are actually expressed, 
RT-PCR was performed on mouse testes RNA (see 2.4.10 and 2.5.2) using 
oligonucleotides that flank the variable region. This produced four closely spaced 
bands (Figure 4.16) corresponding to the predicted sizes, with sequencing confirming 
their identity. Thus, at least at the RNA level, all four isoforms predicted by Ensembl 
are expressed in mouse testes.  
 
4.2.4 DAZL and PABP4 interactions  
4.2.4.1 Interspecies interaction between mammalian 
DAZL and X. laevis PABP4 
It was shown previously that mDazl as well as X. laevis Dazl (xDazl) 
interacts with the C-terminus of X. laevis PABP1 (xPABP1) and ePABP (xePABP) 
(Collier et al., 2005b). However, subsequently a homologue of PABP4 (xPABP4) 
was identified in X. laevis (Gorgoni et al., 2011). Thus its ability to interact either 
with xDazl, or mDazl, was examined by yeast two-hybrid approach (Y2H) (Zhang et 
al., 1999).  
To this end, the C-terminal region of xPABP4 was cloned in frame with the 
lexA DNA-binding domain (see 2.16.2) and the respective DAZL proteins with the 
GAL4 activation domain. The characterised interaction between xPABP1 and xDazl 




served as a positive control (Collier et al., 2005b), whilst iron regulating protein 
(IRP) and MS2 as negative controls (Gray et al., 2000). 
 
Figure 4.17 - X. laevis and mouse Dazl interact with xPABP4. 
Yeast two-hybrid assay between DAZL from different species and the 
C-terminus of X. laevis PABPs. Blue colour indicates a positive 
interaction. ND – not done. 
 
Interestingly, this revealed that xPABP4 was able to interact with both xDazl 
and mDazl (Figure 4.17), despite the C-terminal regions of X. laevis PABP1 and 
PABP4 showing only 58% identity. The findings that interactions are conserved 
between different family members and between species (mDazl interacts with 




4.2.4.2 Mouse Dazl specifically interacts with different 
PABP family members  
Dazl binding has been mapped to the C-terminal region of PABPs. This 
comprises a highly conserved PABC domain (e.g. almost 95% conserved between 
mPabp4 and xPABP4) and a much less conserved proline-rich linker region which is 
subject to alternative splicing in mouse (Figures 4.15 and 4.18).  
 




Figure 4.18 - Comparison of the conservation within C-terminal regions of 
different PABPs. There is a high degree of homology in the PABC domain 
(orange line) between PABP1 and PABP4 but the region containing the 
alternative exons in PABP4 is less conserved. Blue – conserved residues; Red – 
conserved residues between mouse and X. laevis PABP4; Yellow – conserved 
residues in mouse and X. laevis PABP1 and xPABP4 but not in mPabp4 
isoforms; Purple – conserved residues between xP1, mP1 and mP4 isoforms. 
Blue line – region to which the Dazl interaction is mapped. mPabp – mouse 
Pabp; xPabp – X. laevis PABP. 
 
The finding that xPABP4 interacts with both X. laevis and mouse Dazl 
suggests that mPabp4, or specific mPabp4 isoforms, are likely to interact with 
mDazl. To investigate this, Y2H assays were undertaken using the C-terminal 
regions of the mPabp4 isoforms as bait. Each of the mPabp4 isoforms interacted with 
the positive control protein PAIP-1 (blue colonies), but surprisingly, none interacted 
with mDazl (Figure 4.19). mDazl did show a positive interaction with mPabp1  
indicating that it was expressed and capable of interaction. Thus despite the ability of 
xPABP4 and mDazl to interact, it appears none of the mPabp4 isoforms interact with 
mDazl.  
 





Figure 4.19 - Mouse Dazl exhibits specificity in its interactions with 
different mammalian PABPs. Y2H analysis using mDazl and the C-terminal 
regions of mPabp1 and mPabp4 isoforms. PABP-interacting protein 1 (PAIP-1) 
is used as a positive control. IRP and MS2 are used as negative controls. ND – 
not done.  
 
4.2.4.3 Generation of recombinant mouse Pabp4 proteins 
  
 
Figure 4.20 - Recombinant mouse PABP proteins. Lysates from E. 
coli expressing mouse His-Strep-tagged PABP proteins were purified 
by two step affinity chromatography. Eluted proteins were subjected to 
SDS-PAGE followed by staining with GelCode Blue. P1 – mouse 
Pabp1; P4 – mouse Pabp4; .1-.4 – mouse Pabp4 isoforms 1 to 4.  
 
 To confirm this surprising result, a GST-pull-down assay was performed. This 
required the generation of purified recombinant mPabp4 proteins. Thus, each of the 
four isoforms, together with mPabp1, were cloned into Isopropyl-β-D-thio-
galactoside (IPTG) inducible expression vectors. Following induced expression, the 
recombinant proteins were purified from E. coli extracts by two-step affinity 
chromatography based on their N-terminal His tag and C-terminal Strep tag. This 
two-step approach produced highly pure full-length PABP proteins as determined by 
SDS-PAGE and GelCode blue staining (Figure 4.20).  




4.2.4.4 Mouse Pabp4 isoforms do not interact with DAZL 
in a pull-down assay  
 
Figure 4.21 - Schematic of GST-DAZL pull-down assay. GST-DAZL was 
bound to Glutathione Sepharose 4B beads and incubated with recombinant 
purified PABP proteins. Following washes, bound proteins were eluted and 
analysed by Western blotting. Beads bound by GST alone control for non-
specific interactions. GST – glutathione S-transferase and GST-DAZL – GST 
fused to human DAZL. 
 
Equal amounts of the recombinant purified mPABP proteins were utilised in 
GST-pull-down assays with commercially available GST or GST-DAZL (Figure 
4.21). Western blotting (anti-His) showed that each of the mPABP proteins was 
similarly retained by GST and GST-DAZL, suggesting non-specific binding of 
purified mPABP proteins to either GST and/or the beads (Figure 4.22).  
Thus in order to reduce this non-specific background binding, more stringent 
washing conditions were utilised increasing the NaCl in the wash buffer to 300 mM 
(from 150 mM). Under these conditions (Figure 4.23) the signal with the anti-His 
antibody was significantly stronger in the GST-DAZL lane compared the control 
GST lane, suggesting a specific interaction between mPabp1 and DAZL. In contrast, 
Pabp4 isoforms that bound GST-DAZL (e.g. mPabp4.003) were also retained by 
GST alone, indicating that these represent non-specific interactions. Thus consistent 
with the Y2H results, the pull-down failed to detect specific interactions between 
DAZL and any of the mouse Pabp4 isoforms.  




Figure 4.22 - Recombinant PABP proteins bind non-specifically in low (150 
mM NaCl) salt washes. GST or GST-DAZL proteins (3 pmol) were bound to 
Glutathione sepharose 4B beads and incubated with purified recombinant mouse 
PABP proteins (30 pmol) for 1 hour. Beads were washed extensively and bound 
proteins eluted and subject to western blotting with anti-polyhistidine (anti-His) 
and anti-GST antibodies. mP1 – mouse Pabp1; P4.1-4 – mouse Pabp4.001 to 




Figure 4.23 - Recombinant mouse Pabp4 isoforms fail to interact with 
recombinant DAZL protein in pull-down assays. a) GST or GST-DAZL 
proteins (3 pmol) were bound to Glutathione sepharose 4B beads and incubated 
with (30 pmol) purified recombinant mPABP proteins. Columns were washed with 
buffer containing 300 mM NaCl. Samples were eluted and western blotted with 
anti-polyhistidine (anti-His) and anti-GST antibodies. b) Input (3 pmol PABP 
proteins), Western blotted and exposed in parallel, represents 10% of the sample 
used for the pull-down. mP1 – mouse PABP1; P4.1-4 – mouse Pabp4.001 to 
004. G - glutathione S-transferase; G.D – GST bound to human DAZL. 
 




As it remained possible that mammalian or germ-cell specific post-
translational modifications may be required for Dazl-Pabp4 interactions, the ability 
of the PABP4 antibody to co-isolate Dazl, and vice-versa, was tested by co-IP using 
mouse testes extracts. Mouse and rabbit IgGs were used as negative controls for the 
mouse anti-DAZL and the rabbit anti-PABP4 antibodies, respectively. 
 
Figure 4.24 - Endogenous mouse Pabp4 and Dazl fail to interact. 
Immunoprecipitation (IP) with anti-DAZL (D), anti-mouse IgG (mIgG), anti-
PABP4 (P4) and anti-rabbit IgG (rIgG) in adult mouse testes lysates. IPs were 
western blotted for PABP4 and DAZL. Input (Ipt) represents 1% of the material 
used for each IP. IPs were washed with co-IP buffer containing 200 mM NaCl. 
 
 Both the PABP4 and DAZL antibodies had efficacy for immunoprecipitation 
since they were able to IP themselves, as detected by western blotting (Figure 4.24). 
However, despite the co-IPs being performed under the same conditions as the Dazl-
Pabp1 co-IP in Chapter 3 (Figure 3.34), the anti-Pabp4 antibody failed to co-IP 
mDazl and vice-versa.  
Thus, three separate lines of evidence support the surprising finding that 
mouse Pabp4 and Dazl do not interact, identifying Dazl as the first PABP-specific 











4.2.5 Mouse Pabp4 isoforms interact with the DAZ 
family member Boule 
As it was surprising that Pabp4 was unable to interact with DAZL, it was of 
interest to determine whether it could interact with Boule, the other DAZ family 
member expressed in mouse. Thus mouse Boule (mBoll) was retrieved by RT-PCR 
from mouse testes and cloned into an appropriate Y2H vector.  
 
Figure 4.25 - Mouse Pabp4 isoforms exhibit specificity in their interactions 
with Boule. Yeast two-hybrid assay between mBoll (mouse Boule) and the C-
terminus of mPabp1, mtPabp and mPabp4 isoforms. mBoll interacted with the C-
terminal region of mPabp1, mtPabp, mPabp4.002 and mPabp4.003. PABP-
interacting protein - 1 (PAIP) is used as a positive control. IRP and MS2 are used 
as negative controls. –: not done. 
 
 
 The Y2H assay with mBoll (Figure 4.25) showed that it can interact with two 
of the mPabp4 isoforms in addition to mPabp1 and mtPabp. Both Pabp4 isoforms 
that failed to interact with mBoll still interacted with the positive control PAIP-1. 
This not only suggests that there is divergence in the protein partners of Pabp1 and 
tPabp compared to Pabp4, but furthermore that the different Pabp4 isoforms also 










Chapter 3 provided evidence that the DAZL-PABP1 interaction, first proposed in 
X. laevis (Collier et al., 2005b), is conserved in mammals. In this chapter, the role of 
Pabp4 in promoting the ability of Dazl to stimulate translation in mammalian 
gametogenesis was studied by assessing the extent to which both proteins co-reside 
within the male and female germ cells of mouse gonads, together with a molecular 
analysis of their ability to interact. In doing so this provided the first insight into the 
expression of PABP4 protein and the first indication of both PABP and isoform 
specific protein partners.  
 
4.3.1  Mammalian PABP4 expression 
This work revealed that PABP4 is expressed in a wide variety of cell-types 
within the gonads including both germ and somatic cells. This finding is consistent 
with a northern blot of adult human tissues showing that human testis and ovaries 
contain substantial levels of PABP4 mRNA (Yang et al., 1995). This work also 
provided insight into its expression during development where it was found to be 
significant in tissues including the developing liver, heart and pancreas which 
continue to express Pabp4 at high levels in the adult (Hannah Burgess personal 
communication) but also intriguingly in the kidney and lungs, where it is essentially 
undetectable in adults (Hannah Burgess personal communication). The presence of 
Pabp4 in many different cell types likely reflects available evidence suggesting that it 
shares global functions in regulating mRNAs with PABP1 (Gorgoni et al., 2011). 
Confidence in this pattern is provided by commercial antibodies raised 
against distinct epitopes which became available during this work (Table 2.10), one 
of which was found to specifically recognise Pabp4 and produced a pattern highly 
reminiscent of the results in this chapter (Appendix 4). In contrast to its pattern 
within adult gonads, Pabp4 was almost ubiquitously expressed within fetal gonads 
although its expression decreased somewhat between 13.5 and 15.5 dpc in both 
sexes. Comparison with the Pabp1 expression pattern shows that these widely 
expressed PABPs have distinct expression patterns. Some cell types (e.g. granulosa 




cells) appear to express significant quantities of both Pabp1 and Pabp4. Multiple 
PABPs may be required in some cases due to a high protein synthetic load or in 
others because of functional differences between family members (Gorgoni et al., 
2011) which presumably allow for the complex regulation of subsets of mRNAs. 
However, their expression appears almost reciprocal during adult spermatogenesis. 
This is reminiscent of the reciprocal expression of ePABP and PABP1 during 
oogenesis and early embryonic development (Voeltz et al., 2001, Seli et al., 2005, 
Wilkie et al., 2005), and is suggestive of a requirement for particular family 
members during the different stages of gametogenesis to achieve the necessary 
changes in protein synthesis.  
Added complexity regarding the complement of PABPs within the different 
cell types comes from the observation that testis contains four alternatively spliced 
PABP4 transcripts. Although their presence does not establish that they are 
represented within the proteome, western blotting of a panel of mouse tissue lysates 
with PABP4 antibodies  detected at least three distinct bands corresponding to their 
predicted sizes (mPabp4.001 – 72KDa; .002 – 68KDa; .003 – 69KDa; .004 – 71 
KDa) in some but not all tissues (Hannah Burgess, personal communication). This 
observation also suggests that alternative splicing of Pabp4 may be tissue/cell type 
specific. However, as the PABP4 antibody recognises a shared peptide, it is not 
currently possible to distinguish whether these splice variants are differentially 
expressed between cell types from gonads.  
 
4.3.2  DAZL and PABP4 regulation of mammalian 
gametogenesis 
Surprisingly, despite the similarities between Dazl and Pabp4 expression 
within germ cells, these proteins failed to interact in Y2H or pull-down assays. These 
assays use recombinant proteins which may have failed to interact due to an absence 
of mammalian-specific post-translation modifications (PTMs), as human PABP1 
contains PTMs which are predicted to alter its C-terminal protein-protein interactions 
(Brook et al., 2012). However, endogenous proteins from mouse testes failed to co-
IP, although this result cannot formal exclude the possibility that such modifications, 




and therefore Dazl-Pabp4 interactions, only occur dynamically in a subset of germ 
cells.  
Importantly, the inability of mPabp4 to interact with Dazl provides the first 
evidence that its functions in mRNA-specific regulation will not completely overlap 
with PABP1. Such functional differences may underlie the requirement for multiple 
PABPs in vertebrates (Gorgoni et al., 2011). The finding also provides direct 
evidence for the hypothesis (Gorgoni et al., 2011) that such functional differences 
between PABPs are, at least in part, due to differential protein-protein interactions 
mediated by the C-terminal region. Since the PABC domain is 95% identical 
between xPABP1, xPABP4, mPabp1, and the mPabp4 isoforms (Figures 4.18) it 
appears likely that the Dazl binding site lies, at least in part, in the highly variable 
proline rich region. A short amino acid stretch within this region is conserved in 
interacting but not in non-interacting PABPs (Figure 4.18), but its absence in Pabp4 
isoforms that interact with Boule cast doubts on the role of this sequence or suggest 
that the binding sites for Dazl and Boule within PABPs are at least partially distinct. 
 
4.3.3  PABP4 isoforms show specific interactions  
Interestingly, while none of the mPabp4 isoforms interacted with mDazl two 
interacted with Boule, although further validation of this interaction is required. A 
role for these isoforms in Boule-mediated translation would show that they are 
functionally distinct.  
Boule is conserved from worms to humans (Cheng et al., 1998, Karashima et 
al., 2000, Xu et al., 2001, Tung et al., 2006a), and is associated with the regulation of 
meiotic progression in female and male C. elegans (Eberhart et al., 1996, Karashima 
et al., 2000) and Drosophila (Xu et al., 2001, Otori et al., 2006), respectively. In 
mice, Boule is not required for meiotic progression (VanGompel and Xu, 2010) but 
knockout males fail to produce mature sperm due to a spermiogenesis defect, as 
germ cells do not progress past stage 6 round spermatids (VanGompel and Xu, 
2010). Consistent with this phenotype, Boule is expressed in late spermatocytes and 
early round spermatids (VanGompel and Xu, 2010). However, preliminary results 
suggest that Boule and Pabp4 do not colocalise during mouse spermatogenesis.  




Interestingly, the two Pabp4 isoforms that interact with Boule are those 
missing exon 12 (Figures 4.18 and 4.25). However, it is unlikely that amino acids 
spanning the splice site directly mediate Boule interaction, since they are different in 
the two interacting isoforms. This suggests that the amino acids encoded by this exon 
maybe incompatible with Boule interaction, perhaps by altering the conformation of 
Pabp4 to make the Boule binding site unavailable or by providing a binding site for a 
protein that interferes with Boule recruitment. Given that the isoforms show 
differential interactions in an Y2H assay, any such protein would need to be 








































Functional studies of putative 























Infertility affects between 10-15% of couples worldwide (Matzuk and Lamb, 
2002), with impaired gametogenesis being a major contributing factor (Matzuk and 
Lamb, 2008). Whilst many of the genetic causes of infertility remain to be 
determined, deletion of the Y-chromosome encoded DAZ gene is associated with 
azoospermia and oligozoospermia in man (Reijo et al., 1995, Najmabadi et al., 
1996). The contribution of other family members to human fertility is less clear, but 
their roles in gametogenesis are supported by studies in multiple organisms. For 
instance Dazl-KO mice are infertile due to male azoospermia, and female loss of 
oocytes at birth (Ruggiu et al., 1997, Saunders et al., 2003), although heterozygous 
females have larger litter sizes due to increased ovulation rates (McNeilly et al., 
2011).  
In 2006, Tung et al. sequenced the human DAZL (hDAZL) gene in small 
cohorts of patients with impaired fertility (Tung et al., 2006b). This identified four 
putative missense mutations in a small number of individuals (Table 5.1) that were 





Sex Genotype Phenotype 
P6H F Het 
Spontaneous early menopause at age 45 
3 children previously 
N10C 
M Hom Azoospermia 
F Het Familial early menopause at age 44 4 children previously 
I37A F Het 
Spontaneous early menopause at age 43 
1 child previously 
R115G F Hom 
Spontaneous premature ovarian failure at age 34 
0 children previously 
 
Table 5.1 - Putative hDAZL mutations. hDAZL mutations identified in patients 
with impaired fertility. The position and identity of the amino acid substitutions are 
given. Adapted from Tung et al., 2006. 
 
Heterozygous mutations, P6H, N10C or I37A, were found in three female 
patients who underwent menopause in their mid-40s whilst a homozygous R115G 
mutation was identified in a patient with premature ovarian failure (POF) at age 34. 
POF is posited to be due to increased atresia of oocytes (e.g. during fetal 




development) or increased recruitment of oocytes to undergo folliculogenesis prior to 
ovulation (reviewed in (Shelling, 2010)). A male patient homozygous for N10C 
suffered from azoospermia. However, as this study examined small non-familial 
cohorts and no functional studies have been carried out, it is unclear whether these 
putative mutations are causative. Two of the putative mutations I37A and R115G, 
are of particular interest as they are located in the RNA recognition motif (RRM) of 
DAZL, which is highly conserved between DAZ-family members (Yen, 2004) and 
mediates RNA and protein interactions necessary for DAZL function (Ruggiu and 
Cooke, 2000, Tsui et al., 2000a, Tsui et al., 2000b, Collier et al., 2005b, Jenkins et 
al., 2011).  
Whilst several target mRNAs of mDazl have been validated in male and 
female mice (Reynolds et al., 2005, Reynolds et al., 2007, Chen et al., 2011), to date 
potential translational targets of hDAZL have not been investigated experimentally, 
although a number of human mRNAs can be bound by hDAZL. These include 
SDAD1 (Fox et al., 2005), the homolog of the yeast gene which regulates cell cycle 
(Zimmerman and Kellogg, 2001), and the family of testis-specific serine/threonine 
kinases (TSSK) (Zeng et al., 2008). However, the ability of hDAZL to activate 
mRNA translation was established in stage VI X. laevis oocytes (Collier et al., 
2005b). X. laevis oocytes provide an excellent experimentally accessible germ cell 
model: single ovaries contain hundreds of stage VI oocytes which are large 
(approximately 1.3 mm), relatively easy to manipulate and micro-inject and provide 
enough material for biochemical analysis. These oocytes offer two additional 
advantages for the analysis of translation. Firstly, they are essentially transcriptional 
silent (Mendez and Richter, 2001), meaning that effects on translation can be studied 
in the absence of effects on transcription and splicing. This is important as many 
3’UTR-binding proteins are multifunctional (reviewed in (Paronetto and Sette, 2009, 
Nguyen-Chi and Morello, 2011). Secondly, mRNAs can be injected directly into the 
cytoplasm and remain stable even if deadenylated (Colman and Drummond, 1986, 
Gillian-Daniel et al., 1998), allowing effects on translation to be studied in isolation 
from changes in mRNA stability. 
In this chapter, the functional consequences of the four putative mutations on 
the ability of hDAZL to stimulate translation were studied using reporter mRNAs 




micro-injected into oocytes. One reporter mRNA contained the 3’UTR of a human 
mRNA which was found to be susceptible to regulation by hDAZL. A reporter 
containing tethering sites was also used to determine the effects of these mutations 
on the ability of hDAZL to mediate protein interactions independently of any effects 
on RNA binding.  
 
5.2 Results  
5.2.1 Growth differentiation factor 9 is a 
translational target for human DAZL 
No human mRNAs have been shown to be susceptible to translational 
regulation by hDAZL. However, cross-species rescue experiments (Houston et al., 
1998, Slee et al., 1999, Vogel et al., 2002, Xu et al., 2003) suggest that different 
family members share similar mRNA-binding specificity and a loose DAZL binding 
consensus “U2-10[C/G]-U2-10” has been identified from a combination of in vitro and 
in vivo studies (Venables et al., 2001, Jiao et al., 2002, Maegawa et al., 2002, 
Reynolds et al., 2005, Chen et al., 2011). Intriguingly, as part of ongoing studies of 
oocyte expressed mRNAs in the laboratory, it was noted that the 3’UTR of human 
growth differentiation factor 9 (hGDF9) mRNA (Figure 5.1) contained at least one 
excellent putative consensus binding site (N. K. Gray, unpublished). This raised the 
possibility that hGDF9 may be utilised to study the functional consequences of the 
putative mutations on the ability of hDAZL to stimulate translation of oocyte-
specific GDF9 (Richards, 1980, Elvin et al., 1999, Moore et al., 2004b). GDF9 is 
secreted from oocytes and is important for oocyte-granulosa communication at 
various stages of folliculogenesis (Knight and Glister, 2001). Communication 
between these cell types is thought to be crucial both for oocyte survival and the 
initiation of folliculogenesis and as a result mGdf9-KO female mice are infertile 
(Dong et al., 1996) with folliculogenesis arresting at the primary follicle stage, 
slightly later than the described mDazl-KO phenotype (Ruggiu et al., 1997, Saunders 
et al., 2003). Moreover, homozygous Gdf9 mutations that result in female infertility, 
but increased offspring number in heterozygous animals due to increased ovulation 




rates, have been reported in sheep (Nicol et al., 2009), reminiscent of Dazl-KO mice 
(Ruggiu et al., 1997, Saunders et al., 2003, McNeilly et al., 2011). In humans, 
missense mutations in GDF9 have been associated with POF (Laissue et al., 2006, 
Tung et al., 2006b, Kovanci et al., 2007) and heterozygous GDF9 mutations with 










Figure 5.1 - The 3’UTR sequence of hGDF9 has one very good putative 
hDAZL binding site. The consensus “U2-10[C/G]-U2-10” DAZL binding site 
(Venables et al., 2001, Reynolds et al., 2005, Reynolds et al., 2007, Chen et 
al., 2011, Jenkins et al., 2011) is highlighted in green, with the sequence to 
which it was mutated depicted in yellow. Alternative binding sites are presented 
in red (Venables et al., 2001, Reynolds et al., 2005, Reynolds et al., 2007, 
Chen et al., 2011) and blue (Venables et al., 2001)). 
 
Thus, to assess whether hGDF9 mRNA can be regulated by hDAZL, its 
3’UTR was appended to a luciferase reporter mRNA (Figure 5.2). The luciferase-
hGDF9-3’UTR reporter mRNA and a control -gal mRNA, insensitive to Dazl, were 
co-injected into oocytes (Figure 5.2) expressing either hDAZL or U1A, and the 
levels of their translated products were subsequently assayed. U1A is an RRM-
containing protein, which does not affect translation (Jovine et al., 1996) and was 
utilised as a negative control, with stimulation or repression of translation by hDAZL 
being calculated relative to U1A. This revealed a modest but reproducible and highly 
statistically significant increase in hGDF9 translation in the presence of hDAZL 
(Figure 5.3). Thus, hGDF9 translation can be activated, albeit modestly, by hDAZL.  
 
 




Figure 5.2 - Luciferase reporter assay to test the ability of hDAZL to 
regulate the translation of reporter mRNAs. a - X. laevis oocytes were 
injected with hDAZL or U1A mRNA. Following incubation to allow expression, 
they were co-injected with a luciferase reporter fused to the 3’UTR of hGDF9 and 
β-galactosidase (β-gal) control mRNA (mRNAs depicted in b). The oocytes were 
incubated overnight and the effect of hDAZL on translation was assessed by 
measuring luciferase production normalised against any minor differences in the 
β-gal activity. m7GpppG cap and ApG caps are physiological or non-functional 
caps respectively, and the β-gal mRNA contains a internal ribosome entry site, 




































Figure 5.3 - hDAZL stimulates translation of a mRNA containing the 
human growth differentiation factor-9 (hGDF9) 3’UTR. X. laevis oocytes 
were injected with either hDAZL- or U1A-encoding mRNAs, and co-injected with 
a hGDF9 reporter mRNA and an β-gal control mRNA. The effect of hDAZL on 
translation of hGDF9 was normalised to the injection control β-gal. Stimulation 
was expressed relative to U1A which was set to 1. T-test, unpaired, 2 tails, 
p=0.0002, error bars indicate standard error of the mean. Statistical analyses 
were performed on transformed raw data values (Y=Ln(Y)) from 8 experiments.  




5.2.1.1 GDF9 appears to have more than one functional 
DAZL-binding site 
Verified DAZL target mRNAs have multiple DAZL binding sites (Venables 
et al., 2001, Jiao et al., 2002, Fox et al., 2005, Reynolds et al., 2005, Reynolds et al., 
2007, Chen et al., 2011) but hGDF9 only contains one significant match  for the U2-
10[G/C]U2-10 consensus (“UUUUUUUUCUUUU”) (Venables et al., 2001, Reynolds 
et al., 2005, Reynolds et al., 2007, Chen et al., 2011), although it does contain other 
sequences that match the minimal or variant consensus sequences (Figure 5.1). Since 
the number of binding sites affects the level of translational stimulation (Collier et 
al., 2005b), a single functional binding site in GDF9 may explain the relatively 
modest effect observed. Thus to determine whether the best match sequence is the 
only functional hDAZL binding site, this was mutated to “UUUUUCCCCUUUU” by 
site-directed mutagenesis (Figure 5.4). 
 
 
Figure 5.4 - Site directed mutagenesis. a and b - Oligonucleotide 
primers containing the desired mutations (represented by X) are 
used in a PCR reaction with PfuTurbo DNA polymerase to replace 
the nucleotide(s) in the newly synthesised plasmid. c – The 
methylated parental vector (green/yellow) was digested with Dpn1, 
prior to transformation into E. coli. Adapted from 
https://www.genomics.agilent.com . 




The ability of hDAZL to stimulate the translation of reporter mRNAs 
containing either the mutated or wild-type hGDF9-3’UTR was compared and no 
significant difference was observed (Figure 5.5), consistent with the presence of 
other binding sites. This result was unexpected as this sequence represented the best 
consensus site and only a small number of other matches to potential consensus 
sequences were present within the 3’UTR (Figure 5.1). This result highlights the 
need for a better definition of DAZL binding sites as many sequences are able to be 
bound by DAZL to some extent (Maines and Wasserman, 1999, Venables et al., 
2001, Jiao et al., 2002, Maegawa et al., 2002, Fox et al., 2005, Reynolds et al., 2005, 













































Figure 5.5 - The hGDF9 mRNA 3’UTR may contain multiple 
functional DAZL binding sites. X. laevis oocytes expressing 
hDAZL or U1A were co-injected with β-gal and the hGDF9 
reporter mRNA containing the wild type hGDF9 3’UTR or the 
mutated version (hDAZL). Luciferase values were normalised to 
the β-gal injection control. Translation stimulation was calculated 
relative to U1A, which was set to 1. T-test p = 0.8151, unpaired, 2 
tails, error bars indicate standard error of the mean. Results 
represent the average of 6 experiments. 
 




5.2.1.2 Endogenous X. laevis Dazl is not the cause of the 
modest extent of hGDF9 stimulation by hDAZL.  
In tethering assays hDAZL stimulates translation by 4-fold (Collier et al., 
2005b) but the hGDF9 target reporter is only stimulated 1.5 fold (Figure 5.3), despite 
potentially containing multiple DAZL binding sites (Figure 5.1). However, the 
hGDF9 reporter mRNA, but not the tether reporter, contains natural binding sites that 
may bind the endogenous X. laevis DAZL (Xdazl). This may result in a degree of 
activation even in the absence of hDAZL, diminishing its effect. To address this, a 
competition strategy was devised in which an excess of an RNA fragment containing 
only the hGDF9-3’UTR was injected to sequester endogenous Xdazl and prevent it 
from binding the hGDF9 reporter mRNA. Thus, oocytes expressing U1A were 
injected with the hGDF9 reporter mRNA and control mRNAs in the presence or 



































Figure 5.5 - Xdazl is not the cause of the modest extent of hGDF9 
stimulation by hDAZL. X. laevis oocytes expressing U1A were injected with 
reporter and control mRNAs in the presence or absence of a 100x excess of 
hGDF9 3’UTR RNA. Luciferase activity was normalised to the injection control 
β-gal. T-test, unpaired, 2 tails p = 0.4299, error bars indicate standard error of 
the mean. Results represent the average of 6 experiments. 
 




Despite a slight increase in translation of the hGDF9 reporter mRNA in the 
presence of excess hGDF9-3’UTR (Figure 5.6) there was no statistical significance 
between the two pools of oocytes indicating that activation by endogenous Xdazl did 
not underlie the modest extent of stimulation by hDAZL. 
 
5.2.2 Putative hDAZL mutations have a 
compromised ability to stimulate translation of 
hGDF9 
The previous section shows that the hGDF9 reporter mRNA can be used to 
assess the effect of the four putative mutations (Tung et al., 2006b) on the ability of 
hDAZL to activate translation.   
To this end, the putative mutations (Table 5.1) were introduced into hDAZL 
coding sequence by site directed mutagenesis (Figure 5.4), and mRNAs encoding 
these mutants or wild-type hDAZL were injected into X. laevis oocytes. These were 
then subsequently injected with the described hGDF9 reporter and β-gal control 
mRNAs (Figure 5.2).  
Initially the ability of the P6H and N10C mutants to activate translation was 
tested. These putative mutations lie in the N-terminal portion of the RRM and 
showed no significant difference in activity compared to wild-type (Figure 5.7). This 
indicates that the observed phenotype in these patients (Table 5.1) does not appear to 
result from a compromised ability of DAZL, containing these amino acid 

















































Figure 5.6 - Putative mutations P6H and N10C do not disrupt the ability of 
hDAZL to stimulate translation in reporter assays. X. laevis oocytes were 
injected with either hDAZL (WT, P6H, N10C) or U1A and subsequently with the 
hGDF9 luciferase reporter mRNA and the control β-gal mRNA. Luciferase levels 
were normalised for β-gal and translation stimulation compared to U1A (set to 1) 
and wild type hDAZL. T-test, paired, 2 tails; WT vs P6H p=0.6497; WT vs N10C 
p=0.6413; error bars indicate standard error of the mean. Results represent the 
average of 3 experiments. 
 
The I37A and R115G substitutions lie within the functionally important RRM 
domain (amino acids 32-116) (Figure 5.8). The ability of the I37A mutant to 
stimulate translation of the hGDF9 reporter mRNA showed a modest but statistically 
significant decrease compared to wild type hDAZL (Figure 5.9). In contrast R115G 
mutation ablated the ability of hDAZL to stimulate translation, with luciferase levels 
being similar to those obtained in oocytes expressing the negative control U1A 
(Jovine et al., 1996). Western blot analysis of hDAZL and mutants thereof showed 
that they were similarly expressed in oocytes indicating that the observed differences 
in activity are not a result of differential protein levels (Figure 5.10). Thus I37A and 
R115G appear to represent functionally relevant mutations in hDAZL. 
 





Figure 5.7 - Mutations I37A and R115G are located in the RRM domain 
within hDAZL. Diagram of the DAZL protein, depicting the location of the two 
putative hDAZL mutations (I37A and R115G), together with identified DAZL 
interacting proteins (adapted from (Brook et al., 2009)). Pumilio-2 is also a 
protein partner of DAZL, with previously described roles in translation, but its 
binding site in DAZL has not been characterised although human pumilio-2 
interacts with the region between the RRM and the DAZ motif in DAZ (Moore et 










































Figure 5.8 - Putative mutations I37A and R115G disrupt the ability of 
hDAZL to stimulate translation in a luciferase reporter assay. X. laevis 
oocytes were injected with either hDAZL (WT, I37A and R115G) or U1A and 
co-injected with the hGDF9 reporter mRNA and β-gal control mRNA. The 
effect of putative mutants on translation of hGDF9 was normalised to the 
injection control β-gal. U1A was set to 1 and the activity of the mutants 
compared to wild type hDAZL. T-test, paired, 2 tails; WT vs I37A p=0.0341; 
WT vs R115G p=0.0444 error bars indicate standard error of the mean. 
Results represent the average of 3 experiments.  
 
 




Figure 5.9 - Injected wild-type and mutant forms of hDAZL are 
expressed at similar levels in X. laevis oocytes. Stage VI X. laevis 
oocytes were injected with hDAZL (wild type and mutants thereof) 
incubated for 6 hours and whole extracts were western blotted with an 
anti-DAZL antibody. WT- wild type hDAZL; 6 – P6H hDAZL; 10 – N10C 
hDAZL; 37 – I37A hDAZL; 115 – R115G hDAZL; n.inj – non-injected.   
 
5.2.3 The ability of hDAZL to mediate protein-
protein interactions required to stimulate 
translation appears compromised in I37A and 
R115G.  
I37A and R115G mutants (Table 5.1) (Tung et al., 2006b) both show a 
compromised ability to stimulate translation of the hGDF9 luciferase reporter 
compared to wild type hDAZL (Figure 5.3). These amino acids lie within the RRM 
(Tung et al., 2006b) (Figure 5.8), which mediates RNA-binding (Tsui et al., 2000b, 
Jenkins et al., 2011), but outside of the core RNP motifs. However, RRM motifs 
including that of DAZL can also mediate protein-protein interactions (Ruggiu and 
Cooke, 2000, Tsui et al., 2000a, Collier et al., 2005b). Thus in order to understand 
whether the ability of hDAZL to mediate protein interactions required for its 
translation-stimulating ability are compromised by these mutations, a tethered 
function approach was used (Gray et al., 2000, Collier et al., 2005b).  
In this assay, the function of the tethered protein is uncoupled from its ability 
to bind the mRNA target (Figure 5.11), as it is brought or “tethered” to the mRNA 
via the interaction between the RNA-binding protein MS2 and its binding sites 
within the 3’UTR of a luciferase mRNA (Gray et al., 2000). Therefore this assay 
solely examines the ability of proteins (i.e. hDAZL and mutants thereof) to mediate 




protein-protein interactions required to activate translation. Oocytes were injected 
with MS2-hDAZL and mutants thereof or MS2-U1A (Jovine et al., 1996, Gray et al., 
2000) and subsequently with the MS2 reporter mRNA and a -gal mRNA which 
lacks the MS2 binding sites as a co-injection control. Translational stimulation was 
normalised to MS2-U1A.  
 
Figure 5.10 - The tethered function assay. X. laevis oocytes are injected with 
mRNAs encoding the bacteriophage MS2 coat protein fused to hDAZL (MS2-
hDAZL) or U1A (MS2-U1A). Following incubation, oocytes are simultaneously 
injected with a luciferase reporter containing MS2-binding sites within its 3’-UTR, 
and a β-gal control mRNA. The MS2-hDAZL fusion protein binds the MS2-binding 
sites within the luciferase reporter mRNA 3’-UTR via MS2, independent of the 
ability of hDAZL to bind mRNA. The effect of hDAZL on translation of the reporter is 
assessed by measuring luciferase activity normalised against the injection control 
β-gal. Translation stimulation is normalised to MS2-U1A, set to 1 and compared to 
wild type MS2-hDAZL. Adapted from (Gray et al., 2000). 





Tethered hDAZL stimulated the translation of the MS2 reporter mRNA 
approximately 5-fold compared to U1A (Figure 5.12), consistent with published 
analyses (Collier et al., 2005b). Critically, the ability of the I37A mutant to stimulate 
translation in this assay was compromised and that of the R115G mutant was almost 
completely abrogated. This pattern is highly reminiscent of that obtained with the 
hGDF9 reporter mRNA (Figure 5.9). Since both mutants were efficiently expressed 
(Figure 5.13), these results reveal that the compromised ability of these mutants to 
stimulate translation is, at least in part, due to impaired interactions with protein 








































Figure 5.11 - I37A and R115G mutations disrupt the ability of hDAZL to 
interact with proteins required for its function in stimulating translation. X. 
laevis oocytes were injected with MS2 fusion proteins with either hDAZL (WT, 
I37A and R115G) or U1A and subsequently with luciferase reporter mRNA with 
three MS2 binding sites in its 3’UTR and a β-gal control mRNA. The effect of 
putative mutants on translation was normalised to the injection control β-gal. 
Translation stimulation was normalised to U1A =1 and compared to wild type 
MS2-hDAZL. T-test, paired, 2 tails; WT vs 37A p=0.0248; WT vs R115G 
p=0.0023. Error bars indicate standard error of the mean. Results represent the 
average of 10 experiments.  
 




Figure 5.12 - Expression of MS2-hDAZL wild-type and mutants in X. 
laevis oocytes. Stage VI X. laevis oocytes were injected with MS2-hDAZL 
(wild type and mutant versions) and incubated for 6 hours. Subsequently, 
extracts were western blotted with an anti-DAZL antibody. WT - wild type 
hDAZL; 37 – I37A hDAZL; 115 – R115G hDAZL; n.inj – non-injected. 
 
 
5.3 Discussion  
In this chapter the association between the putative hDAZL mutations 
described in patients with impaired fertility (Table 5.1) (Tung et al., 2006b) and the 
ability of hDAZL to stimulate translation (Collier et al., 2005b) was examined. 
Importantly, two of the mutations were found to impair the function of hDAZL, 
suggesting that they may be causative. Further characterisation of these mutations 
indicated that loss of function is due, at least in part, to impaired protein-protein 
interactions.  
 
5.3.1 hGDF9 is a translational target for hDAZL 
In order to assess the role of the four putative mutations in the ability of 
hDAZL to stimulate translation, a mRNA (hGDF9) that could be regulated by 
hDAZL was identified. Since injected, as well as endogenous, mRNAs are highly 
stable in X. laevis oocytes (Ford et al., 1977, Colman and Drummond, 1986), the 
observed effects likely reflect changes in translation rather than mRNA stability, 
consistent with the described functions of DAZL in this model system. However, a 
formal demonstration of reporter mRNA stability (e.g. Q-PCR or injection of 
radiolabelled mRNAs) is still desirable.  
Translation of the hGDF9 reporter mRNA was only modestly enhanced by 
hDAZL. Nevertheless, this effect was statistically significant and some overlap exists 




between the GDF9 and DAZL phenotypes, both show increased ovulation rates or 
infertility in heterozygous (Palmer et al., 2006, Nicol et al., 2009, McNeilly et al., 
2011) and homozygous animals respectively (Dong et al., 1996, Ruggiu et al., 1997, 
McNeilly et al., 2000, Saunders et al., 2003). Although this latter phenotype arises 
later in the Gdf9-KO animals, it is likely that DAZL activates cascades of mRNAs 
during oogenesis (see sections 3.2.5 and 3.2.7) suggesting that conditional knockout 
mice may display later phenotypes. Moreover, both proteins have been reported to be 
associated with POF in humans (Tung et al., 2006b, Kovanci et al., 2007).  
Nonetheless, further work would be required before concluding whether 
GDF9 mRNA is a biologically significant target of DAZL in mammals. Such studies 
(e.g RNA-IPs from oocytes; IHC analysis of mGdf9 protein levels in wild type and 
mDazl-KO oocytes) would be facilitated by a conditional Dazl-KO mouse. However, 
recent technical progress in the in vitro development of human follicles (Telfer et al., 
2008, Telfer and McLaughlin, 2011, White et al., 2012), opens the exciting 
possibility of addressing such questions in human oocytes in the future. 
Although hDAZL stimulates translation to a lesser degree than mouse and X. 
laevis Dazl (4-fold compared to 10- and 8-fold) in tethering assays (Collier et al., 
2005b), stimulation of hGDF9 by hDAZL was significantly reduced (Figure 5.3) 
compared to tethered hDAZL (Figure 5.12) (Collier et al., 2005b). Sequestration of 
endogenous Xdazl, using excess hGDF9 3’UTR excluded partial stimulation of this 
reporter by Xdazl as underlying the reduced stimulation. In contrast to the tether 
reporter mRNA that has three MS2 binding sites (Collier et al., 2005b), the hGDF9 
3’UTR only has one very good match to the consensus U(2-10)[G/C]U(2-10). However 
mutation of this binding site did not significantly diminish stimulation, suggesting 
that either other functional binding sites are present or that these mutations did not 
significantly reduce hDAZL binding to this site.  
This result draws attention to the debate regarding the nature of DAZL 
binding sites. In addition to the consensus U2-10[G/C]U2-10 present in validated mDazl 
targets in mouse (Reynolds et al., 2005, Reynolds et al., 2007, Chen et al., 2011) 
other binding sites have been reported. DAZL has been reported to bind U-rich 
elements (Tsui et al., 2000b, Fox et al., 2005); (GUn)n elements (Venables et al., 
2001), the sequence “GUUC” (Maegawa et al., 2002); and most recently the crystal 




structure of mDazl bound to Mvh and Sycp3 RNA showed high affinity for 
GUU[U\C] repeats (Jenkins et al., 2011). Whilst these reports share common 
observations, they to do not allow for the accurate prediction of binding sites and 
may help to explain why mutation of the “best” site in the luciferase hGDF9’UTR 
reporter (Figure 5.1) did not reduce stimulation (Figure 5.5). Thus further RNA-
binding studies (e.g. EMSAs and/or RNA-IP) to determine the efficacy of the 
mutations would be informative. Similarly, such studies may shed light on whether 
low affinity binding of hDAZL to this mRNA accounts for its limited translational 
stimulation.  
 
5.3.2  I37A and R115G mutations reduce the ability 
of hDAZL to stimulate translation due to 
impaired protein-protein interactions 
The hGDF9 reporter mRNA allowed for the functional characterisation of 
putative mutations. Two of these mutations, P6H and N10C, appeared not to impair 
the ability of hDAZL to stimulate translation, suggesting that these amino acids are 
not critical for this function. In keeping with this observation, proline 6 (P6) is 
maintained in human DAZ (Figure 5.14 - green) but not in DAZL proteins from 
other species indicating that it has a less important, or divergent, role. Asparagine at 
position 10 (N10) is maintained in DAZL proteins from different species and hDAZ 
but is absent in BOULE, despite its ability to stimulate translation (Figure 5.14 - red). 
Moreover, deletion of the amino acids 1-32 does not affect the ability of tethered 
mDazl to stimulate translation (Collier et al., 2005b) suggesting that this region is not 
required for protein interactions that mediate this function. These results suggest that 
these putative mutations are either not causative of the observed phenotypes or that 
they affect another function of hDAZL. 
In contrast R115G, and to a lesser extent I37A, mutation results in a 
compromised ability to stimulate translation, suggesting that they may play a 
causative role in the early menopause/POF that occurred in the patients in which they 
were identified. It is thought that increased oocyte atresia and/or activation of 
follicles both play an important role in diminishing the oocyte pool but the genetics 




of POF are poorly understood. Moreover it was found that these mutations 
compromised the ability of hDAZL to mediate protein-protein interactions that are 
important for its ability to stimulate translation. Both these mutations occur in the 
RRM (Yen, 2004) and both are preserved in all DAZ family members in all studied 
species (Figure 5.14), indicating that they are important for DAZL function. 
Although these results implicate altered protein-protein interactions for the hDAZL 
mutants, they do not rule out additional effects on RNA-binding. Indeed recent 
structural studies of the isolated RRM bound to RNA shows a hydrogen bond 
between R115 and RNA, despite this residue being located outside the core RNP 
motifs. The R115G mutation decreased in vitro RNA-binding affinity 50-fold 
(Jenkins et al., 2011), suggesting that this residue may be important for both RNA 
and protein binding. Structural studies have also indirectly implicate I37 in RNA-
binding (Jenkins et al., 2011) suggesting that the effects of I37A mutation could be 
due to altered protein-protein interactions and RNA binding. Whether this reflects an 
indirect role in maintaining hDAZL conformation in a manner favourable for partner 
interactions or whether it forms a protein-interaction site remain to be determined.  
 
           P6H N10C        I37A              R115G 
hDAZ   MSAANPETPNSTISRE…LPEGKIVPNTVFVGGID…LGPAIRKQ 
hDAZL  MSTANPETPNSTISRE…LPEGKIMPNTVFVGGID…LGPAIRKQ 
mDazl  MSATTSEAPNSAVSRE…LPEGKIMPNTVFVGGID…LGPAIRKQ 
Xdazl  MSGKE-ESSNYAAT--…LPEGKIMPNTVFVGGID…LGPAIRK- 
hBOULE ------MQTDSLSPSP…RYGTVI-PNRIFVGGID…IGPAIRKQ 
mBoule AQSTNQTQTDSLSPSP…RYGTVI-PNRIFVGGID…IGPAIRKQ
Figure 5.13 - Conservation of putative hDAZL mutations amino acids 
in the DAZ family. Amino acid 6 (proline) is only conserved in hDAZL and 
hDAZ whereas an asparagine at position 10 is present in both hDAZ and 
DAZL from different species. Both isoleucine at position 37 and arginine at 
position 115 are maintained in the three DAZ family members in all the 
species studied. h – human; m – mouse; x – X. laevis. Green – Pro 6; Red 










































This work examined the function of DAZL in mRNA-specific translational 
activation during mammalian gametogenesis. In particular it addressed whether this 
function in mammals may be mediated via recruitment of one or more members of 
the PABP family, and whether putative mutations identified in patients with reduced 
fertility alter its ability to stimulate translation. These results highlight the 
importance of translation regulation in gametogenesis and provide new lines of 
research for future work, into both the mechanisms of DAZL function and the 
potential clinical consequences of disrupting DAZL function.  
 
6.1.1 PABP expression within mammalian gonads.  
By providing the first detailed insight into the expression of PABP1 and 
PABP4 in mammals, this work has revealed that both proteins are widely but not 
ubiquitously expressed. Within the gonads they are both present in a subset of germ 
and somatic cells. This is in contrast to the other two family members that share the 
same domain organisation, tPABP and ePABP. In mice, tPabp is only expressed in 
round spermatids (Kimura et al., 2009), and ePabp mRNA is mainly found in 
oocytes and pre-implantation embryos (Seli et al., 2005). Taken together with this 
data, the work presented here provides a picture of the PABP complement within the 
germ cells of adult mice.  
In primordial through pre-antral follicles, oocytes appear to simultaneous 
express three PABP-family members Pabp1, Pabp4 and ePabp. Although ePABP is 
the predominant PABP protein in X. laevis oocytes (Wilkie et al., 2005), its relative 
abundance compared to Pabp1 and Pabp4 in mammalian oocytes remains to be 
determined as data is only available for ePabp mRNA (Seli et al., 2005, Wilkie et al., 
2005). Nevertheless, a recent ePabp knock-out mouse has established the importance 
of this protein in regulating oocyte mRNAs (Guzeloglu-Kayisli et al., 2012) that are 
required for oocyte maturation and cumulus expansion (Guzeloglu-Kayisli et al., 
2012). However, it is unclear whether phenotype onset corresponds to the time when 
ePabp mRNA is initially translated or whether ePabp is normally present prior to this 




stage and has functions that can be compensated, to some degree, by the Pabp1 and 
Pabp4. A degree of functional redundancy would be consistent with analysis in X. 
laevis (Gorgoni et al., 2011) and the ePabp phenotype arising at the point when 
Pabp1 and Pabp4 levels were found to diminish.  
Although, Pabp1 and Pabp4 are co-expressed in oocytes, in male germ cells 
they show clear temporal differences in their expression pattern, being almost 
reciprocal. Both of their patterns of expression are distinct from that of tPabp, 
although tPabp and Pabp1 both appear relatively abundant in round spermatids 
(Kimura et al., 2009), suggesting that higher overall levels of PABPs may be 
required at specific stages. Conversely, it also appears important to reduce PABP 
levels during spermiogenesis and spermiation, as Paip2-KO mice have aberrant 
expression of PABPs late in spermatogenesis and fail to activate the deadenylation-
dependent translation of critical mRNAs, leading to morphological defects 
(Yanagiya et al., 2010). The observed temporal regulation of individual PABPs may 
not only serve to modulate overall PABP levels but may also be a consequence of 
PABP-specific functions that are required within different germ cell stages. In 
support of such functional differences, the sub-cellular distribution of tPabp and 
Pabp1 within round spermatids is distinct: tPabp, but not Pabp1, is localised in 
chromatoid bodies and is not polysome associated, despite its ability to activate 
reporter mRNA translation and to interact with Pabp1 partners (Kimura et al., 2009).  
The expression pattern of Pabp1 and Pabp4 established here suggest that 
these PABPs likely play, at least partially, distinct physiological roles during 
gametogenesis, which are also likely to differ from that of tPabp and ePabp. 
Furthermore the protein interaction studies herein revealed functional differences that 
could also contribute to differences in their physiological roles: Pabp4 function, but 
not Pabp1 function, is entirely Dazl-independent. Given the multi-functional nature 
of Pabp1, many of its roles even within Dazl-expressing cells are also likely to be 
DAZL-independent. However, the generation of knock-out mice will be required to 
evaluate their individual physiological roles, with the limited expression analysis that 
was performed in mouse embryos suggesting that conditional approaches may be 
required. Breeding of compound knock-out mice would enable further assessment of 
the functional redundancy within this family.  




6.1.2 Interplay between the DAZ-PABP families  
Potential interactions between the mouse DAZ and PABP family members 
were examined. Pabp1 was found to be co-expressed with Dazl in multiple germ 
cells stages associated with Dazl-KO phenotypes and to maintain the interaction first 
described in X. laevis, consistent with the model in which PABPs are involved in 
DAZL-mediated translational activation of specific mRNAs in germ cells. 
Surprisingly, in males a role in Dazl-mediated translation activation appeared to be 
Pabp1-specific. tPabp expression does not overlap with Dazl and although Pabp4 
expression is co-incident with Dazl in early male germ cells (spermatogonia and 
early spermatocytes), none of the mouse Pabp4 isoforms interacted with Dazl. Thus, 
Dazl represents the first PABP-specific protein partner, the potential existence of 
which was suggested by findings that the C-terminal regions of X. laevis PABPs are 
not functionally equivalent (Gorgoni et al., 2011).  
In females, Pabp1 and Dazl are co-expressed during fetal development in 
oogonia at 13.5 and 15.5 dpc and after birth in the oocytes of primordial through pre-
antral follicles, suggesting that they may functionally interact within these cells. 
However, in situ hybridisation showed that ePabp transcripts are also present in 
oocytes from primary through pre-antral follicles (Seli et al., 2005). Although the 
ePabp phenotype occurs much later than that of Dazl (Ruggiu et al., 1997, Saunders 
et al., 2003, Guzeloglu-Kayisli et al., 2012), this does not preclude a functional 
interaction between these proteins, as Pabp1 may be able to compensate for loss of 
ePabp function in Dazl-mediated translation, as suggested by the expression analysis 
and protein-protein interaction data. However, the finding that DAZL and PABP4 
can interact in X. laevis but not in mouse, caution any extrapolation from X. laevis 
that murine Dazl and ePabp interact. Indeed, the divergence between mouse and X. 
laevis ePABP is greater than that of PABP4, and the C-terminal region of mouse 
ePabp is subject to alternative splicing (Seli et al., 2008) which may also influence 
any potential Dazl interaction.  
Dazl has also recently been shown to function during mouse oocyte 
maturation and initial embryonic cleavages (Chen et al., 2011). Meiosis II oocytes 




and early embryos contain both Pabp1 and ePabp mRNA (Seli et al., 2005), but their 
respective protein levels at these stages remain unknown. 
Interactions with PABP family members may not be restricted to DAZL. In 
male mice, Pabp1 expression persists beyond the stages that express Dazl and 
overlaps with that of Boule which is present in late spermatocytes and peaks in round 
spermatids (VanGompel and Xu, 2010). Round spermatids also express tPabp 
(Kimura et al., 2009). Since Pabp1 and tPabp interact with Boule, at least by Y2H, 
this suggests that Boule, unlike Dazl, may utilise multiple members of the PABP 
family to promote the translation of mRNAs during spermatogenesis. Boule is not 
expressed in female mice (Xu et al., 2001). Moreover, the differential interaction of 
Pabp4 isoforms with Boule provides a potential explanation for Pabp4 alternative 
splicing within testes, suggesting that this modifies its protein interactome.  
Whilst these results are consistent with a model in which PABPs are 
important for the function of DAZL and BOULE, establishing the physiological 
consequences of these interactions may ultimately require the generation of animal 
models. Identification of the minimal Pabp1 binding site within Dazl (or Boule) may 
allow for the identification of mutations that only disrupt PABP binding. Creating a 
mouse model where only the Dazl-Pabp1 interaction is disrupted would allow the 
physiological consequences of disrupting interaction to be assessed.  
Such a model may also provide insight into the extent by which Dazl 
phenotypes are due to a loss of mRNA-specific translation. Whilst further work is 
required to delineate other functions of DAZL, suggested by multiple protein 
partners (Figure 5.8), evidence that it can localise mRNAs (Lee et al., 2006) and is 
required for the formation of stress granules (Kim et al., 2012) is available. Other 
functions are consistent with the expression of Dazl in male mice germ cell types that 
do not contain Pabp1, e.g. Dazl-dependent stress granules form in preleptotene and 
early pachytene spermatocytes (Kim et al., 2012) which do not express Pabp1. 
 
6.1.3 Translational targets of DAZL  
Previous studies have identified but not experimentally investigated putative 
human targets for hDAZL. Here it was shown that a reporter mRNA with the 3’ UTR 




of hGDF9 can be regulated by hDAZL although the level of stimulation was modest. 
Preliminary observations show that the putative binding site in hGDF9 mRNA is 
present in another mono-ovulatory species, sheep, but appears absent in mouse, 
arguing that it may not be physiologically important. However, mutation of this site 
in hGDF9 did not abrogate Dazl-mediated stimulation, suggesting other sequences, 
which may be present in mGdf9, are also important for its Dazl-mediated regulation. 
Thus, the extent to which GDF9 represents a physiologically important target mRNA 
remains unclear in the absence of further experimentation.  
It also remains important to identify and validate the full spectrum of DAZL 
target mRNAs. For instance, Sycp3 has only been validated as a misregulated mRNA 
in the first wave of mouse spermatogenesis (Reynolds et al., 2007). However, Sycp3 
is also translationally activated with the onset of meiosis in females mice during fetal 
development, where Dazl and Pabp1 are both expressed, and prior to birth Dazl-
deficient oocytes display defects in synapsis of homologous chromosomes, a 
function associated with synaptonemal complex formation of which Sycp3 is a 
component (Lammers et al., 1994, Yuan et al., 2000). Thus Dazl may also regulate 
Sycp3 translation in female mice. 
Similarly, it would be valuable to identify target mRNAs whose 
misregulation may underlie other DAZL-associated phenotypes such as the failure to 
acquire sex specific imprinting (Haston et al., 2009). In this regard it is interesting 
that Dnmt3L (DNA (cytosine-5)-methyltransferase 3-like) which regulates sex 
specific methylation during germ cell development ((Kato et al., 2007) reviewed in 
(Smallwood and Kelsey, 2012)) was immunoprecipitated from mouse testes extract 
as a potential mDazl target mRNA (Zeng et al., 2008), since both Dnmt3L-/- and 
Dazl-KO male mice show similar phenotypes (Ruggiu et al., 1997, Saunders et al., 
2003, Webster et al., 2005). Visual inspection of the 3’UTR of mouse Dnmt3L 
reveals the presence of putative DAZL binding sites, suggesting that further study of 
this putative target mRNA is warranted.  
Boule-KO mice have post-meiotic defects in spermiogenesis and do not 
progress beyond stage VI spermatids (VanGompel and Xu, 2010). Intriguingly, 
levels of Crem protein, but not mRNA, a master transcription factor of 
spermiogenesis, are significantly reduced in these mice (VanGompel and Xu, 2010). 




A similar reduction, but not complete loss of protein, was observed with Mvh and 
Sycp3 in Dazl-KO mice (Reynolds et al., 2005, Reynolds et al., 2007). Since Crem 
expression is required during the spermatid phase, when Boule is co-expressed with 
Pabp1 and tPabp (Kimura et al., 2009), all of which can interact with Boule, this 
raises the possibility that Boule may be recruiting one, or more, of these PABPs to 
activate the translation of mRNAs, such as Crem. Such a role would be consistent 
with the ability of hBoule to stimulate translation in tethering assays (Collier et al., 
2005b) and Daz-1 to activate translation in C. elegans (Otori et al., 2006).  
 
 
6.1.4 Functional consequences of mutations in 
human DAZL 
Two mutations, both within the RRM of hDAZL (Tung et al., 2006b), were 
found to impair the ability of DAZL to stimulate translation. Whilst these may also 
affect RNA-binding (Jenkins et al., 2011), their inability to activate translation in 
tethering assays directly implicates impaired protein interactions. More than ten 
proteins have been shown to interact with DAZ family members, although their 
binding sites within DAZL have only been partially characterised in six cases (Figure 
5.8). Of these, the sites for PABP and DAZL itself overlap the RRM, including 
residue R115. Given the role of PABP in DAZL-mediated stimulation, disruption of 
this interaction would be an attractive hypothesis to explain the loss of function. 
However, the efficacy of translational stimulation is partly dependent on the number 
of DAZL molecules bound (Collier et al., 2005b) and could be impacted by a 
reduction in the amount of DAZL loaded onto mRNAs due to a loss of DAZL-DAZL 
interactions.  
Moreover it remains plausible that these mutations may disrupt protein 
binding at sites outside the RRM by altering the conformation of DAZL or by 
disrupting post-translational modifications (PTMs), such as arginine methylations, 
which can act as licensing events for PTMs at distant sites: structural information for 
full length DAZL is not available to rule out conformational effects and Xdazl is 
apparently subject to PTMs (Mita and Yamashita, 2000). Thus, effects of these 




mutations on other known, or as yet to be identified, DAZL partners cannot be 
excluded with DAZAP-1 being of particular interest given its recently described role 
in translational activation (Smith et al., 2011).  
 
6.1.5 DAZ family mediated translational activation in 
human germ cells.  
When germ cells colonize the gonodal ridges in developing mice they express 
Oct3/4, Dazl and Mvh (Fujiwara et al., 1994, Pesce et al., 1998, Seligman and Page, 
1998, Toyooka et al., 2000, Kehler et al., 2004). At the equivalent developmental 
point, human germ cells contain OCT3/4 and nuclear DAZL, with VASA only 
becoming detectable in females once the oogonia stop expressing OCT3/4, enter 
meiosis, and DAZL translocates to the cytoplasm (Anderson et al., 2007). However, 
VASA mRNA is detectable prior to the onset of meiosis (Anderson et al., 2007) 
suggesting it may be subjected to translational control as observed in the first wave 
of spermatogenesis in  mice (Reynolds et al., 2005).  
Such differences in the timing of markers (e.g. VASA) alludes to differences 
between the development of mouse and human germ cells that may affect our ability 
to extrapolate from genetic studies of DAZL and BOULE function in mice to human 
gametogenesis. Human males also encode an additional family member, DAZ. As a 
result, it would be desirable to examine the co-expression of DAZ- and PABP- 
family members in developing human and adult gonads, which could provide in vivo 
support for the observed interactions between human DAZL and PABP1 and tPABP. 
However such studies are severely restricted by the availability of tissue.  
To date no direct evidence to support a role of DAZL or BOULE in human 
gametogenesis is available. However, the finding that mutations from patients with 
early menopause/POF, disrupt DAZL function is intriguing and opens the possibility 
that these mutations are causative. Given the advances in high-throughput 
sequencing, it would be of interest to investigate whether other patients with POF, or 
indeed those with other relevant defects in gametogenesis (e.g. azoospermia), also 
contain functional mutations in DAZL. In the case of POF, genome-wide association 
studies may also be informative.  




Finally, the recent finding that mDazl is critical for oocyte maturation (Chen 
et al., 2011), combined with advances in growing human follicles in culture which 
may increase the availability of GV oocytes for experimentation (Telfer et al., 2008, 
White et al., 2012), raises the possibility that morpholino knock-down of DAZL in 
human oocytes prior to in vitro maturation could confirm its importance, at least at 













































































A1.1 DAZL antibody Validation 
A1.1.1 Serotec Antibody 
Published work, described in Chapter 1, examining the expression of DAZL 
utilised a discontinued mouse monoclonal antibody from Abcam. However, a mouse 
monoclonal antibody bearing the same clone number became available from Serotec 
(#MCA2336-3/11A). This antibody was raised against a C-terminal peptide within 
human DAZL (hDAZL), highly conserved in the mouse Dazl (mDazl) but not mouse 
Boule (mBoll) (Figure A1.1). The specificity of the new anti-DAZL antibody was 
assessed in mouse adult testes, using two different fixatives, Bouin’s and 4% NBF. 
Bouin’s better preserves tissue morphology within the testes, but previous analysis of 
Dazl expression pattern was performed on NBF fixed tissue (Niederberger et al., 
1997, Ruggiu et al., 1997). Two dilutions were utilised and for comparison, the 
discontinued Abcam anti-DAZL antibody (gift from Alan McNeilly) was tested in 
parallel.  
 
     Serotec     RVHHFRRSRAMLKSV 
hDAZL       RVHHFRRSRAMLKSV 
mDazl       RVHHFRRSRAVLKSD 
mBoll       ASSAIAMPAPMMQPE 
 
Figure A1.1 - Serotec anti-DAZL antibody. Sequence 
homology between the synthetic peptide corresponding to the 
sequence within the C terminal domain of human DAZL 
(hDAZL) used to raise the Serotec anti-DAZL antibody. mDazl – 
mouse Dazl and mBoll – mouse Boule. Blue - sequence used to 
raise antibody; Green - amino-acids matching the synthetic 
peptide; Red - amino-acid not matching the synthetic peptide. 
 
In adult mouse testes, the new Serotec anti-DAZL antibody showed strongest 
Dazl expression in germ cells, with a peak of expression in early stages, namely 
spermatogonia and spermatocytes (Figure A1.2). However, at the lower dilution 
(1/100), it also detected Dazl in the round spermatids in both fixatives, inconsistent 
with the published literature. In contrast, the higher dilution (1/500) in NBF fixed 
tissue only showed Dazl expression in the spermatogonia and pachytene 
spermatocytes, as expected, whilst in Bouin’s the  spermatogonia and early 




spermatocytes were not consistently immunostained. In the absence of primary 
antibody, the non-specific signal in Leydig cells, was also stronger in Bouin’s 
compared to NBF fixed tissue.  
 
Figure A1.2 - Serotec DAZL antibody validation in mouse adult testes. A 
new Serotec anti-DAZL antibody was applied to adult mouse testes fixed in 4% 
NBF or Bouin’s, at two different dilutions; 1/100 and 1/500. An Abcam antibody 
was used as a positive control. Neg; no primary antibody control. rSd – round 
spermatid; eSc – early spermatocytes; Sg – spermatogonium; L – Leydig cell; 
pSc – pachytene spermatocytes. x20 magnification. 
 




Figure A1.3 - DAZL antibody titration in mouse testes. Titration of the anti-
DAZL Serotec antibody in mouse testes with five different dilutions in normal 
goat serum, ranging from 1/50 to 1/1000. Neg - negative control preformed with 
no primary antibody. rSd – round spermatid; eSc – early spermatocytes; Sg – 
spermatogonium; L – Leydig cell; pSc – pachytene spermatocytes. x40 
magnification. 
 
In summary, the new Serotec mouse monoclonal anti-DAZL gives a specific 
signal that agrees with published literature (Niederberger et al., 1997, Ruggiu et al., 
1997), when used in NBF fixed tissue.  
To further optimise this antibody, a titration was performed on mouse adult 
testes fixed in NBF. Figure A1.3 shows five different anti-DAZL antibody dilutions, 
ranging from 1/50 to 1/1000. Lower dilutions (1/50 and 1/100) detected Dazl in the 
cytoplasm of round spermatids, a pattern that does not agree with the published 
literature. Both the 1/250 and 1/500 anti-DAZL dilution gave the expected pattern of 




Dazl expression (i.e. in the cytoplasm of spermatogonia, early and pachytene 
spermatocytes). The higher dilution of 1/1000 detected Dazl more weakly. Positive 
immunostainingwas observed in the Leydig cells even in the absence of primary 
antibody. Since, the Serotec anti-Dazl antibody is a mouse monoclonal some degree 
of non-specific immunostaining in mouse tissues was expected due to the presence of 
endogenous mouse immunoglobulins (IgG) that can be recognised by the secondary 
antibody. Therefore, a mouse on mouse block (Vector #BMK-2202) containing an 
affinity purified anti-mouse IgG was used to try to reduce the background signal by 
blocking endogenous IgG, but without success (data not shown). Fortunately, the 
Leydig cells lie outside the seminiferous tubules which contain the germ cells.  
Throughout this project Dazl expression was assessed on NBF fixed tissue 
using the Serotec antibody at a 1/250 dilution.  
 
A1.1.2 Everest 
A newly available anti-DAZL antibody (Everest #EB06857) raised in goat 
was tested for Dazl specificity in mouse testes to establish whether it could be used 
for PLA. This antibody was raised against a C-terminal peptide of hDAZL that is 
conserved in mouse Dazl (mDazl) but not Boule (mBoll) (Figure A1.4). Specificity 




Everest  GNGPQKKSVDR 
hDAZL    GNGPQKKSVDR 
mDazl    GNGPQKKSVDR 
mBoll    ETSVPEPYSDH 
 
 Figure A1.4 - Everest anti-DAZL antibody. Sequence 
homology between the human DAZL (hDAZL) peptide (shown in 
blue) used to raise the Everest anti-DAZL antibody and mouse 
Dazl (mDazl) and Boule (mBoll). Green - amino-acids matching 
the peptide; Red – mismatched amino-acids. 
 




This antibody detected Dazl in spermatogonia and spermatocytes located in 
the more peripheral regions of the seminiferous tubules, as previously shown with 
the Serotec anti-DAZL antibody. However, it also cross-reacted with non-specific 
epitopes present in the cytoplasm of elongated spermatids (Figure A1.5): previously 
published RNA and protein expression data (Niederberger et al., 1997, Ruggiu et al., 
1997), together with findings described earlier in this appendix , show that Dazl is 
not present in these cells. This pattern was not observed in the absence of primary 
antibody (Figure A1.5). These results indicate that the new anti-DAZL antibody from 
Everest is not specific for Dazl and is therefore unsuitable for use in the PLA. 
 
Figure A1.5 - Testing a new Everest anti-DAZL antibody. IHC using the anti-
DAZL antibody from Everest Biotech #EB06857 in wild-type and DAZL-KO 
mouse testes at two different antibody concentrations with DAB detection. Anti-





























A2.1 PABP1 antibody validation for IHC 
 
MARSHALL   AQKAVNSATGVPTV 
mPabp1     AQKAVNSATGVPTV 





mePabp     DRN----------- 
 
VINPY      PVINPYQPAPPSGY 
mPabp1     PVINPYQPAPPSGY 





mePabp     PVLSSFQQPT-SYL 
 
Figure A2.1 - Peptide homology corresponding to sequence within the 
C terminal domain of mouse Pabp1 used to raise the Marshall and 
VINPY anti-PABP1 antibodies. Blue - sequence used to raise the antibody; 
Green - amino-acids matching the peptide; Red - amino-acid not matching 
the peptide. mPabp1 – mouse Pabp1; mtPabp – mouse tPabp; mPabp4.001-
004 – mouse Pabp4 isoforms 1 to 4; mePabp – mouse ePabp.  
 
Previous literature describing the presence of PABPs in male germ cells did 
not discern between different PABP family members (Kleene et al., 1994). Thus, in 
order to characterize Pabp1 expression two new antibodies were raised against C-
terminal peptides: Marshall (AQKAVNSATGVPTV) and VINPY 
(PVINPYQPAPPSGY) in mouse Pabp1 that were not well conserved in different 
PABP family members (Figure A2.1). tPabp shares the highest degree of homology 
with these peptides due to its relatively high degree of conservation with Pabp1. 
Other potentially immunogenic peptides showing less conservation with tPabp were 
not identified during the original epitope selection.  
 




































Figure A2.2 - Anti-PABP1 antibodies validation in adult mouse testes. 
Validation of anti-PABP1 antibodies in adult mouse testes fixed in 4%NBF or 
Bouin’s, at two different dilutions; 1/500 and 1/1000. Negative control preformed 












The efficacy and specificity of the antibodies was assessed using two 
dilutions in both Bouin’s and 4% NBF-fixed adult mouse testes (Figure A2.2), for 
which Pabp1 mRNA expression data is available (Kleene et al., 1994). Bouin’s fixed 
tissue showed a peak of expression in round and elongating spermatids. The pattern 
obtained from testes fixed with NBF was more difficult to interpret, due to the poor 
morphology of the tissue. Further titration of these antibodies over a greater 
concentration range (1/500-1/5000) was therefore performed on Bouin’s fixed tissue 
(Figure A2.3). This showed that the lowest dilution (1/500) appeared to produce 
some non-specific immunostaining since both antibodies detected proteins in early 
stage germ cells which do not contain PABP1 mRNA (Kleene et al., 1994). This 
non-specific signal was also observed for Marshall using 1/1000 and 1/2500 dilutions 
but not 1/5000. At this dilution the Marshall anti-PABP1 antibody detects PABP1 in 
the pachytene spermatocytes through elongating spermatids signal, agreeing with the 
onset of PABP1 mRNA expression (Kleene et al., 1994). This expression pattern was 
also observed at a 1/1000 dilution of the VINPY antibody, although further dilution 
of this antibody gave an increasing weak and diffuse signal. In the absence of 
primary antibody, or in the presence of rabbit IgG or normal rabbit serum (Ross 
Anderson; Figure A2.4), no signal was observed in any cells within or outside the 
seminiferous tubules. Since both antibodies (at different dilutions) give the same 
expression pattern, which is supported by the published RNA data (Kleene et al., 
1994, Kimura et al., 2009), this suggests that both antibodies can be used for IHC 
(Marshall: 1/5000 dilution [0.025 ng/μl] and VINPY: 1/1000 dilution [0.06 ng/μl]). 
Since the specificity of the Marshall anti-PABP1 antibody was further supported by 
western blotting and immunofluroescence following PABP1 knockdown in cultured 










Figure A2.3 - Titration of PABP1 antibodies in IHC using mouse testes. Four 
dilutions (1/500 to 1/5000) of anti-PABP1 antibodies were applied to mouse testes in 
normal goat serum. Neg - no primary antibody. eSc – early spermatocytes; pSc – 













Figure A2.4 - Additional controls further support the specificity of the 
Marshall anti-PABP1 antibody. Sections of adult mouse testes were 
immunostained using a – Marshall anti-PABP1 antibody; b –rabbit IgG; c - 





































A3.1 Optimising HeLa cell transfection  
 
Figure A3.1 - Optimisation of HeLa cell transfection with Lipofectamine 
2000™. 6 well plates were seeded with 1.8 x 104/cm2 of HeLa cells and incubated 
for 24 hours followed by transfection with different ratios between pEGFP-C1 
plasmid DNA (2 μg): Lipofectamine 2000™(1-0 μl). No DNA (0:2) and no 
transfection reagent (2:0) controls are shown. 
 
The transfection protocol was optimised using a plasmid expressing green 
fluorescent protein, pEGFP-C1, and different volumes of transfection reagent 
(Lipofectamine 2000™). Transfection efficiency was assessed 24 hours post–
transfection using an axiovert 200 inverted microscope to identify GFP-expressing 
cells (Figure A3.1). For transfection of a sub-confluent 6-well plate well of HeLa 
cells with 2ug plasmid DNA, the best transfection efficiency was obtained using 10 
μl Lipofectamine 2000™, with over 80% of the cells expressing GFP. No GFP 
expression was observed in the negative controls (no DNA or no transfection 
reagent) showing this was not due to autofluorescence. Higher cell density was 
observed in the absence of transfection reagent indicating a degree of toxicity 






































A4.1 Anti-PABP4 antibodies validation in HeLa 
cell extracts  
The specificity of an Abnova anti-PABP4 antibody (# H000087610D1P) and 
a Bethyl labs antibody (#IHC-00561) was assessed by siRNAs in HeLa cells. The 
Abnova antibody detected a protein of around 90 kDa, larger than the predicted 
molecular weight (70 kDa), and the protein detected by the in house anti-PABP4 
antibody (Figure A4.1). This larger protein was not diminished by PABP4 
knockdown showing that this antibody is not specific for PABP4. Conversely, the 
Bethyl lab antibody recognised a protein of the expected size that was absent 
following PABP4 but not PABP1 knockdown providing evidence that it specifically 
recognised PABP4.  
 
 
Figure A4.1 - An anti-PABP4 antibody from Abnova is not specific for 
PABP4 in HeLa cells. HeLa cells were transfected with 5 nM of siPABP1 
(siP1), siPABP4 (siP4) or mock transfected and incubated for 48 hours prior to 
western blotting with the in house PABP4 antibody (left hand panel) or the 
Abnova antibody (right hand panel) and GAPDH which served as a loading 
control..  
 






Figure A4.2 - A Bethyl labs anti-PABP4 antibody specifically detects 
PABP4 in HeLa cells. HeLa cells were transfected with 5 nM of siPABP1 
(siP1), siPABP4 (siP4) or were mock transfected and incubated for 48 hours 
prior to Western blotting for PABP4. GAPDH served as a loading control.  
 
 
A4.2 Bethyl anti-PABP4 Anti-PABP4 #IHC-00561 
antibody validation for IHC  
To determine if this antibody would replicate the Pabp4 expression pattern 
observed with the in house antibody, IHC was performed using adult mouse testis 
(Figure A4.3). This showed robust expression of Pabp4 in the cytoplasm of 
spermatogonia (Sg), early spermatocytes (eSc), and Sertoli cells (S) and also within 
Leydig cells (L). The pattern obtained with this antibody is highly reminiscent of the 
results described with the in house anti-PABP4 antibody described in Chapter 4 













Figure A4.3 - IHC using the Bethyl anti-PABP4 #IHC-00561 antibody in 
mouse adult testes. IHC with DAB detection using the Bethyl anti-PABP4 
antibody (1/150) in adult mouse testes. Inset shows a negative control 
performed with rabbit IgG. L – Leydig cell; S – Serolti cell; Sg – 
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